JAX Mouse Strain Datasheet - 000696

BKS.Cg-Lep^ob/J

Stock No:: 000696

Congenic

Cryo Recovery

Overview

Genetic overview

Genetic Background	Generation
000662 C57BLKS/J

Lep^ob

Allele Type	Gene Symbol	Gene Name
Spontaneous (Null/Knockout)	Lep	leptin

View Genetics

Research Applications

Diabetes and Obesity Research
Internal/Organ Research
Endocrine Deficiency Research
Immunology, Inflammation and Autoimmunity Research
Metabolism Research
Reproductive Biology Research

View All Research Applications

Base Price

Starting at:

$2,595.00 Domestic price Cryo Recovery

View Price List

Details

Detailed Description

Mice homozygous for the obese spontaneous mutation (Lep^ob, commonly referred to as ob or ob/ob) are first recognizable at about 4 weeks old. Homozygous mutant mice increase in weight rapidly and may reach three times the normal weight of wildtype controls. In addition to obesity, mutant mice exhibit hyperphagia; a diabetes-like syndrome of hyperglycemia, glucose intolerance, and elevated plasma insulin; subfertility; and increased hormone production from both pituitary and adrenal. They are also hypometabolic and hypothermic. The obesity is characterized by both an increased number and size of adipocytes. Although hyperphagia contributes to the obesity, homozygotes gain excess weight and deposit excess fat even when restricted to a diet sufficient for normal weight maintenance in lean mice. Hyperinsulinemia does not develop until after the increase body weight and is probably the result of it. Homozygotes do have an abnormally low threshold for stimulation of pancreatic islet insulin secretion even in very young preobese animals. As is the case with the diabetes mutant (Lep^db), manifestation of the diabetic syndrome is strikingly dependent on genetic background. On the C57BLKS background Lep^ob/Lep^obhomozygotes become severely diabetic with regression of islets and early death. Cloning of the Lep gene has made possible the production of recombinant leptin. Injection of this protein into Lep^ob/Lep^ob homozygotes sharply reduced body weight, decreased food intake, and increased energy expenditure.

Control Suggestions

Untyped from the colony
000662 C57BLKS/J

Additional Information

Considerations for Choosing Controls

Selected References

Ewart-Toland A; Mounzih K; Qiu J; Chehab FF. 1999. Effect of the genetic background on the reproduction of leptin-deficient obese mice. Endocrinology 140(2):732-8. PubMed: 9927300 MGI: J:52903
Malik NM; Carter ND; Murray JF; Scaramuzzi RJ; Wilson CA; Stock MJ. 2001. Leptin requirement for conception, implantation, and gestation in the mouse. Endocrinology 142(12):5198-202. PubMed: 11713215 MGI: J:94783
Oler AT; Attie AD. 2008. A rapid, microplate SNP genotype assay for the leptinob allele. J Lipid Res 49(5):1126-9. PubMed: 18272929 MGI: J:133040

View All References

Genetics

Lep^ob

Allele Symbol: Lep^ob

Allele Name	obese
Allele Type	Spontaneous (Null/Knockout)
Allele Synonym(s)	ob; ob/ob
Gene Symbol and Name	Lep, leptin
Gene Synonym(s)	LEPD; OB; OBS; ob; obese; obese
Strain of Origin	STOCK Mlph a Tgfa Cdh23 Ednrb
Chromosome	6
Molecular Note	Sequencing of RT-PCR products revealed a nonsense mutation in codon 105 resulting from a C to T point mutation. The 16 kDa leptin protein, expressed predominantly in adipose tissue of normal mice, is missing from homozygous mutant mice (J:29081).

Disease/Phenotype

Disease Terms

Research Areas By Genotype

This mouse can be used to support research in many areas including:

Diabetes and Obesity Research
- Hyperglycemia
- Type 2 Diabetes (NIDDM)
Internal/Organ Research
- Wound Healing
  - delayed/impaired

Genotype: Lep^ob related

Diabetes and Obesity Research
- Hyperinsulinemia
- Impaired Wound Healing
- Insulin Resistance
- Obesity With Diabetes
Endocrine Deficiency Research
- Adipose Defects
- Hypothalamus/Pituitary Defects
- Pancreas Defects
Immunology, Inflammation and Autoimmunity Research
- Immunodeficiency Associated with Other Defects
Internal/Organ Research
- Adipose Defects
Metabolism Research
Reproductive Biology Research
- Fertility Defects

Mammalian Phenotype Terms by Genotype

Genotype: Lep^ob/Lep^ob
BKS.Cg-Lep^ob/J

mortality/aging

premature death

growth/size/body region phenotype

increased growth rate
- mice reach 45-55 g by 3-4 months of age
- slowly lose weight from 4 months on

homeostasis/metabolism phenotype

abnormal circulating cholesterol level

abnormal circulating glucose level

hyperglycemia
- blood sugar continues to rise
- blood sugar never returns to control levels
- stabilizes at around 400-500 mg/100 ml

increased circulating HDL cholesterol level

increased circulating LDL cholesterol level

increased circulating VLDL cholesterol level

increased circulating cholesterol level
- fasting plasma total cholesterol concentration is increased 2-3 fold over controls

increased circulating insulin level
- insulin levels increase only through the first 2 months
- levels drop back to normal

increased circulating triglyceride level
- triglyceride levels are elevated 1.5- to 2-fold

increased urine glucose level

endocrine/exocrine gland phenotype

abnormal pancreatic beta cell physiology
- Background Sensitivity - more beta cell degranulation than seen on the 'B6' background

small pancreatic islets
- after 2 months, islets become smaller and atrophic

renal/urinary system phenotype

increased urine glucose level

polyuria

The following phenotype information is associated with a similar, but not exact match to this JAX^® Mice strain

Genotype: Lep^ob/Lep⁺
involves: C57BL/6J

skeleton phenotype

increased bone mass
- increased bone mass even on a low fat diet to delay obesity

Genotype: Lep^ob/Lep⁺
involves: 129X1/SvJ * C57BL/6

liver/biliary system phenotype

increased liver weight
- mice show significant increase in relative and absolute hepatic weight compared to wild-type; otherwise, no differences from wild-type are noted

Genotype: Lep^ob/Lep^ob
B6.Cg-Lep^ob/J

growth/size/body region phenotype

abnormal body weight
- body weight reduced by treatment with Leptin
- treatment with triiodothyronine significantly reduces body weight relative to the reduction seen in controls

increased body weight

increased growth rate
- mice reach 60-70 g by 10 months of age

obese
- 12-week old males are obese
- develop progressive obesity

renal/urinary system phenotype

abnormal urine catecholamine level
- less epinephrine in the urine of ad libitum fed mice
- males show elevated levels of dopamine in urine
- urine levels of norepinephrine only slightly elevated

abnormal urine homeostasis
- males show elevated levels of serotonin and 5'hydroxyindolineacetic acid in urine

immune system phenotype

decreased NK cell number
- reduced numbers can be restored by treatment with leptin

lung inflammation
- ozone induces a nonsignificant elevation of TNFR2 levels
- ozone induces significantly elevated levels of TNFR1

neoplasm

increased metastatic potential
- increased metastasis to the lung of both melanoma cell lines and lung cancer cell lines initially injected in the tail vein
- leptin reduces the level of metastasis

hematopoietic system phenotype

decreased NK cell number
- reduced numbers can be restored by treatment with leptin

nervous system phenotype

abnormal sympathetic nervous system physiology

liver/biliary system phenotype

abnormal liver weight
- treatment with triiodothyronine significantly reduces relative and absolute liver weight

integument phenotype

abnormal pain threshold

allodynia
- epineural application of leptin treated peritoneal macrophage induces tactile allodynia
- resistant to tactile allodynia caused by partial sciatic nerve ligation

hyperalgesia
- display thermal hyperalgesia after partial sciatic nerve ligation

skeleton phenotype

abnormal bone marrow morphology
- bone marrow is almost completely replaced with mature adipocytes

homeostasis/metabolism phenotype

abnormal circulating cholesterol level

abnormal circulating glucose level

abnormal oxygen consumption
- increased by treatment with triiodothyronine
- insulin stimulated oxygen consumption by the soleus muscle is little affected by triiodothyronine
- oxygen consumption about 2/3 that observed in controls

abnormal protein level
- total body protein increased by treatment with triiodothyronine
- total body protein lower than in controls

abnormal urine catecholamine level
- less epinephrine in the urine of ad libitum fed mice
- males show elevated levels of dopamine in urine
- urine levels of norepinephrine only slightly elevated

abnormal urine homeostasis
- males show elevated levels of serotonin and 5'hydroxyindolineacetic acid in urine

decreased body temperature
- body temperature is maintained a basal level when the ambient temperature is gradually reduced to 4C

decreased circulating glucose level
- 4 weeks' treatment with Adipor2-ASO (antisense oligonucleotide) significantly reduces plasma glucose levels in fed mice
- after feeding, serum glucose levels are more than 30% lower than in wild-type mice
- when treated with AdipoR2-ASO, mice exhibit a decrease in plasma glucose level

decreased insulin secretion
- leptin-treated islet cells exhibit decreased insulin secretion compared to similarly treated wild-type islets

decreased oxygen consumption
- in the epididymal and brown fat pads

hyperglycemia
- Background Sensitivity - blood glucose levels are lower than obese mice on the BTBR background
- Background Sensitivity - homozygotes exhibit a mild, transient hyperglycemia between 10-14 weeks of age as compared to the severe, progressive hyperglycemia observed on the BTBR background
- blood sugar peaks at 2-3 months
- males exhibit elevated blood glucose levels (254.4 +/-33.7 mg/dl) as compared to wild-type between 20-22 weeks of age
- mice infrequently transition to severe hyperglycemia
- returns to normal by 4-5 months of age
- serum glucose is 320 mg/dl compared to 134 mg/dl in wild-type controls
- transient hyperglycemia

hypoglycemia
- older mice are usually hypoglycemic

impaired glucose tolerance
- following an acute intraperitoneal glucose injection, the post-challenge glucose level remained elevated up to 120 min compared to controls, indicating glucose intolerance
- glucose intolerance which improved when treated with rosiglitazone

increased circulating HDL cholesterol level

increased circulating LDL cholesterol level

increased circulating VLDL cholesterol level

increased circulating cholesterol level
- fasting plasma total cholesterol concentration is increased 2-3 fold over controls

increased circulating insulin level
- at 2 weeks, insulin levels are increased 2.5-fold compared to in wild-type mice
- however, mice treated with isoproterenol exhibit lowered serum levels of insulin
- insulin levels increase rapidly to over 50X normal controls
- seen in 12-week old males
- serum insulin is 41.5 ng/ml compared to 0.8 ng/ml in wild-type

increased circulating triglyceride level
- seen in 12-week old males
- triglyceride levels are elevated 1.5- to 2-fold

increased insulin secretion
- insulin content in the pancreata is increased compared to in wild-type mice

increased oxygen consumption
- in the liver

insulin resistance

cardiovascular system phenotype

abnormal myocardial fiber morphology
- cardiomyocytes exhibit a significantly enlarged cross-sectional area
- exhibit extensive focal damage in myocardial tissue, showing an abundance of lipid droplets in myocytes and damaged mitochondria that are swelled, have disorganized cristae and show loss of integrity
- exhibit myocyte hypertrophy, with increased myocyte diameter and distorted nuclear architecture

abnormal myocardial fiber physiology
- cardiomyocytes exhibit decreased peak shortening and maximal velocity of shortening/relengthening, prolonged time-to-90% relengthening, reduced intracellular calcium release upon electrical stimulus associated with a slowed intracellular calcium decay rate, and significantly higher oxygen levelse, and significantly higher oxygen levels

decreased cardiac muscle contractility
- cardiomyocytes exhibit a reduced contractile capacity
- decreased peak shortening
- elevated resting peak calcium ion concentration
- exhibit cardiac contractile dysfunction that is due to leptin deficiency and not obesity as high fat diet-induced obese controls show normal cardiomyocyte morphology and contractile function
- prolonged relengthening
- slowed intracellular calcium ion decay

enlarged myocardial fiber
- cardiomyocytes display larger resting cell length and cross-sectional area

heart left ventricle hypertrophy
- increase in left ventricle wall thickness and mass is seen by 6 months of age but not at 2 months of age
- induced weight loss via leptin infusion, but not via caloric restriction, partially resolves the hypertrophy

muscle phenotype

abnormal muscle morphology
- muscle protein content is reduced

abnormal myocardial fiber morphology
- cardiomyocytes exhibit a significantly enlarged cross-sectional area
- exhibit extensive focal damage in myocardial tissue, showing an abundance of lipid droplets in myocytes and damaged mitochondria that are swelled, have disorganized cristae and show loss of integrity
- exhibit myocyte hypertrophy, with increased myocyte diameter and distorted nuclear architecture

abnormal skeletal muscle fiber type ratio
- lower proportion of faster myosin heavy chain isoforms

decreased cardiac muscle contractility
- cardiomyocytes exhibit a reduced contractile capacity
- decreased peak shortening
- elevated resting peak calcium ion concentration
- exhibit cardiac contractile dysfunction that is due to leptin deficiency and not obesity as high fat diet-induced obese controls show normal cardiomyocyte morphology and contractile function
- prolonged relengthening
- slowed intracellular calcium ion decay

decreased skeletal muscle fiber size
- cross-sectional area of muscle fibers is generally smaller

decreased skeletal muscle mass
- mean muscle mass consistently less than controls but magnitude of difference is muscle specific

enlarged myocardial fiber
- cardiomyocytes display larger resting cell length and cross-sectional area

adipose tissue phenotype

abnormal epididymal fat pad morphology
- adipocyte size remains larger after treatment with triiodothyronine relative to controls
- treatment with triiodothyronine significantly reduces epididymal fat pad weight relative to the degree of reduction seen in controls

decreased white fat cell number
- treatment with triiodothyronine reduces adipocyte numbers
- treatment with triiodothyronine significantly reduces adipocyte numbers relative to the degree of reduction seen in controls

increased fat cell size

increased interscapular fat pad weight
- affected less by treatment with triiodothyronine than controls
- brown adipocyte numbers are normal
- greater weight than for controls

increased percent body fat/body weight
- mice have fat mass of ~42 g compared to ~3 g in wild-type at 16 weeks

behavior/neurological phenotype

abnormal food intake

abnormal frequency of paradoxical sleep
- increased REM in dark phase
- reduced REM in light phase

abnormal pain threshold

abnormal sleep pattern
- additional sleep primarily in the dark phase
- increased non-REM sleep time
- increased total sleep time in a 24 hour period
- recovery from sleep deprivation involves increased duration of non-REM bouts rather than increased number of bouts as seen in controls

allodynia
- epineural application of leptin treated peritoneal macrophage induces tactile allodynia
- resistant to tactile allodynia caused by partial sciatic nerve ligation

decreased food intake
- food intake is reduced by Leptin treatment

fragmentation of sleep/wake states
- more arousals
- shorter wake periods
- sleep more fragmented

hyperalgesia
- display thermal hyperalgesia after partial sciatic nerve ligation

hypoactivity
- less wheel running activity
- more wheel running activity in light phase and less in dark phase
- significantly reduced activity relative to wild-type controls

increased food intake
- increased food intake when ambient temperature drops from 28 to 21C

polyphagia
- mice eat 70% more than wild-type controls

reproductive system phenotype

female infertility
- females do not produce litters

respiratory system phenotype

lung inflammation
- ozone induces a nonsignificant elevation of TNFR2 levels
- ozone induces significantly elevated levels of TNFR1

endocrine/exocrine gland phenotype

abnormal pancreatic beta cell physiology
- Background Sensitivity - less beta cell degranulation than seen on the "BKS" background

decreased insulin secretion
- leptin-treated islet cells exhibit decreased insulin secretion compared to similarly treated wild-type islets

enlarged pancreatic islets

increased insulin secretion
- insulin content in the pancreata is increased compared to in wild-type mice

Genotype: Lep^ob/Lep^ob
B6.Cg-Lep^ob/JRj

cellular phenotype

abnormal cell cycle
- hepatocytes accumulate in G2 phase in cultures at 60 hours after plating indicating a G2/M arrest
- hepatocytes accumulate in S phase at late time points during culture compared to control hepatocytes which exit S phase
- treatment with the antioxidant NAC reduces accumulation of BrdU at 60 hours after plating, indicating normal progression through the cell cycle

oxidative stress
- long-term administration of NAC alleviates oxidative stress in the liver parenchyma
- markers of oxidative stress are detectable in hepatocytes both in vitro and in vivo
- treatment with the antioxidant NAC impairs the accumulation of ROS with no impact on cell viability

liver/biliary system phenotype

abnormal hepatocyte physiology
- binuclear fraction of hepatocytes is lower in the liver parenchyma
- liver contains highly polyploid mononuclear hepatocytes which are infrequently seen in wild-type liver
- livers are enriched in hepatocytes with high DNA content compared to controls
- the mononuclear diploid (2n) hepatocyte population is lower in the mutant liver than in wild-type liver while mononuclear tetraploid hepatocytes are enriched in the mutant liver
- treatment with the antioxidant NAC restores a normal ploidy profile in mutant cultures

Genotype: Lep^ob/Lep^ob
B6.Cg-Lep^ob/OlaHsd

digestive/alimentary phenotype

abnormal digestive system physiology
- transepithelial resistance in the epithelium is reduced, indictive of a disrupted mucosal barrier function

abnormal intestinal epithelium morphology
- reduced levels of occludin in intestinal sections
- zonula occludens 1 has a discontinuous distribution

immune system phenotype

abnormal acute inflammation
- higher levels of endotoxin are found in portal blood (entotoxemia)

abnormal chemokine secretion
- increased release of monocyte chemo attractant protein by hepatic stellate cells

increased interleukin-6 secretion
- increased release by hepatic stellate cells

increased susceptibility to endotoxin shock
- increased succeptibility of hepatic stellate cells to LPS

liver inflammation

liver/biliary system phenotype

liver inflammation

Genotype: Lep^ob/Lep^ob
involves: 129/Sv * C57BL/6

homeostasis/metabolism phenotype

abnormal lipid level
- sphingomeylin and antioxidant ethanolamine plasmlogen are markedly decreased

increased circulating insulin level
- at 4 and 16 weeks of age

increased insulin secretion
- at 16 weeks of age

insulin resistance
- at 16 weeks

endocrine/exocrine gland phenotype

abnormal pancreatic islet morphology
- at 16 weeks, increased islet-to-pancreases volume ratios
- at 16 weeks, islet insulin content is 30-fold greater than in Pparg^tm1Avb Lep^ob homozygotes

enlarged pancreatic islets

increased insulin secretion
- at 16 weeks of age

increased pancreatic islet number

behavior/neurological phenotype

hypoactivity
- at 20 weeks, mice have decreased locomotor activity compared to wild-type

polyphagia
- hyperphagic

growth/size/body region phenotype

increased body weight
- mice quickly become heavier and have significantly elevated body weights at 4 and 6 weeks of age in females and males, respectively

adipose tissue phenotype

increased percent body fat/body weight
- 40% increase compared to wild-type at 20 weeks

liver/biliary system phenotype

hepatic steatosis

Genotype: Lep^ob/Lep^ob
BTBR.Cg-Lep^ob/WiscJ

cardiovascular system phenotype

cardiovascular system phenotype
- mice do not develop atherosclerosis

hypotension

growth/size/body region phenotype

increased body weight
- body weight is increased by 8 weeks of age as compared to heterozygotes and wild-type

homeostasis/metabolism phenotype

albuminuria
- albuminuria is detected as early as 8 weeks of age, progressing to a 10-fold difference by 20 weeks of age
- increased albumin creatinine ratio

hyperglycemia
- Background Sensitivity - blood glucose levels are higher than obese mice on the C57BL/6 background
- females progress to blood glucose levels of 333 +/- 46.3 mg/dl by 22 weeks of age
- hyperglycemia is more evident in males than females, but after a time delay, also occurs in females
- males progress to blood glucose levels of 399 +/- 38.8 mg/dl by 22 weeks of age
- mice exhibit hyperglycemia by 8 weeks of age

impaired glucose tolerance
- inability to clear plasma glucose following an overnight fast

increased blood urea nitrogen level
- increased BUN levels in both male and female mice

increased cholesterol level
- increased cholesterol levels in both male and female mice

increased circulating insulin level
- mice are hyperinsulinemic by 6 weeks of age but levels decrease as glucose levels rise

increased circulating triglyceride level
- increased serum triglyceride levels in both male and female mice

insulin resistance
- at 6 weeks of age, most females are insulin resistant; they are hyperinsulinemic while maintaining only moderately elevated glucose levels
- by 10 weeks of age, female mice are hyperglycemic while still maintaining high (but insufficient) levels of insulin
- by 14 weeks of age, many females have even lower plasma insulin and increasing plasma glucose levels
- males show a similar progression of insulin resistance as females but starting at an earlier age, showing high insulin and high glucose at 6 weeks of age

renal/urinary system phenotype

abnormal podocyte morphology
- reduced podocyte density
- reduced podocyte number

albuminuria
- albuminuria is detected as early as 8 weeks of age, progressing to a 10-fold difference by 20 weeks of age
- increased albumin creatinine ratio

enlarged kidney
- renal hypertrophy

expanded mesangial matrix
- renal lesions are characterized by increased glomerular mesangial matrix accumulation

glomerulosclerosis

increased kidney weight
- both sexes exhibit increased kidney weight as compared to wild-type
- kidney weight of males is increased compared to females

increased renal glomerulus basement membrane thickness
- glomerular basement membrane thickness is increased by 18% as compared to wild-type

mesangiolysis
- diffuse mesangial sclerosis
- mesangiolysis increases with age reaching 33.1% by 22 weeks of age
- mesangiolysis is observed in 8% of glomeruli 8 week old mice

renal glomerulus hypertrophy
- increased glomerular size

renal interstitial fibrosis
- focal and mild interstitial fibrosis is observed in 12 week old mice
- interstitial collagen accumulation is increased at 24 weeks of age as compared to wild-type

endocrine/exocrine gland phenotype

abnormal pancreatic islet morphology
- architecture of islets is disrupted, with many noninsulin staining cells in the central core
- whole pancreas insulin content is reduced by 75-80% compared to mutants on the C57BL/6 background

decreased pancreatic beta cell mass

small pancreatic islets
- many small islets that show poor insulin staining

Genotype: Lep^ob/Lep^ob
involves: STOCK Mlph^ln a Tgfa^wa1 Cdh23^v Ednrb^s

growth/size/body region phenotype

decreased body length
- expansive hind quarters
- first noticeable at 4-6 weeks of age
- short body
- square shape

increased body weight

increased growth rate
- begin to gain weight rapidly by 4-6 weeks of age
- weigh 75-90g at 10 months
- weigh twice as much as controls at 3 months of age

cardiovascular system phenotype

abnormal arteriole morphology
- basal arteriolar diameter is greater than controls
- potassium-ATP channel inhibition eliminates diameter difference from controls

abnormal vascular wound healing
- neointimal area increased by leptin injection or adenoviral leptin treatment
- reduced neointimal area relative to controls 4 weeks after femoral artery injury
- vascular smooth muscle proliferation significantly reduced

altered response to myocardial infarction
- mice exhibit a significant decline in cardiac function, and increase in apoptosis and necrosis, and elevated reactive oxygen species generation after myocardial ischemia/reperfusion injury

immune system phenotype

abnormal microglial cell physiology
- 30-40% as many activated microglia 5 days after kainic acid treatment as for controls
- migrate normally to injury sites but do not proliferate

decreased circulating tumor necrosis factor level
- 48% of control levels after kainate injection

limbs/digits/tail phenotype

short femur

short humerus

embryo phenotype

abnormal embryonic neuroepithelium morphology
- cell proliferation is lower at E14 and E16
- significantly fewer cells at E16 and E18 but not at E14

decreased embryonic neuroepithelium thickness
- thin at E18

hematopoietic system phenotype

abnormal microglial cell physiology
- 30-40% as many activated microglia 5 days after kainic acid treatment as for controls
- migrate normally to injury sites but do not proliferate

liver/biliary system phenotype

decreased liver triglyceride level
- lower level than wild-type after 36 hour fasting in 7-week-old mice.

decreased susceptibility to hepatic steatosis
- after 36 hour fasting in 7-week-old mice

increased liver triglyceride level
- double the control littermate's triglyceride level in 7 to 14 weeks old mice

behavior/neurological phenotype

polyphagia
- hyperphagia

homeostasis/metabolism phenotype

abnormal glucose homeostasis

abnormal hormone level
- increased beta endorphin levels
- increased levels of melanocyte stimulating hormone

abnormal vascular wound healing
- neointimal area increased by leptin injection or adenoviral leptin treatment
- reduced neointimal area relative to controls 4 weeks after femoral artery injury
- vascular smooth muscle proliferation significantly reduced

altered response to myocardial infarction
- mice exhibit a significant decline in cardiac function, and increase in apoptosis and necrosis, and elevated reactive oxygen species generation after myocardial ischemia/reperfusion injury

decreased body temperature
- mice have a lower basal body temperature than controls

decreased circulating tumor necrosis factor level
- 48% of control levels after kainate injection

decreased liver triglyceride level
- lower level than wild-type after 36 hour fasting in 7-week-old mice.

hyperglycemia
- transient hyperglycemia

impaired adaptive thermogenesis
- 60 minute exposure of 17 day old mice to 4C results in a marked drop in body temperature
- extreme cold susceptibility
- mice acclimated to 12C before exposure survive better to 4C exposure than un-acclimated controls
- mice moved directly to 4C from 21C become hypothermic and die

impaired glucose tolerance

increased adrenocorticotropin level
- increased pituitary ACTH

increased circulating insulin level

increased liver triglyceride level
- double the control littermate's triglyceride level in 7 to 14 weeks old mice

endocrine/exocrine gland phenotype

abnormal gland physiology

abnormal pancreatic beta cell morphology

decreased activity of thyroid

hypersecretion of corticosterone
- increased glucocorticoids from the adrenal

increased pancreatic beta cell mass
- increased size

increased pancreatic beta cell number

adipose tissue phenotype

abnormal fat cell morphology
- hyperplasia

increased fat cell size

skeleton phenotype

abnormal long bone epiphyseal plate morphology
- breakage at the chondro-osseous junction
- failure at a force of 4.9 Newtons as compared to 8.4 Newtons in controls
- less organized loose reticular distribution of collagen fibrils
- more fragile than controls
- reduced expression of "type-X" collagen

abnormal long bone epiphyseal plate proliferative zone
- column structure is disturbed
- poor alignment

abnormal long bone hypertrophic chondrocyte zone
- column structure is disturbed
- increased numbers of apoptotic chondrocytes
- mostly mineralized as compared to less than 50% mineralized in controls
- poor alignment

decreased bone mass
- reduced bone mass

decreased length of long bones

short femur

short humerus

reproductive system phenotype

female infertility
- homozygous females fail to ovulate

infertility

male infertility
- all older males are sterile

reduced male fertility
- only 20% of young males are fertile

nervous system phenotype

abnormal cortical plate morphology
- fewer cells in the cortical plate at E18

abnormal embryonic neuroepithelium morphology
- cell proliferation is lower at E14 and E16
- significantly fewer cells at E16 and E18 but not at E14

abnormal microglial cell physiology
- 30-40% as many activated microglia 5 days after kainic acid treatment as for controls
- migrate normally to injury sites but do not proliferate

decreased embryonic neuroepithelial cell proliferation
- cell proliferation is lower at E14 and E16

decreased embryonic neuroepithelium thickness
- thin at E18

Genotype: Lep^ob/Lep^ob
involves: 129X1/SvJ * C57BL/6

growth/size/body region phenotype

decreased lean body mass
- decreased (16.0 g, 33% of body weight) compared to wild-type (25.5 g 87% of body weight) or double mutants (19.8g)

increased body weight
- higher than wild-type

integument phenotype

abnormal branching of the mammary ductal tree
- in virgin females, no ductal development occurs

homeostasis/metabolism phenotype

abnormal circulating hormone level

abnormal circulating pancreatic peptide level
- plasma levels of pancreatic polypeptide (PP) are strongly reduced compared to wild-type

decreased circulating testosterone level
- level is markedly decreased compared to wild-type or Lep heterozygotes
- significantly lower (4.2 nmol/l) compared to wild-type (14.2 nmol/l)

hyperglycemia

increased circulating cholesterol level
- 5.74 mmol/l vs 3.54 mmol/l in wild-type

increased circulating corticosterone level
- mice display hypercorticosteronemia compared to wild-type
- mice display hypercorticosteronemia compared to wild-type, Npy2r^tm1.1Hhz homozygotes, or Npy2r, Lep double mutants

increased circulating insulin level
- hyperinsulinemic compared to wild-type
- level is significantly increased over wild-type

increased circulating leptin level
- level is significantly increased over wild-type

increased circulating triglyceride level
- 2.48 mmol/l vs 1.62 mmol/l in wild-type

endocrine/exocrine gland phenotype

abnormal branching of the mammary ductal tree
- in virgin females, no ductal development occurs

abnormal ovarian folliculogenesis
- ovaries have very few primary or secondary follicles

absent corpus luteum
- no corpora lutea develops properly in ovary

decreased seminal vesicle weight
- weight of gland is significantly lower than wild-type or heterozygotes

decreased testis weight
- testes weigh 0.19 g compared to 0.33 g in wild-type
- testis weight is significantly lower than in Lep^ob heterozygotes or Lep, Ppyr1 double null mice

increased pancreas weight
- 0.41 g vs 0.29 in wild-type

adipose tissue phenotype

abnormal adipose tissue amount
- combined white adipose tissue (WAT) mass is increased compared to wild-type

reproductive system phenotype

abnormal ovarian folliculogenesis
- ovaries have very few primary or secondary follicles

abnormal vagina orifice morphology
- vaginal opening is very small compared to wild-type

absent corpus luteum
- no corpora lutea develops properly in ovary

decreased seminal vesicle weight
- weight of gland is significantly lower than wild-type or heterozygotes

decreased testis weight
- testes weigh 0.19 g compared to 0.33 g in wild-type
- testis weight is significantly lower than in Lep^ob heterozygotes or Lep, Ppyr1 double null mice

female infertility
- homozygous females produce no litters

male infertility
- no males could produce offspring
- only one male tested was able to sire a litter

prolonged diestrus
- mice have diestrous-like swab until 9 weeks of age

prolonged estrous cycle
- beginning at 9 weeks of age, estrous cycles last 11-15 days

prolonged estrus
- beginning at 9 weeks of age, estrous-like cytology lasts 6-8 days

behavior/neurological phenotype

polyphagia

digestive/alimentary phenotype

abnormal intestine morphology
- mice display intestinal hypertrophy compared to wild-type mice (intestine weight - 1.89 g vs 1.03 g in wild-type; intestine length 43 cm vs 33 cm in wild-type)

liver/biliary system phenotype

increased liver weight
- 4.56 g vs 1.44 g in wild-type

renal/urinary system phenotype

increased kidney weight
- 0.54 g vs 0.41 g in wild-type

Genotype: Lep^ob/Lep^ob
involves: BTBR * C57BL/6 * V stock

endocrine/exocrine gland phenotype

decreased pancreatic beta cell number
- severely diabetic mice exhibit reduced numbers of beta cells

disorganized pancreatic islets
- moderate to severely diabetic F2 mice have no hyperplasia, but exhibit cellular disorganization and fibrosis
- severely diabetic F2 mice exhibit concavities with acinar tissue intrusions

pancreatic islet hyperplasia
- mildly diabetic F2 mice exhibit large numbers of hyperplastic pancreatic islets

homeostasis/metabolism phenotype

hyperglycemia
- homozygotes exhibit a 7.5 fold range in fasting glucose (100-750 mg/dl)

increased circulating insulin level
- homozygotes exhibit a 50 fold range in fasting insulin (2.5-125 ng/ml)

Genotype: Lep^ob/Lep^ob
involves: C57BL/6J

liver/biliary system phenotype

hepatic steatosis

increased liver weight

cardiovascular system phenotype

abnormal cardiovascular system physiology
- attenuated heart response to increased calcium
- oxygen consumption is elevated when perfused with glucose and palmitate
- oxygen consumption of the heart does not increase with an increased workload

abnormal retinal vasculature morphology
- neovascularization is significantly suppressed under standard oxygen conditions relative to controls

increased heart weight
- heart weight elevated relative to controls

muscle phenotype

abnormal muscle contractility
- basal calcium ion concentration increases sharply toward the end of a series of 50 tetanic contractions (single cell measures)
- number of tetani required to reduce force by 40% is significantly less than for controls

vision/eye phenotype

abnormal retinal vasculature morphology
- neovascularization is significantly suppressed under standard oxygen conditions relative to controls

nervous system phenotype

decreased nerve conduction velocity
- 16% lower motor nerve conduction velocity than controls
- hind limb sensory nerve conduction velocity reduced 22%

behavior/neurological phenotype

abnormal behavior
- faster in food finding trials relative to controls

hypoactivity

increased thermal nociceptive threshold
- 88% increased latency of hind-limb withdrawal from a heat stimulus

polyphagia
- mice eat twice as much as wild-type mice

immune system phenotype

abnormal osteoclast differentiation
- increased numbers of osteoclasts

cellular phenotype

abnormal osteoclast differentiation
- increased numbers of osteoclasts

abnormal respiratory electron transport chain
- increased ADP dependent mitochondrial respiration in glucose and palmitate perfused hearts
- mitochondrial respiration is inhibited in glucose perfused hearts
- mitochondrial respiration is uncoupled in glucose and palmitate perfused hearts

integument phenotype

abnormal epidermal layer morphology
- significant reduction in intraepidermal nerve fiber density

increased thermal nociceptive threshold
- 88% increased latency of hind-limb withdrawal from a heat stimulus

growth/size/body region phenotype

abnormal postnatal growth
- pair fed mice gain considerably more weight as fat than controls eating the same quantity of food
- pair fed mice gain less weight as protein than when feeding is unrestricted
- pair fed mice gain less weight than when feeding is unrestricted
- pair fed mice restrict food intake to that of controls

increased body length

increased lean body mass
- increase in lean mass at 8 and 16 weeks of age

obese
- increase in weight gain in a short period of time

endocrine/exocrine gland phenotype

abnormal colon goblet cell morphology
- increased number of mucus filled goblet cells in the colon

abnormal insulin secretion
- acetyl choline has a greater affect to lower the glucose induced threshold for insulin secretion
- lower threshold for glucose induced insulin secretion by beta cells

enlarged pancreatic islets
- increase in the size of islets of Langerhans and appearance of enormous islets in the pancreas of 30 week old mice

mortality/aging

postnatal lethality, incomplete penetrance
- 50 % higher postnatal death rate of males

homeostasis/metabolism phenotype

abnormal corticosterone level
- corticosterone response to stress greater than in controls
- diurnal variation greater than in controls

abnormal glucose homeostasis

abnormal hormone level

abnormal insulin secretion
- acetyl choline has a greater affect to lower the glucose induced threshold for insulin secretion
- lower threshold for glucose induced insulin secretion by beta cells

hyperglycemia

impaired glucose tolerance
- observed prior to any significant increase in body weight

increased adrenocorticotropin level
- levels in the pituitary are much higher than in pituitaries of controls

increased circulating corticosterone level
- severe

increased circulating insulin level

increased fasted circulating glucose level
- fasting mice show increased glucose levels at 6 weeks of age

insulin resistance
- in the insulin tolerance test, mice reduce their glucose levels within 30 min to about 80% compared to 50% in wild-type mice at 6 weeks of age
- mice do not respond to insulin in the insulin tolerance test at 15 weeks of age, indicating insulin resistance

skeleton phenotype

abnormal osteoclast differentiation
- increased numbers of osteoclasts

abnormal skeleton development
- rate of new bone formation increased at both 3 and 6 months

increased bone mass
- denser vertebrae and long bones at 6 months
- increased bone mass even on a low fat diet to delay obesity

osteopetrosis
- 2 fold increase in trabecular bone volume
- increased numbers of thick trabeculae at 3 and 6 months

hematopoietic system phenotype

abnormal osteoclast differentiation
- increased numbers of osteoclasts

adipose tissue phenotype

increased fat cell size
- increase in area size of epigonadal fat cells

increased gonadal fat pad weight
- increase in epigonadal fat tissue weight

increased inguinal fat pad weight

increased interscapular fat pad weight

increased percent body fat/body weight
- increase in fat mass at 8 and 16 weeks of age

digestive/alimentary phenotype

abnormal colon goblet cell morphology
- increased number of mucus filled goblet cells in the colon

abnormal intestinal mucosa morphology
- thick mucus gel covers the epithelium of the colon

Genotype: Lep^ob/Lep^ob
BTBR.Cg-Lep^ob

homeostasis/metabolism phenotype

hyperglycemia
- Background Sensitivity - homozygotes exhibit severe, progressive hyperglycemia between 10-14 weeks of age as compared to the mild, transient hyperglycemia observed on the C57BL/6 background

Genotype: Lep^ob/Lep^ob
FVB.Cg-Lep^ob/Chua

homeostasis/metabolism phenotype

hyperglycemia
- mice are hyperglycemic like congenic FVB Lepr mice

increased circulating insulin level
- mice are hyperinsulinemic like congenic FVB Lepr^db mice

Genotype: Lep^ob/Lep^ob
involves: C57BL/6

homeostasis/metabolism phenotype

increased circulating HDL cholesterol level
- slightly elevated at 3 and 8 months of age

increased circulating cholesterol level
- seen at 3-4 months of age

increased circulating triglyceride level
- seen at 3-4 months of age

increased liver cholesterol level
- livers exhibit slightly, but significantly, higher levels of cholesterol

increased liver triglyceride level
- livers exhibit about 10x higher levels of triglyceride

liver/biliary system phenotype

increased liver cholesterol level
- livers exhibit slightly, but significantly, higher levels of cholesterol

increased liver triglyceride level
- livers exhibit about 10x higher levels of triglyceride

immune system phenotype

decreased CD4-positive, alpha beta T cell number

decreased T cell proliferation

decreased splenocyte number

hematopoietic system phenotype

decreased CD4-positive, alpha beta T cell number

decreased T cell proliferation

decreased splenocyte number

Genotype: Lep^ob/Lep^ob
B6.Cg-Lep^ob/JBomTac

homeostasis/metabolism phenotype

increased circulating triglyceride level
- 3-fold

Genotype: Lep^ob/Lep^ob
D2.Cg-Lep^ob/Chua

growth/size/body region phenotype

obese

homeostasis/metabolism phenotype

hyperglycemia
- at 3 months of age, males are hyperglycemic with blood glucose levels of ~574 mg/dl; females have levels of ~388 mg/dl

increased circulating insulin level
- some mutant DBA/2J mice have high insulin levels compared to controls

endocrine/exocrine gland phenotype

abnormal pancreatic islet morphology
- islets of mutants with low insulin levels are abnormal in appearance, being found in clusters of 1-4 cells, scattered within the ductal epithelium

decreased pancreatic beta cell number
- mutants with low insulin secretion have a low number of insulin-secreting cells compared to controls or high-insulin secreting mutants

increased pancreatic beta cell number
- there is a 5-fold increase in number of insulin-secreting cells per islet in obese mice with high insulin secretion

References

Ewart-Toland A; Mounzih K; Qiu J; Chehab FF. 1999. Effect of the genetic background on the reproduction of leptin-deficient obese mice. Endocrinology 140(2):732-8. PubMed: 9927300 MGI: J:52903
Malik NM; Carter ND; Murray JF; Scaramuzzi RJ; Wilson CA; Stock MJ. 2001. Leptin requirement for conception, implantation, and gestation in the mouse. Endocrinology 142(12):5198-202. PubMed: 11713215 MGI: J:94783
Oler AT; Attie AD. 2008. A rapid, microplate SNP genotype assay for the leptinob allele. J Lipid Res 49(5):1126-9. PubMed: 18272929 MGI: J:133040

Additional References

Campfield LA; Smith FJ; Guisez Y; Devos R; Burn P. 1995. Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks [see comments] Science 269(5223):546-9. PubMed: 7624778 MGI: J:29160
Charlton HM. 1984. Mouse mutants as models in endocrine research. Q J Exp Physiol 69(4):655-76. PubMed: 6393185 MGI: J:7702
Coleman DL. 1982. Thermogenesis in diabetes-obesity syndromes in mutant mice. Diabetologia 22(3):205-11. PubMed: 7075918 MGI: J:6756
Coleman DL. 1973. Effects of parabiosis of obese with diabetes and normal mice. Diabetologia 9(4):294-8. PubMed: 4767369 MGI: J:5401
Coleman DL; Hummel KP. 1973. The influence of genetic background on the expression of the obese (Ob) gene in the mouse. Diabetologia 9(4):287-93. PubMed: 4588246 MGI: J:5400
Erickson JC; Hollopeter G; Palmiter RD. 1996. Attenuation of the obesity syndrome of ob/ob mice by the loss of neuropeptide Y. Science 274(5293):1704-7. PubMed: 8939859 MGI: J:37106
Halaas JL; Gajiwala KS; Maffei M; Cohen SL; Chait BT; Rabinowitz D; Lallone RL; Burley SK; Friedman JM. 1995. Weight-reducing effects of the plasma protein encoded by the obese gene [see comments] Science 269(5223):543-6. PubMed: 7624777 MGI: J:29161
Haluzik M; Colombo C; Gavrilova O; Chua S; Wolf N; Chen M; Stannard B; Dietz KR; Le Roith D; Reitman ML. 2004. Genetic background (C57BL/6J versus FVB/N) strongly influences the severity of diabetes and insulin resistance in ob/ob mice. Endocrinology 145(7):3258-64. PubMed: 15059949 MGI: J:90742
Herberg L; Coleman DL. 1977. Laboratory animals exhibiting obesity and diabetes syndromes. Metabolism 26(1):59-99. PubMed: 834144 MGI: J:5759
Kaplan ML; Trout JR; Leveille GA. 1976. Adipocyte size distribution in ob/ob mice during preobese and obese phases of development. Proc Soc Exp Biol Med 153(3):476-82. PubMed: 1013161 MGI: J:5765
MacDougald OA; Hwang CS; Fan H; Lane MD. 1995. Regulated expression of the obese gene product (leptin) in white adipose tissue and 3T3-L1 adipocytes. Proc Natl Acad Sci U S A 92(20):9034-7. PubMed: 7568067 MGI: J:29081
Nishina PM; Lowe S; Wang J; Paigen B. 1994. Characterization of plasma lipids in genetically obese mice: the mutants obese, diabetes, fat, tubby, and lethal yellow. Metabolism 43(5):549-53. PubMed: 8177042 MGI: J:18161
Pelleymounter MA; Cullen MJ; Baker MB; Hecht R; Winters D; Boone T; Collins F. 1995. Effects of the obese gene product on body weight regulation in ob/ob mice [see comments] Science 269(5223):540-3. PubMed: 7624776 MGI: J:29162
Trayhurn P; James WP. 1978. Thermoregulation and non-shivering thermogenesis in the genetically obese (ob/ob) mouse. Pflugers Arch 373(2):189-93. PubMed: 565045 MGI: J:5958
Trayhurn P; Thurlby PL; James WP. 1977. Thermogenic defect in pre-obese ob/ob mice. Nature 266(5597):60-2. PubMed: 840297 MGI: J:12010
Zhang Y; Proenca R; Maffei M; Barone M; Leopold L; Friedman JM. 1994. Positional cloning of the mouse obese gene and its human homologue [published erratum appears in Nature 1995 Mar 30;374(6521):479] [see comments] Nature 372(6505):425-32. PubMed: 7984236 MGI: J:20512

Additional - Lep^ob related

Abdelkarim M; Caron S; Duhem C; Prawitt J; Dumont J; Lucas A; Bouchaert E; Briand O; Brozek J; Kuipers F; Fievet C; Cariou B; Staels B. 2010. The farnesoid X receptor regulates adipocyte differentiation and function by promoting peroxisome proliferator-activated receptor-gamma and interfering with the Wnt/beta-catenin pathways. J Biol Chem 285(47):36759-67. PubMed: 20851881 MGI: J:167021
Abe KC; Mori MA; Pesquero JB. 2007. Leptin deficiency leads to the regulation of kinin receptors expression in mice. Regul Pept 138(2-3):56-8. PubMed: 17184856 MGI: J:137078
Ablamunits V; Cohen Y; Brazee IB; Gaetz HP; Vinson C; Klebanov S. 2006. Susceptibility to Induced and Spontaneous Carcinogenesis Is Increased in Fatless A-ZIP/F-1 but not in Obese ob/ob Mice. Cancer Res 66(17):8897-902. PubMed: 16951207 MGI: J:112412
Agarwal AK; Tunison K; Dalal JS; Yen CL; Farese RV Jr; Horton JD; Garg A. 2016. Mogat1 deletion does not ameliorate hepatic steatosis in lipodystrophic (Agpat2-/-) or obese (ob/ob) mice. J Lipid Res 57(4):616-30. PubMed: 26880786 MGI: J:231617
Ahima RS; Prabakaran D; Flier JS. 1998. Postnatal leptin surge and regulation of circadian rhythm of leptin by feeding. Implications for energy homeostasis and neuroendocrine function. J Clin Invest 101(5):1020-7. PubMed: 9486972 MGI: J:118976
Ai D; Baez JM; Jiang H; Conlon DM; Hernandez-Ono A; Frank-Kamenetsky M; Milstein S; Fitzgerald K; Murphy AJ; Woo CW; Strong A; Ginsberg HN; Tabas I; Rader DJ; Tall AR. 2012. Activation of ER stress and mTORC1 suppresses hepatic sortilin-1 levels in obese mice. J Clin Invest 122(5):1677-87. PubMed: 22466652 MGI: J:184540
Ait-Omar A; Monteiro-Sepulveda M; Poitou C; Le Gall M; Cotillard A; Gilet J; Garbin K; Houllier A; Chateau D; Lacombe A; Veyrie N; Hugol D; Tordjman J; Magnan C; Serradas P; Clement K; Leturque A; Brot-Laroche E. 2011. GLUT2 accumulation in enterocyte apical and intracellular membranes: a study in morbidly obese human subjects and ob/ob and high fat-fed mice. Diabetes 60(10):2598-607. PubMed: 21852673 MGI: J:189265
Akasheh RT; Pini M; Pang J; Fantuzzi G. 2013. Increased adiposity in annexin A1-deficient mice. PLoS One 8(12):e82608. PubMed: 24312665 MGI: J:209746
Akpinar P; Kuwajima S; Krutzfeldt J; Stoffel M. 2005. Tmem27: a cleaved and shed plasma membrane protein that stimulates pancreatic beta cell proliferation. Cell Metab 2(6):385-97. PubMed: 16330324 MGI: J:129667
Alapatt P; Guo F; Komanetsky SM; Wang S; Cai J; Sargsyan A; Rodriguez Diaz E; Bacon BT; Aryal P; Graham TE. 2013. Liver retinol transporter and receptor for serum retinol-binding protein (RBP4). J Biol Chem 288(2):1250-65. PubMed: 23105095 MGI: J:210500
Albarado DC; McClaine J; Stephens JM; Mynatt RL; Ye J; Bannon AW; Richards WG; Butler AA. 2004. Impaired coordination of nutrient intake and substrate oxidation in melanocortin-4 receptor knockout mice. Endocrinology 145(1):243-52. PubMed: 14551222 MGI: J:96671
Alberts P; Nilsson C; Selen G; Engblom LO; Edling NH; Norling S; Klingstrom G; Larsson C; Forsgren M; Ashkzari M; Nilsson CE; Fiedler M; Bergqvist E; Ohman B; Bjorkstrand E; Abrahmsen LB. 2003. Selective inhibition of 11 beta-hydroxysteroid dehydrogenase type 1 improves hepatic insulin sensitivity in hyperglycemic mice strains. Endocrinology 144(11):4755-62. PubMed: 12960099 MGI: J:87239
Albiero M; Poncina N; Tjwa M; Ciciliot S; Menegazzo L; Ceolotto G; Vigili de Kreutzenberg S; Moura R; Giorgio M; Pelicci P; Avogaro A; Fadini GP. 2014. Diabetes causes bone marrow autonomic neuropathy and impairs stem cell mobilization via dysregulated p66Shc and Sirt1. Diabetes 63(4):1353-65. PubMed: 24270983 MGI: J:229061
Allen DL; Cleary AS; Speaker KJ; Lindsay SF; Uyenishi J; Reed JM; Madden MC; Mehan RS. 2008. Myostatin, activin receptor IIb, and follistatin-like-3 gene expression are altered in adipose tissue and skeletal muscle of obese mice. Am J Physiol Endocrinol Metab 294(5):E918-27. PubMed: 18334608 MGI: J:135996
Allison SJ; Baldock PA; Enriquez RF; Lin E; During M; Gardiner EM; Eisman JA; Sainsbury A; Herzog H. 2009. Critical interplay between neuropeptide Y and sex steroid pathways in bone and adipose tissue homeostasis. J Bone Miner Res 24(2):294-304. PubMed: 18847327 MGI: J:168527
Alon T; Friedman JM. 2006. Late-onset leanness in mice with targeted ablation of melanin concentrating hormone neurons. J Neurosci 26(2):389-97. PubMed: 16407534 MGI: J:104264
Altarejos JY; Goebel N; Conkright MD; Inoue H; Xie J; Arias CM; Sawchenko PE; Montminy M. 2008. The Creb1 coactivator Crtc1 is required for energy balance and fertility. Nat Med 14(10):1112-7. PubMed: 18758446 MGI: J:142448
Amano SU; Cohen JL; Vangala P; Tencerova M; Nicoloro SM; Yawe JC; Shen Y; Czech MP; Aouadi M. 2014. Local proliferation of macrophages contributes to obesity-associated adipose tissue inflammation. Cell Metab 19(1):162-71. PubMed: 24374218 MGI: J:210550
Anand A; Chada K. 2000. In vivo modulation of Hmgic reduces obesity. Nat Genet 24(4):377-80. PubMed: 10742101 MGI: J:61493
Ando H; Kumazaki M; Motosugi Y; Ushijima K; Maekawa T; Ishikawa E; Fujimura A. 2011. Impairment of peripheral circadian clocks precedes metabolic abnormalities in ob/ob mice. Endocrinology 152(4):1347-54. PubMed: 21285316 MGI: J:173868
Ando H; Ushijima K; Shimba S; Fujimura A. 2016. Daily Fasting Blood Glucose Rhythm in Male Mice: A Role of the Circadian Clock in the Liver. Endocrinology 157(2):463-9. PubMed: 26653333 MGI: J:233617
Aouadi M; Laurent K; Prot M; Le Marchand-Brustel Y; Binetruy B; Bost F. 2006. Inhibition of p38MAPK increases adipogenesis from embryonic to adult stages. Diabetes 55(2):281-9. PubMed: 16443758 MGI: J:106432
Aouadi M; Vangala P; Yawe JC; Tencerova M; Nicoloro SM; Cohen JL; Shen Y; Czech MP. 2014. Lipid storage by adipose tissue macrophages regulates systemic glucose tolerance. Am J Physiol Endocrinol Metab 307(4):E374-83. PubMed: 24986598 MGI: J:215463
Araujo TG; Oliveira AG; Carvalho BM; Guadagnini D; Protzek AO; Carvalheira JB; Boschero AC; Saad MJ. 2012. Hepatocyte growth factor plays a key role in insulin resistance-associated compensatory mechanisms. Endocrinology 153(12):5760-9. PubMed: 23024263 MGI: J:192374
Arble DM; Holland J; Ottaway N; Sorrell J; Pressler JW; Morano R; Woods SC; Seeley RJ; Herman JP; Sandoval DA; Perez-Tilve D. 2015. The melanocortin-4 receptor integrates circadian light cues and metabolism. Endocrinology 156(5):1685-91. PubMed: 25730108 MGI: J:222118
Arble DM; Vitaterna MH; Turek FW. 2011. Rhythmic leptin is required for weight gain from circadian desynchronized feeding in the mouse. PLoS One 6(9):e25079. PubMed: 21949859 MGI: J:177674
Ariyasu H; Takaya K; Hosoda H; Iwakura H; Ebihara K; Mori K; Ogawa Y; Hosoda K; Akamizu T; Kojima M; Kangawa K; Nakao K. 2002. Delayed short-term secretory regulation of ghrelin in obese animals: evidenced by a specific RIA for the active form of ghrelin. Endocrinology 143(9):3341-50. PubMed: 12193546 MGI: J:81463
Arteaga-Solis E; Zee T; Emala CW; Vinson C; Wess J; Karsenty G. 2013. Inhibition of leptin regulation of parasympathetic signaling as a cause of extreme body weight-associated asthma. Cell Metab 17(1):35-48. PubMed: 23312282 MGI: J:195073
Arvaniti K; Huang Q; Richard D. 2001. Effects of Leptin and Corticosterone on the Expression of Corticotropin-Releasing Hormone, Agouti-Related Protein, and Proopiomelanocortin in the Brain of ob/ob Mouse. Neuroendocrinology 73(4):227-36. PubMed: 11340336 MGI: J:69137
Asakawa A; Inui A; Ueno N; Makino S; Fujino MA; Kasuga M. 1999. Urocortin reduces food intake and gastric emptying in lean and ob/ob obese mice [see comments] Gastroenterology 116(6):1287-92. PubMed: 10348810 MGI: J:57224
Askari B; Wietecha T; Hudkins KL; Fox EJ; O'Brien KD; Kim J; Nguyen TQ; Alpers CE. 2014. Effects of CP-900691, a novel peroxisome proliferator-activated receptor alpha, agonist on diabetic nephropathy in the BTBR ob/ob mouse. Lab Invest 94(8):851-62. PubMed: 24955894 MGI: J:213864
Assini JM; Mulvihill EE; Burke AC; Sutherland BG; Telford DE; Chhoker SS; Sawyez CG; Drangova M; Adams AC; Kharitonenkov A; Pin CL; Huff MW. 2015. Naringenin prevents obesity, hepatic steatosis, and glucose intolerance in male mice independent of fibroblast growth factor 21. Endocrinology 156(6):2087-102. PubMed: 25774553 MGI: J:222169
Asterholm IW; McDonald J; Blanchard PG; Sinha M; Xiao Q; Mistry J; Rutkowski JM; Deshaies Y; Brekken RA; Scherer PE. 2012. Lack of "immunological fitness" during fasting in metabolically challenged animals. J Lipid Res 53(7):1254-67. PubMed: 22504909 MGI: J:186271
Atkinson RD; Coenen KR; Plummer MR; Gruen ML; Hasty AH. 2008. Macrophage-derived apolipoprotein E ameliorates dyslipidemia and atherosclerosis in obese apolipoprotein E-deficient mice. Am J Physiol Endocrinol Metab 294(2):E284-90. PubMed: 18029445 MGI: J:133332
Avall K; Ali Y; Leibiger IB; Leibiger B; Moede T; Paschen M; Dicker A; Dare E; Kohler M; Ilegems E; Abdulreda MH; Graham M; Crooke RM; Tay VS; Refai E; Nilsson SK; Jacob S; Selander L; Berggren PO; Juntti-Berggren L. 2015. Apolipoprotein CIII links islet insulin resistance to beta-cell failure in diabetes. Proc Natl Acad Sci U S A 112(20):E2611-9. PubMed: 25941406 MGI: J:221652
Babak T; Garrett-Engele P; Armour CD; Raymond CK; Keller MP; Chen R; Rohl CA; Johnson JM; Attie AD; Fraser HB; Schadt EE. 2010. Genetic validation of whole-transcriptome sequencing for mapping expression affected by cis-regulatory variation. BMC Genomics 11:473. PubMed: 20707912 MGI: J:163832
Back M; Sultan A; Ovchinnikova O; Hansson GK. 2007. 5-Lipoxygenase-activating protein: a potential link between innate and adaptive immunity in atherosclerosis and adipose tissue inflammation. Circ Res 100(7):946-9. PubMed: 17379835 MGI: J:133901
Badman MK; Kennedy AR; Adams AC; Pissios P; Maratos-Flier E. 2009. A Very Low Carbohydrate Ketogenic Diet Improves Glucose Tolerance in ob/ob Mice Independent of Weight Loss. Am J Physiol Endocrinol Metab :. PubMed: 19738035 MGI: J:159570
Baffy G; Zhang CY; Glickman JN; Lowell BB. 2002. Obesity-related fatty liver is unchanged in mice deficient for mitochondrial uncoupling protein 2. Hepatology 35(4):753-61. PubMed: 11915020 MGI: J:106023
Bailly-Maitre B; Belgardt BF; Jordan SD; Coornaert B; von Freyend MJ; Kleinridders A; Mauer J; Cuddy M; Kress CL; Willmes D; Essig M; Hampel B; Protzer U; Reed JC; Bruning JC. 2010. Hepatic Bax inhibitor-1 inhibits IRE1alpha and protects from obesity-associated insulin resistance and glucose intolerance. J Biol Chem 285(9):6198-207. PubMed: 19996103 MGI: J:159765
Baldock PA; Allison S; McDonald MM; Sainsbury A; Enriquez RF; Little DG; Eisman JA; Gardiner EM; Herzog H. 2006. Hypothalamic regulation of cortical bone mass: opposing activity of Y2 receptor and leptin pathways. J Bone Miner Res 21(10):1600-7. PubMed: 16995815 MGI: J:128105
Baldock PA; Sainsbury A; Allison S; Lin EJ; Couzens M; Boey D; Enriquez R; During M; Herzog H; Gardiner EM. 2005. Hypothalamic control of bone formation: distinct actions of leptin and y2 receptor pathways. J Bone Miner Res 20(10):1851-7. PubMed: 16160743 MGI: J:128137
Balland E; Dam J; Langlet F; Caron E; Steculorum S; Messina A; Rasika S; Falluel-Morel A; Anouar Y; Dehouck B; Trinquet E; Jockers R; Bouret SG; Prevot V. 2014. Hypothalamic tanycytes are an ERK-gated conduit for leptin into the brain. Cell Metab 19(2):293-301. PubMed: 24506870 MGI: J:210650
Bandsma RH; Grefhorst A; van Dijk TH; van der Sluijs FH; Hammer A; Reijngoud DJ; Kuipers F. 2004. Enhanced glucose cycling and suppressed de novo synthesis of glucose-6-phosphate result in a net unchanged hepatic glucose output in ob/ob mice. Diabetologia 47(11):2022-31. PubMed: 15599701 MGI: J:107197
Bandyopadhyay GK; Vu CU; Gentile S; Lee H; Biswas N; Chi NW; O'Connor DT; Mahata SK. 2012. Catestatin (chromogranin A(352-372)) and novel effects on mobilization of fat from adipose tissue through regulation of adrenergic and leptin signaling. J Biol Chem 287(27):23141-51. PubMed: 22535963 MGI: J:188389
Banerjee SK; McGaffin KR; Pastor-Soler NM; Ahmad F. 2009. SGLT1 is a novel cardiac glucose transporter that is perturbed in disease states. Cardiovasc Res 84(1):111-8. PubMed: 19509029 MGI: J:172485
Banks AS; McAllister FE; Camporez JP; Zushin PJ; Jurczak MJ; Laznik-Bogoslavski D; Shulman GI; Gygi SP; Spiegelman BM. 2015. An ERK/Cdk5 axis controls the diabetogenic actions of PPARgamma. Nature 517(7534):391-5. PubMed: 25409143 MGI: J:217537
Barouch LA; Berkowitz DE; Harrison RW; O'Donnell CP; Hare JM. 2003. Disruption of leptin signaling contributes to cardiac hypertrophy independently of body weight in mice. Circulation 108(6):754-9. PubMed: 12885755 MGI: J:103063
Barouch LA; Gao D; Chen L; Miller KL; Xu W; Phan AC; Kittleson MM; Minhas KM; Berkowitz DE; Wei C; Hare JM. 2006. Cardiac myocyte apoptosis is associated with increased DNA damage and decreased survival in murine models of obesity. Circ Res 98(1):119-24. PubMed: 16339484 MGI: J:118064
Barros CC; Haro A; Russo FJ; Schadock I; Almeida SS; Reis FC; Moraes MR; Haidar A; Hirata AE; Mori M; Bacurau RF; Wurtele M; Bader M; Pesquero JB; Araujo RC. 2012. Bradykinin inhibits hepatic gluconeogenesis in obese mice. Lab Invest 92(10):1419-27. PubMed: 22868909 MGI: J:188609
Barros CC; Haro A; Russo FJ; Schadock I; Almeida SS; Ribeiro RA; Vanzela EC; Lanzoni VP; Barros FC; Moraes MR; Mori MA; Bacurau RF; Wurtele M; Boschero AC; Carneiro EM; Bader M; Pesquero JB; Araujo RC. 2012. Altered glucose homeostasis and hepatic function in obese mice deficient for both kinin receptor genes. PLoS One 7(7):e40573. PubMed: 22829877 MGI: J:189589
Basantani MK; Sitnick MT; Cai L; Brenner DS; Gardner NP; Li JZ; Schoiswohl G; Yang K; Kumari M; Gross RW; Zechner R; Kershaw EE. 2011. Pnpla3/Adiponutrin deficiency in mice does not contribute to fatty liver disease or metabolic syndrome. J Lipid Res 52(2):318-29. PubMed: 21068004 MGI: J:168857
Batra A; Pietsch J; Fedke I; Glauben R; Okur B; Stroh T; Zeitz M; Siegmund B. 2007. Leptin-dependent toll-like receptor expression and responsiveness in preadipocytes and adipocytes. Am J Pathol 170(6):1931-41. PubMed: 17525261 MGI: J:122150
Becerril S; Rodriguez A; Catalan V; Sainz N; Ramirez B; Collantes M; Penuelas I; Gomez-Ambrosi J; Fruhbeck G. 2010. Deletion of inducible nitric-oxide synthase in leptin-deficient mice improves brown adipose tissue function. PLoS One 5(6):e10962. PubMed: 20532036 MGI: J:161815
Bechtold DA; Sidibe A; Saer BR; Li J; Hand LE; Ivanova EA; Darras VM; Dam J; Jockers R; Luckman SM; Loudon AS. 2012. A Role for the Melatonin-Related Receptor GPR50 in Leptin Signaling, Adaptive Thermogenesis, and Torpor. Curr Biol 22(1):70-7. PubMed: 22197240 MGI: J:180291
Beck Jorgensen S; O'Neill HM; Hewitt K; Kemp BE; Steinberg GR. 2009. Reduced AMP-activated protein kinase activity in mouse skeletal muscle does not exacerbate the development of insulin resistance with obesity. Diabetologia 52(11):2395-404. PubMed: 19688337 MGI: J:154477
Bedinger DH; Adams SH. 2015. Metabolic, anabolic, and mitogenic insulin responses: A tissue-specific perspective for insulin receptor activators. Mol Cell Endocrinol 415:143-56. PubMed: 26277398 MGI: J:228806
Begin-Heick N. 1994. Liver beta-adrenergic receptors, G proteins, and adenylyl cyclase activity in obesity-diabetes syndromes. Am J Physiol 266(6 Pt 1):C1664-72. PubMed: 8023896 MGI: J:18963
Begriche K; Letteron P; Abbey-Toby A; Vadrot N; Robin MA; Bado A; Pessayre D; Fromenty B. 2008. Partial leptin deficiency favors diet-induced obesity and related metabolic disorders in mice. Am J Physiol Endocrinol Metab 294(5):E939-51. PubMed: 18349116 MGI: J:136084
Bellefontaine N; Chachlaki K; Parkash J; Vanacker C; Colledge W; d'Anglemont de Tassigny X; Garthwaite J; Bouret SG; Prevot V. 2014. Leptin-dependent neuronal NO signaling in the preoptic hypothalamus facilitates reproduction. J Clin Invest 124(6):2550-9. PubMed: 24812663 MGI: J:212751
Benzler J; Andrews ZB; Pracht C; Stohr S; Shepherd PR; Grattan DR; Tups A. 2013. Hypothalamic WNT signalling is impaired during obesity and reinstated by leptin treatment in male mice. Endocrinology 154(12):4737-45. PubMed: 24105484 MGI: J:205145
Benzler J; Ganjam GK; Kruger M; Pinkenburg O; Kutschke M; Stohr S; Steger J; Koch CE; Olkrug R; Schwartz MW; Shepherd PR; Grattan DR; Tups A. 2012. Hypothalamic glycogen synthase kinase 3beta has a central role in the regulation of food intake and glucose metabolism. Biochem J 447(1):175-84. PubMed: 22849606 MGI: J:191319
Berk PD; Zhou S; Kiang C; Stump DD; Fan X; Bradbury MW. 1999. Selective up-regulation of fatty acid uptake by adipocytes characterizes both genetic and diet-induced obesity in rodents. J Biol Chem 274(40):28626-31. PubMed: 10497230 MGI: J:57965
Bezy O; Tran TT; Pihlajamaki J; Suzuki R; Emanuelli B; Winnay J; Mori MA; Haas J; Biddinger SB; Leitges M; Goldfine AB; Patti ME; King GL; Kahn CR. 2011. PKCdelta regulates hepatic insulin sensitivity and hepatosteatosis in mice and humans. J Clin Invest 121(6):2504-17. PubMed: 21576825 MGI: J:173902
Bhat GK; Hamm ML; Igietseme JU; Mann DR. 2003. Does leptin mediate the effect of photoperiod on immune function in mice? Biol Reprod 69(1):30-6. PubMed: 12606383 MGI: J:84031
Bhatnagar S; Oler AT; Rabaglia ME; Stapleton DS; Schueler KL; Truchan NA; Worzella SL; Stoehr JP; Clee SM; Yandell BS; Keller MP; Thurmond DC; Attie AD. 2011. Positional cloning of a type 2 diabetes quantitative trait locus; tomosyn-2, a negative regulator of insulin secretion. PLoS Genet 7(10):e1002323. PubMed: 21998599 MGI: J:178002
Bi L; Chiang JY; Ding WX; Dunn W; Roberts B; Li T. 2013. Saturated fatty acids activate ERK signaling to downregulate hepatic sortilin 1 in obese and diabetic mice. J Lipid Res 54(10):2754-62. PubMed: 23904453 MGI: J:202622
Bi P; Shan T; Liu W; Yue F; Yang X; Liang XR; Wang J; Li J; Carlesso N; Liu X; Kuang S. 2014. Inhibition of Notch signaling promotes browning of white adipose tissue and ameliorates obesity. Nat Med 20(8):911-8. PubMed: 25038826 MGI: J:226881
Bi P; Yue F; Karki A; Castro B; Wirbisky SE; Wang C; Durkes A; Elzey BD; Andrisani OM; Bidwell CA; Freeman JL; Konieczny SF; Kuang S. 2016. Notch activation drives adipocyte dedifferentiation and tumorigenic transformation in mice. J Exp Med 213(10):2019-37. PubMed: 27573812 MGI: J:237232
Biddinger SB; Miyazaki M; Boucher J; Ntambi JM; Kahn CR. 2006. Leptin suppresses stearoyl-CoA desaturase 1 by mechanisms independent of insulin and sterol regulatory element-binding protein-1c. Diabetes 55(7):2032-41. PubMed: 16804073 MGI: J:111873
Bie J; Zhao B; Marqueen KE; Wang J; Szomju B; Ghosh S. 2012. Macrophage-specific transgenic expression of cholesteryl ester hydrolase attenuates hepatic lipid accumulation and also improves glucose tolerance in ob/ob mice. Am J Physiol Endocrinol Metab 302(10):E1283-91. PubMed: 22395110 MGI: J:186860
Bina KG; Cincotta AH. 2000. Dopaminergic agonists normalize elevated hypothalamic neuropeptide Y and corticotropin-releasing hormone, body weight gain, and hyperglycemia in ob/ob mice. Neuroendocrinology 71(1):68-78. PubMed: 10644901 MGI: J:60273
Bjorbaek C; Elmquist JK; Frantz JD; Shoelson SE; Flier JS. 1998. Identification of SOCS-3 as a potential mediator of central leptin resistance. Mol Cell 1(4):619-25. PubMed: 9660946 MGI: J:119803
Bjursell M; Gerdin AK; Ploj K; Svensson D; Svensson L; Oscarsson J; Snaith M; Tornell J; Bohlooly-Y M. 2006. Melanin-concentrating hormone receptor 1 deficiency increases insulin sensitivity in obese leptin-deficient mice without affecting body weight. Diabetes 55(3):725-33. PubMed: 16505236 MGI: J:106845
Blasco-Baque V; Coupe B; Fabre A; Handgraaf S; Gourdy P; Arnal JF; Courtney M; Schuster-Klein C; Guardiola B; Terce F; Burcelin R; Serino M. 2017. Associations between hepatic miRNA expression, liver triacylglycerols and gut microbiota during metabolic adaptation to high-fat diet in mice. Diabetologia 60(4):690-700. PubMed: 28105518 MGI: J:240958
Blum B; Roose AN; Barrandon O; Maehr R; Arvanites AC; Davidow LS; Davis JC; Peterson QP; Rubin LL; Melton DA. 2014. Reversal of beta cell de-differentiation by a small molecule inhibitor of the TGFbeta pathway. Elife 3:e02809. PubMed: 25233132 MGI: J:218054
Bobe G; Barrett KG; Mentor-Marcel RA; Saffiotti U; Young MR; Colburn NH; Albert PS; Bennink MR; Lanza E. 2008. Dietary cooked navy beans and their fractions attenuate colon carcinogenesis in azoxymethane-induced ob/ob mice. Nutr Cancer 60(3):373-81. PubMed: 18444172 MGI: J:138534
Bock T; Pakkenberg B; Buschard K. 2003. Increased islet volume but unchanged islet number in ob/ob mice. Diabetes 52(7):1716-22. PubMed: 12829638 MGI: J:84295
Bodary PF; Shen Y; Ohman M; Bahrou KL; Vargas FB; Cudney SS; Wickenheiser KJ; Myers MG Jr; Eitzman DT. 2007. Leptin regulates neointima formation after arterial injury through mechanisms independent of blood pressure and the leptin receptor/STAT3 signaling pathways involved in energy balance. Arterioscler Thromb Vasc Biol 27(1):70-6. PubMed: 17095713 MGI: J:135034
Bolze F; Morath V; Bast A; Rink N; Schlapschy M; Mocek S; Skerra A; Klingenspor M. 2016. Long-Acting PASylated Leptin Ameliorates Obesity by Promoting Satiety and Preventing Hypometabolism in Leptin-Deficient Lep(ob/ob) Mice. Endocrinology 157(1):233-44. PubMed: 26492472 MGI: J:233639
Bonnavion P; Jackson AC; Carter ME; de Lecea L. 2015. Antagonistic interplay between hypocretin and leptin in the lateral hypothalamus regulates stress responses. Nat Commun 6:6266. PubMed: 25695914 MGI: J:221792
Bonner C; Kerr-Conte J; Gmyr V; Queniat G; Moerman E; Thevenet J; Beaucamps C; Delalleau N; Popescu I; Malaisse WJ; Sener A; Deprez B; Abderrahmani A; Staels B; Pattou F. 2015. Inhibition of the glucose transporter SGLT2 with dapagliflozin in pancreatic alpha cells triggers glucagon secretion. Nat Med 21(5):512-7. PubMed: 25894829 MGI: J:228371
Borg ML; Omran SF; Weir J; Meikle PJ; Watt MJ. 2012. Consumption of a high-fat diet, but not regular endurance exercise training, regulates hypothalamic lipid accumulation in mice. J Physiol 590(Pt 17):4377-89. PubMed: 22674717 MGI: J:200055
Borthwick EB; Burchell A; Coughtrie MW. 1995. Differential expression of hepatic oestrogen, phenol and dehydroepiandrosterone sulphotransferases in genetically obese diabetic (ob/ob) male and female mice. J Endocrinol 144(1):31-7. PubMed: 7891022 MGI: J:22650
Boston BA; Blaydon KM; Varnerin J; Cone RD. 1997. Independent and additive effects of central POMC and leptin pathways on murine obesity. Science 278(5343):1641-4. PubMed: 9374468 MGI: J:44399
Bouchard G; Johnson D; Carver T; Paigen B; Carey MC. 2002. Cholesterol gallstone formation in overweight mice establishes that obesity per se is not linked directly to cholelithiasis risk. J Lipid Res 43(7):1105-13. PubMed: 12091495 MGI: J:88773
Boudina S; Sena S; O'Neill BT; Tathireddy P; Young ME; Abel ED. 2005. Reduced mitochondrial oxidative capacity and increased mitochondrial uncoupling impair myocardial energetics in obesity. Circulation 112(17):2686-95. PubMed: 16246967 MGI: J:116841
Bouhidel O; Pons S; Souktani R; Zini R; Berdeaux A; Ghaleh B. 2008. Myocardial ischemic postconditioning against ischemia-reperfusion is impaired in ob/ob mice. Am J Physiol Heart Circ Physiol 295(4):H1580-6. PubMed: 18689499 MGI: J:141317
Boundy VA; Cincotta AH. 2000. Hypothalamic adrenergic receptor changes in the metabolic syndrome of genetically obese (ob/ob) mice. Am J Physiol Regul Integr Comp Physiol 279(2):R505-14. PubMed: 10938239 MGI: J:94672
Bouret SG; Draper SJ; Simerly RB. 2004. Trophic action of leptin on hypothalamic neurons that regulate feeding. Science 304(5667):108-10. PubMed: 15064420 MGI: J:90241
Breslow MJ; An Y; Berkowitz DE. 1997. Beta-3 adrenoceptor (beta-3AR) expression in leptin treated OB/OB mice. Life Sci 61(1):59-64. PubMed: 9200670 MGI: J:41326
Breslow MJ; Min-Lee K; Brown DR; Chacko VP; Palmer D; Berkowitz DE. 1999. Effect of leptin deficiency on metabolic rate in ob/ob mice. Am J Physiol 276(3 Pt 1):E443-9. PubMed: 10070008 MGI: J:53833
Bricambert J; Miranda J; Benhamed F; Girard J; Postic C; Dentin R. 2010. Salt-inducible kinase 2 links transcriptional coactivator p300 phosphorylation to the prevention of ChREBP-dependent hepatic steatosis in mice. J Clin Invest 120(12):4316-31. PubMed: 21084751 MGI: J:171868
Briggs DI; Lockie SH; Benzler J; Wu Q; Stark R; Reichenbach A; Hoy AJ; Lemus MB; Coleman HA; Parkington HC; Tups A; Andrews ZB. 2014. Evidence that diet-induced hyperleptinemia, but not hypothalamic gliosis, causes ghrelin resistance in NPY/AgRP neurons of male mice. Endocrinology 155(7):2411-22. PubMed: 24742194 MGI: J:214257
Brix AE; Elgavish A; Nagy TR; Gower BA; Rhead WJ; Wood PA. 2002. Evaluation of liver fatty acid oxidation in the leptin-deficient obese mouse. Mol Genet Metab 75(3):219-26. PubMed: 11914033 MGI: J:94662
Brun P; Castagliuolo I; Leo VD; Buda A; Pinzani M; Palu G; Martines D. 2007. Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis. Am J Physiol Gastrointest Liver Physiol 292(2):G518-25. PubMed: 17023554 MGI: J:124815
Bruno RS; Dugan CE; Smyth JA; DiNatale DA; Koo SI. 2008. Green tea extract protects leptin-deficient, spontaneously obese mice from hepatic steatosis and injury. J Nutr 138(2):323-31. PubMed: 18203899 MGI: J:133407
Bruton JD; Katz A; Lannergren J; Abbate F; Westerblad H. 2002. Regulation of myoplasmic Ca(2+) in genetically obese (ob/ob) mouse single skeletal muscle fibres. Pflugers Arch 444(6):692-9. PubMed: 12355168 MGI: J:106205
Bunger L; Forsting J; McDonald KL; Horvat S; Duncan J; Hochscheid S; Baile CA; Hill WG; Speakman JR. 2003. Long-term divergent selection on fatness in mice indicates a regulation system independent of leptin production and reception. FASEB J 17(1):85-7. PubMed: 12424222 MGI: J:118012
Burak MF; Inouye KE; White A; Lee A; Tuncman G; Calay ES; Sekiya M; Tirosh A; Eguchi K; Birrane G; Lightwood D; Howells L; Odede G; Hailu H; West S; Garlish R; Neale H; Doyle C; Moore A; Hotamisligil GS. 2015. Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes. Sci Transl Med 7(319):319ra205. PubMed: 26702093 MGI: J:234126
Burcelin R; Kamohara S; Li J; Tannenbaum GS; Charron MJ; Friedman JM. 1999. Acute intravenous leptin infusion increases glucose turnover but not skeletal muscle glucose uptake in ob/ob mice. Diabetes 48(6):1264-9. PubMed: 10342814 MGI: J:55776
Busso N; So A; Chobaz-Peclat V; Morard C; Martinez-Soria E; Talabot-Ayer D; Gabay C. 2002. Leptin signaling deficiency impairs humoral and cellular immune responses and attenuates experimental arthritis. J Immunol 168(2):875-82. PubMed: 11777985 MGI: J:73743
Butler AA; Marks DL; Fan W; Kuhn CM; Bartolome M; Cone RD. 2001. Melanocortin-4 receptor is required for acute homeostatic responses to increased dietary fat. Nat Neurosci 4(6):605-11. PubMed: 11369941 MGI: J:69814
Campfield LA; Smith FJ; Guisez Y; Devos R; Burn P. 1995. Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks [see comments] Science 269(5223):546-9. PubMed: 7624778 MGI: J:29160
Cani PD; Bibiloni R; Knauf C; Waget A; Neyrinck AM; Delzenne NM; Burcelin R. 2008. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 57(6):1470-81. PubMed: 18305141 MGI: J:136880
Cao H; Maeda K; Gorgun CZ; Kim HJ; Park SY; Shulman GI; Kim JK; Hotamisligil GS. 2006. Regulation of metabolic responses by adipocyte/macrophage Fatty Acid-binding proteins in leptin-deficient mice. Diabetes 55(7):1915-22. PubMed: 16804058 MGI: J:111878
Cao L; Liu X; Lin EJ; Wang C; Choi EY; Riban V; Lin B; During MJ. 2010. Environmental and genetic activation of a brain-adipocyte BDNF/leptin axis causes cancer remission and inhibition. Cell 142(1):52-64. PubMed: 20603014 MGI: J:167939
Cariou B; Capitaine N; Le Marcis V; Vega N; Bereziat V; Kergoat M; Laville M; Girard J; Vidal H; Burnol AF. 2004. Increased adipose tissue expression of Grb14 in several models of insulin resistance. FASEB J 18(9):965-7. PubMed: 15059968 MGI: J:118114
Cariou B; van Harmelen K; Duran-Sandoval D; van Dijk TH; Grefhorst A; Abdelkarim M; Caron S; Torpier G; Fruchart JC; Gonzalez FJ; Kuipers F; Staels B. 2006. The farnesoid X receptor modulates adiposity and peripheral insulin sensitivity in mice. J Biol Chem 281(16):11039-49. PubMed: 16446356 MGI: J:110560
Carley AN; Severson DL. 2005. Fatty acid metabolism is enhanced in type 2 diabetic hearts. Biochim Biophys Acta 1734(2):112-26. PubMed: 15904868 MGI: J:99066
Carobbio S; Hagen RM; Lelliott CJ; Slawik M; Medina-Gomez G; Tan CY; Sicard A; Atherton HJ; Barbarroja N; Bjursell M; Bohlooly-Y M; Virtue S; Tuthill A; Lefai E; Laville M; Wu T; Considine RV; Vidal H; Langin D; Oresic M; Tinahones FJ; Fernandez-Real JM;Griffin JL; Sethi JK; Lopez M; Vidal-Puig A. 2013. Adaptive changes of the Insig1/SREBP1/SCD1 set point help adipose tissue to cope with increased storage demands of obesity. Diabetes 62(11):3697-708. PubMed: 23919961 MGI: J:208931
Chakraborty S; Sachdev A; Salton SR; Chakraborty TR. 2008. Stereological analysis of estrogen receptor expression in the hypothalamic arcuate nucleus of ob/ob and agouti mice. Brain Res 1217:86-95. PubMed: 18502406 MGI: J:138366
Chan JY; Luzuriaga J; Bensellam M; Biden TJ; Laybutt DR. 2013. Failure of the adaptive unfolded protein response in islets of obese mice is linked with abnormalities in beta-cell gene expression and progression to diabetes. Diabetes 62(5):1557-68. PubMed: 23274897 MGI: J:208583
Chan JY; Luzuriaga J; Maxwell EL; West PK; Bensellam M; Laybutt DR. 2015. The balance between adaptive and apoptotic unfolded protein responses regulates beta-cell death under ER stress conditions through XBP1, CHOP and JNK. Mol Cell Endocrinol 413:189-201. PubMed: 26135354 MGI: J:227034
Chang BH; Li L; Saha P; Chan L. 2010. Absence of adipose differentiation related protein upregulates hepatic VLDL secretion, relieves hepatosteatosis, and improves whole body insulin resistance in leptin-deficient mice. J Lipid Res 51(8):2132-42. PubMed: 20424269 MGI: J:162936
Charalambous M; Da Rocha ST; Radford EJ; Medina-Gomez G; Curran S; Pinnock SB; Ferron SR; Vidal-Puig A; Ferguson-Smith AC. 2014. DLK1/PREF1 regulates nutrient metabolism and protects from steatosis. Proc Natl Acad Sci U S A 111(45):16088-93. PubMed: 25349437 MGI: J:216767
Charlton HM. 1984. Mouse mutants as models in endocrine research. Q J Exp Physiol 69(4):655-76. PubMed: 6393185 MGI: J:7702
Chavey C; Lazennec G; Lagarrigue S; Clape C; Iankova I; Teyssier J; Annicotte JS; Schmidt J; Mataki C; Yamamoto H; Sanches R; Guma A; Stich V; Vitkova M; Jardin-Watelet B; Renard E; Strieter R; Tuthill A; Hotamisligil GS; Vidal-Puig A; Zorzano A; Langin D; Fajas L. 2009. CXC ligand 5 is an adipose-tissue derived factor that links obesity to insulin resistance. Cell Metab 9(4):339-49. PubMed: 19356715 MGI: J:148169
Cheema SK; Clandinin MT. 1996. Diet fat alters expression of genes for enzymes of lipogenesis in lean and obese mice. Biochim Biophys Acta 1299(3):284-8. PubMed: 8597582 MGI: J:31603
Chehab FF; Lim ME; Lu R. 1996. Correction of the sterility defect in homozygous obese female mice by treatment with the human recombinant leptin. Nat Genet 12(3):318-20. PubMed: 8589726 MGI: J:31761
Chen HC; Ladha Z; Farese RV Jr. 2002. Deficiency of acyl coenzyme a:diacylglycerol acyltransferase 1 increases leptin sensitivity in murine obesity models. Endocrinology 143(8):2893-8. PubMed: 12130553 MGI: J:78337
Chen HC; Smith SJ; Ladha Z; Jensen DR; Ferreira LD; Pulawa LK; McGuire JG; Pitas RE; Eckel RH; Farese RV Jr. 2002. Increased insulin and leptin sensitivity in mice lacking acyl CoA:diacylglycerol acyltransferase 1. J Clin Invest 109(8):1049-55. PubMed: 11956242 MGI: J:76091
Chen HL; Romsos DR. 1994. Type II glucocorticoid receptors in the CNS regulate metabolism in ob/ob mice independent of protein synthesis. Am J Physiol 266(3 Pt 1):E427-32. PubMed: 8166263 MGI: J:17505
Chen HL; Romsos DR. 1996. Dexamethasone rapidly increases hypothalamic neuropeptide Y secretion in adrenalectomized ob/ob mice. Am J Physiol 271(1 Pt 1):E151-8. PubMed: 8760093 MGI: J:34501
Chen J; Hui ST; Couto FM; Mungrue IN; Davis DB; Attie AD; Lusis AJ; Davis RA; Shalev A. 2008. Thioredoxin-interacting protein deficiency induces Akt/Bcl-xL signaling and pancreatic beta-cell mass and protects against diabetes. FASEB J 22(10):3581-94. PubMed: 18552236 MGI: J:140264
Chen J; Saxena G; Mungrue IN; Lusis AJ; Shalev A. 2008. Thioredoxin-interacting protein: a critical link between glucose toxicity and beta-cell apoptosis. Diabetes 57(4):938-44. PubMed: 18171713 MGI: J:135529
Chen JL; Lu XJ; Zou KL; Ye K. 2014. Kruppel-like factor 2 promotes liver steatosis through upregulation of CD36. J Lipid Res 55(1):32-40. PubMed: 23861552 MGI: J:203965
Chen JY; Tsai PJ; Tai HC; Tsai RL; Chang YT; Wang MC; Chiou YW; Yeh ML; Tang MJ; Lam CF; Shiesh SC; Li YH; Tsai WC; Chou CH; Lin LJ; Wu HL; Tsai YS. 2013. Increased aortic stiffness and attenuated lysyl oxidase activity in obesity. Arterioscler Thromb Vasc Biol 33(4):839-46. PubMed: 23413430 MGI: J:217970
Chen NG; Romsos DR. 1995. Enhanced sensitivity of pancreatic islets from preobese 2-week-old ob/ob mice to neurohormonal stimulation of insulin secretion. Endocrinology 136(2):505-11. PubMed: 7835283 MGI: J:22634
Chen NG; Tassava TM; Romsos DR. 1993. Threshold for glucose-stimulated insulin secretion in pancreatic islets of genetically obese (ob/ob) mice is abnormally low. J Nutr 123(9):1567-74. PubMed: 8360782 MGI: J:14402
Chen W; Chang B; Wu X; Li L; Sleeman M; Chan L. 2013. Inactivation of Plin4 downregulates Plin5 and reduces cardiac lipid accumulation in mice. Am J Physiol Endocrinol Metab 304(7):E770-9. PubMed: 23423172 MGI: J:195987
Chen Z; Morris DL; Jiang L; Liu Y; Rui L. 2014. SH2B1 in beta-cells promotes insulin expression and glucose metabolism in mice. Mol Endocrinol 28(5):696-705. PubMed: 24645678 MGI: J:214138
Chen Z; Newberry EP; Norris JY; Xie Y; Luo J; Kennedy SM; Davidson NO. 2008. ApoB100 is required for increased VLDL-triglyceride secretion by microsomal triglyceride transfer protein in ob/ob mice. J Lipid Res 49(9):2013-22. PubMed: 18519977 MGI: J:139764
Chen Z; Shen H; Sun C; Yin L; Tang F; Zheng P; Liu Y; Brink R; Rui L. 2015. Myeloid cell TRAF3 promotes metabolic inflammation, insulin resistance, and hepatic steatosis in obesity. Am J Physiol Endocrinol Metab 308(6):E460-9. PubMed: 25628422 MGI: J:220716
Chen Z; Vigueira PA; Chambers KT; Hall AM; Mitra MS; Qi N; McDonald WG; Colca JR; Kletzien RF; Finck BN. 2012. Insulin resistance and metabolic derangements in obese mice are ameliorated by a novel peroxisome proliferator-activated receptor gamma-sparing thiazolidinedione. J Biol Chem 287(28):23537-48. PubMed: 22621923 MGI: J:188864
Cheng A; Uetani N; Simoncic PD; Chaubey VP; Lee-Loy A; McGlade CJ; Kennedy BP; Tremblay ML. 2002. Attenuation of Leptin Action and Regulation of Obesity by Protein Tyrosine Phosphatase 1B. Dev Cell 2(4):497-503. PubMed: 11970899 MGI: J:75969
Cheng Z; Guo S; Copps K; Dong X; Kollipara R; Rodgers JT; Depinho RA; Puigserver P; White MF. 2009. Foxo1 integrates insulin signaling with mitochondrial function in the liver. Nat Med 15(11):1307-11. PubMed: 19838201 MGI: J:154295
Cheung SY; Huang Y; Kwan HY; Chung HY; Yao X. 2015. Activation of transient receptor potential vanilloid 3 channel suppresses adipogenesis. Endocrinology 156(6):2074-86. PubMed: 25774551 MGI: J:222171
Chiarreotto-Ropelle EC; Pauli LS; Katashima CK; Pimentel GD; Picardi PK; Silva VR; de Souza CT; Prada PO; Cintra DE; Carvalheira JB; Ropelle ER; Pauli JR. 2013. Acute exercise suppresses hypothalamic PTP1B protein level and improves insulin and leptin signaling in obese rats. Am J Physiol Endocrinol Metab 305(5):E649-59. PubMed: 23880311 MGI: J:203888
Chiba T; Han CY; Vaisar T; Shimokado K; Kargi A; Chen MH; Wang S; McDonald TO; O'Brien KD; Heinecke JW; Chait A. 2009. Serum amyloid A3 does not contribute to circulating SAA levels. J Lipid Res 50(7):1353-62. PubMed: 19286646 MGI: J:158176
Chiu CH; Lin WD; Huang SY; Lee YH. 2004. Effect of a C/EBP gene replacement on mitochondrial biogenesis in fat cells. Genes Dev 18(16):1970-5. PubMed: 15289464 MGI: J:91840
Cho KW; Zhou Y; Sheng L; Rui L. 2011. Lipocalin-13 regulates glucose metabolism by both insulin-dependent and insulin-independent mechanisms. Mol Cell Biol 31(3):450-7. PubMed: 21135134 MGI: J:170422
Choo HJ; Kim JH; Kwon OB; Lee CS; Mun JY; Han SS; Yoon YS; Yoon G; Choi KM; Ko YG. 2006. Mitochondria are impaired in the adipocytes of type 2 diabetic mice. Diabetologia 49(4):784-91. PubMed: 16501941 MGI: J:107887
Christoffersen C; Bollano E; Lindegaard ML; Bartels ED; Goetze JP; Andersen CB; Nielsen LB. 2003. Cardiac lipid accumulation associated with diastolic dysfunction in obese mice. Endocrinology 144(8):3483-90. PubMed: 12865329 MGI: J:84820
Chu MJ; Hickey AJ; Tagaloa S; Zhang L; Dare AJ; MacDonald JR; Yeong ML; Bartlett AS; Phillips AR. 2014. Ob/ob mouse livers show decreased oxidative phosphorylation efficiencies and anaerobic capacities after cold ischemia. PLoS One 9(6):e100609. PubMed: 24956382 MGI: J:216824
Chua S Jr; Liu SM; Li Q; Yang L; Thassanapaff VT; Fisher P. 2002. Differential beta cell responses to hyperglycaemia and insulin resistance in two novel congenic strains of diabetes (FVB- Lepr (db)) and obese (DBA- Lep (ob)) mice. Diabetologia 45(7):976-90. PubMed: 12136396 MGI: J:78850
Chung J; Koo K; Lian F; Hu KQ; Ernst H; Wang XD. 2012. Apo-10'-lycopenoic acid, a lycopene metabolite, increases sirtuin 1 mRNA and protein levels and decreases hepatic fat accumulation in ob/ob mice. J Nutr 142(3):405-10. PubMed: 22259190 MGI: J:181923
Chung JJ; Markiewicz MA; Polic B; Shaw AS. 2014. Role of NKG2D in obesity-induced adipose tissue inflammation and insulin resistance. PLoS One 9(10):e110108. PubMed: 25333972 MGI: J:223438
Chung WK; Belfi K; Chua M; Wiley J; Mackintosh R; Nicolson M; Boozer CN; Leibel RL. 1998. Heterozygosity for Lep(ob) or Lep(rdb) affects body composition and leptin homeostasis in adult mice. Am J Physiol 274(4 Pt 2):R985-90. PubMed: 9575960 MGI: J:47168
Ciciliot S; Albiero M; Menegazzo L; Poncina N; Scattolini V; Danesi A; Pagnin E; Marabita M; Blaauw B; Giorgio M; Trinei M; Foletto M; Prevedello L; Nitti D; Avogaro A; Fadini GP. 2015. p66Shc deletion or deficiency protects from obesity but not metabolic dysfunction in mice and humans. Diabetologia 58(10):2352-60. PubMed: 26122877 MGI: J:226448
Cipolletta D; Cohen P; Spiegelman BM; Benoist C; Mathis D. 2015. Appearance and disappearance of the mRNA signature characteristic of Treg cells in visceral adipose tissue: age, diet, and PPARgamma effects. Proc Natl Acad Sci U S A 112(2):482-7. PubMed: 25550516 MGI: J:218908
Cipolletta D; Feuerer M; Li A; Kamei N; Lee J; Shoelson SE; Benoist C; Mathis D. 2012. PPAR-gamma is a major driver of the accumulation and phenotype of adipose tissue Treg cells. Nature 486(7404):549-53. PubMed: 22722857 MGI: J:186708
Clark EA; Shultz LD; Pollack SB. 1981. Mutations in mice that influence natural killer (NK) cell activity. Immunogenetics 12(5-6):601-13. PubMed: 6971254 MGI: J:6485
Claycombe K; King LE; Fraker PJ. 2008. A role for leptin in sustaining lymphopoiesis and myelopoiesis. Proc Natl Acad Sci U S A 105(6):2017-21. PubMed: 18250302 MGI: J:131806
Cleary MP; Bergstrom HM; Dodge TL; Getzin SC; Jacobson MK; Phillips FC. 2001. Restoration of fertility in young obese (Lep(ob) Lep(ob)) male mice with low dose recombinant mouse leptin treatment. Int J Obes Relat Metab Disord 25(1):95-7. PubMed: 11244463 MGI: J:68694
Cleary MP; Phillips FC; Getzin SC; Jacobson TL; Jacobson MK; Christensen TA; Juneja SC; Grande JP; Maihle NJ. 2003. Genetically obese MMTV-TGF-alpha/Lep(ob)Lep(ob) female mice do not develop mammary tumors. Breast Cancer Res Treat 77(3):205-15. PubMed: 12602920 MGI: J:81933
Clee SM; Nadler ST; Attie AD. 2005. Genetic and genomic studies of the BTBR ob/ob mouse model of type 2 diabetes. Am J Ther 12(6):491-8. PubMed: 16280642 MGI: J:106121
Clouthier DE; Comerford SA; Hammer RE. 1997. Hepatic fibrosis, glomerulosclerosis, and a lipodystrophy-like syndrome in PEPCK-TGF-beta1 transgenic mice. J Clin Invest 100(11):2697-713. PubMed: 9389733 MGI: J:135399
Coleman DL. 1982. Thermogenesis in diabetes-obesity syndromes in mutant mice. Diabetologia 22(3):205-11. PubMed: 7075918 MGI: J:6756
Coleman DL. 1973. Effects of parabiosis of obese with diabetes and normal mice. Diabetologia 9(4):294-8. PubMed: 4767369 MGI: J:5401
Coleman DL; Hummel KP. 1973. The influence of genetic background on the expression of the obese (Ob) gene in the mouse. Diabetologia 9(4):287-93. PubMed: 4588246 MGI: J:5400
Collin M; Hakansson-Ovesjo ML; Misane I; Ogren SO; Meister B. 2000. Decreased 5-HT transporter mRNA in neurons of the dorsal raphe nucleus and behavioral depression in the obese leptin-deficient ob/ob mouse. Brain Res Mol Brain Res 81(1-2):51-61. PubMed: 11000478 MGI: J:109340
Collin de l'Hortet A; Zerrad-Saadi A; Prip-Buus C; Fauveau V; Helmy N; Ziol M; Vons C; Billot K; Baud V; Gilgenkrantz H; Guidotti JE. 2014. GH administration rescues fatty liver regeneration impairment by restoring GH/EGFR pathway deficiency. Endocrinology 155(7):2545-54. PubMed: 24708244 MGI: J:214266
Collins S; Daniel KW; Rohlfs EM; Ramkumar V; Taylor IL; Gettys TW. 1994. Impaired expression and functional activity of the beta 3- and beta 1-adrenergic receptors in adipose tissue of congenitally obese (C57BL/6J ob/ob) mice. Mol Endocrinol 8(4):518-27. PubMed: 7914350 MGI: J:17709
Collins S; Surwit RS. 1996. Pharmacologic manipulation of ob expression in a dietary model of obesity. J Biol Chem 271(16):9437-40. PubMed: 8621612 MGI: J:33332
Cooksey RC; Jones D; Gabrielsen S; Huang J; Simcox JA; Luo B; Soesanto Y; Rienhoff H; Abel ED; McClain DA. 2010. Dietary iron restriction or iron chelation protects from diabetes and loss of beta-cell function in the obese (ob/ob lep-/-) mouse. Am J Physiol Endocrinol Metab 298(6):E1236-43. PubMed: 20354157 MGI: J:162955
Cope K; Risby T; Diehl AM. 2000. Increased gastrointestinal ethanol production in obese mice: implications for fatty liver disease pathogenesis. Gastroenterology 119(5):1340-7. PubMed: 11054393 MGI: J:94789
Cottrell EC; Martin-Gronert MS; Fernandez-Twinn DS; Luan J; Berends LM; Ozanne SE. 2011. Leptin-independent programming of adult body weight and adiposity in mice. Endocrinology 152(2):476-82. PubMed: 21209019 MGI: J:173885
Cowerd RB; Asmar MM; Alderman JM; Alderman EA; Garland AL; Busby WH; Bodnar WM; Rusyn I; Medoff BD; Tisch R; Mayer-Davis E; Swenberg JA; Zeisel SH; Combs TP. 2010. Adiponectin lowers glucose production by increasing SOGA. Am J Pathol 177(4):1936-45. PubMed: 20813965 MGI: J:165436
Crepin D; Benomar Y; Riffault L; Amine H; Gertler A; Taouis M. 2014. The over-expression of miR-200a in the hypothalamus of ob/ob mice is linked to leptin and insulin signaling impairment. Mol Cell Endocrinol 384(1-2):1-11. PubMed: 24394757 MGI: J:211951
Cretenet G; Le Clech M; Gachon F. 2010. Circadian clock-coordinated 12 Hr period rhythmic activation of the IRE1alpha pathway controls lipid metabolism in mouse liver. Cell Metab 11(1):47-57. PubMed: 20074527 MGI: J:157002
Cristino L; Busetto G; Imperatore R; Ferrandino I; Palomba L; Silvestri C; Petrosino S; Orlando P; Bentivoglio M; Mackie K; Di Marzo V. 2013. Obesity-driven synaptic remodeling affects endocannabinoid control of orexinergic neurons. Proc Natl Acad Sci U S A 110(24):E2229-38. PubMed: 23630288 MGI: J:197326
Croizier S; Prevot V; Bouret SG. 2016. Leptin Controls Parasympathetic Wiring of the Pancreas during Embryonic Life. Cell Rep 15(1):36-44. PubMed: 27052164 MGI: J:235085
Dai C; Kayton NS; Shostak A; Poffenberger G; Cyphert HA; Aramandla R; Thompson C; Papagiannis IG; Emfinger C; Shiota M; Stafford JM; Greiner DL; Herrera PL; Shultz LD; Stein R; Powers AC. 2016. Stress-impaired transcription factor expression and insulin secretion in transplanted human islets. J Clin Invest 126(5):1857-70. PubMed: 27064285 MGI: J:234937
Dattaroy D; Pourhoseini S; Das S; Alhasson F; Seth RK; Nagarkatti M; Michelotti GA; Diehl AM; Chatterjee S. 2015. Micro-RNA 21 inhibition of SMAD7 enhances fibrogenesis via leptin-mediated NADPH oxidase in experimental and human nonalcoholic steatohepatitis. Am J Physiol Gastrointest Liver Physiol 308(4):G298-312. PubMed: 25501551 MGI: J:223984
Davis DB; Lavine JA; Suhonen JI; Krautkramer KA; Rabaglia ME; Sperger JM; Fernandez LA; Yandell BS; Keller MP; Wang IM; Schadt EE; Attie AD. 2010. FoxM1 is up-regulated by obesity and stimulates beta-cell proliferation. Mol Endocrinol 24(9):1822-34. PubMed: 20660304 MGI: J:182843
De Rosa V; Procaccini C; Cali G; Pirozzi G; Fontana S; Zappacosta S; La Cava A; Matarese G. 2007. A Key Role of Leptin in the Control of Regulatory T Cell Proliferation. Immunity 26(2):241-255. PubMed: 17307705 MGI: J:118425
Della-Fera MA; Choi YH; Hartzell DL; Duan J; Hamrick M; Baile CA. 2005. Sensitivity of ob/ob mice to leptin-induced adipose tissue apoptosis. Obes Res 13(9):1540-7. PubMed: 16222056 MGI: J:114433
Delporte ML; El Mkadem SA; Quisquater M; Brichard SM. 2004. Leptin treatment markedly increased plasma adiponectin but barely decreased plasma resistin of ob/ob mice. Am J Physiol Endocrinol Metab 287(3):E446-53. PubMed: 15126241 MGI: J:95406
Deng J; Hua K; Caveney EJ; Takahashi N; Harp JB. 2006. Protein inhibitor of activated STAT3 inhibits adipogenic gene expression. Biochem Biophys Res Commun 339(3):923-31. PubMed: 16329991 MGI: J:104136
Deng T; Lyon CJ; Minze LJ; Lin J; Zou J; Liu JZ; Ren Y; Yin Z; Hamilton DJ; Reardon PR; Sherman V; Wang HY; Phillips KJ; Webb P; Wong ST; Wang RF; Hsueh WA. 2013. Class II major histocompatibility complex plays an essential role in obesity-induced adipose inflammation. Cell Metab 17(3):411-22. PubMed: 23473035 MGI: J:198135
Deng ZB; Poliakov A; Hardy RW; Clements R; Liu C; Liu Y; Wang J; Xiang X; Zhang S; Zhuang X; Shah SV; Sun D; Michalek S; Grizzle WE; Garvey T; Mobley J; Zhang HG. 2009. Adipose tissue exosome-like vesicles mediate activation of macrophage-induced insulin resistance. Diabetes 58(11):2498-505. PubMed: 19675137 MGI: J:154383
Deveaux V; Cadoudal T; Ichigotani Y; Teixeira-Clerc F; Louvet A; Manin S; Nhieu JT; Belot MP; Zimmer A; Even P; Cani PD; Knauf C; Burcelin R; Bertola A; Le Marchand-Brustel Y; Gual P; Mallat A; Lotersztajn S. 2009. Cannabinoid CB2 receptor potentiates obesity-associated inflammation, insulin resistance and hepatic steatosis. PLoS One 4(6):e5844. PubMed: 19513120 MGI: J:150201
Diaz-Delfin J; Morales M; Caelles C. 2007. Hypoglycemic action of thiazolidinediones/peroxisome proliferator-activated receptor gamma by inhibition of the c-Jun NH2-terminal kinase pathway. Diabetes 56(7):1865-71. PubMed: 17416798 MGI: J:126454
Dickie MM; Lane PW. 1957. [Linkage of ob to L.G. XI] Mouse News Lett 17:52. MGI: J:159
Ding H; Zhang Y; Xu C; Hou D; Li J; Zhang Y; Peng W; Zen K; Zhang CY; Jiang X. 2014. Norathyriol reverses obesity- and high-fat-diet-induced insulin resistance in mice through inhibition of PTP1B. Diabetologia 57(10):2145-54. PubMed: 24985145 MGI: J:216994
Dixon D; Horton J; Haseman JK; Talley F; Greenwell A; Nettesheim P; Hook GE; Maronpot RR. 1991. Histomorphology and ultrastructure of spontaneous pulmonary neoplasms in strain A mice. Exp Lung Res 17(2):131-55. PubMed: 1646706 MGI: J:27691
Djogo T; Robins SC; Schneider S; Kryzskaya D; Liu X; Mingay A; Gillon CJ; Kim JH; Storch KF; Boehm U; Bourque CW; Stroh T; Dimou L; Kokoeva MV. 2016. Adult NG2-Glia Are Required for Median Eminence-Mediated Leptin Sensing and Body Weight Control. Cell Metab 23(5):797-810. PubMed: 27166944 MGI: J:235371
Dobrzyn A; Dobrzyn P; Lee SH; Miyazaki M; Cohen P; Asilmaz E; Hardie DG; Friedman JM; Ntambi JM. 2005. Stearoyl-CoA desaturase-1 deficiency reduces ceramide synthesis by downregulating serine palmitoyltransferase and increasing beta-oxidation in skeletal muscle. Am J Physiol Endocrinol Metab 288(3):E599-607. PubMed: 15562249 MGI: J:96073
Dobrzyn P; Dobrzyn A; Miyazaki M; Cohen P; Asilmaz E; Hardie DG; Friedman JM; Ntambi JM. 2004. Stearoyl-CoA desaturase 1 deficiency increases fatty acid oxidation by activating AMP-activated protein kinase in liver. Proc Natl Acad Sci U S A 101(17):6409-14. PubMed: 15096593 MGI: J:89545
Dokmanovic-Chouinard M; Chung WK; Chevre JC; Watson E; Yonan J; Wiegand B; Bromberg Y; Wakae N; Wright CV; Overton J; Ghosh S; Sathe GM; Ammala CE; Brown KK; Ito R; LeDuc C; Solomon K; Fischer SG; Leibel RL. 2008. Positional cloning of 'Lisch-Like', a candidate modifier of susceptibility to type 2 diabetes in mice. PLoS Genet 4(7):e1000137. PubMed: 18654634 MGI: J:138216
Dominguez Rieg JA; Chirasani VR; Koepsell H; Senapati S; Mahata SK; Rieg T. 2016. Regulation of intestinal SGLT1 by catestatin in hyperleptinemic type 2 diabetic mice. Lab Invest 96(1):98-111. PubMed: 26552046 MGI: J:228070
Donato J Jr; Cravo RM; Frazao R; Gautron L; Scott MM; Lachey J; Castro IA; Margatho LO; Lee S; Lee C; Richardson JA; Friedman J; Chua S Jr; Coppari R; Zigman JM; Elmquist JK; Elias CF. 2011. Leptin's effect on puberty in mice is relayed by the ventral premammillary nucleus and does not require signaling in Kiss1 neurons. J Clin Invest 121(1):355-68. PubMed: 21183787 MGI: J:171840
Donato J Jr; Frazao R; Fukuda M; Vianna CR; Elias CF. 2010. Leptin induces phosphorylation of neuronal nitric oxide synthase in defined hypothalamic neurons. Endocrinology 151(11):5415-27. PubMed: 20881244 MGI: J:165660
Dong B; Saha PK; Huang W; Chen W; Abu-Elheiga LA; Wakil SJ; Stevens RD; Ilkayeva O; Newgard CB; Chan L; Moore DD. 2009. Activation of nuclear receptor CAR ameliorates diabetes and fatty liver disease. Proc Natl Acad Sci U S A 106(44):18831-6. PubMed: 19850873 MGI: J:154669
Dong F; Zhang X; Yang X; Esberg LB; Yang H; Zhang Z; Culver B; Ren J. 2006. Impaired cardiac contractile function in ventricular myocytes from leptin-deficient ob/ob obese mice. J Endocrinol 188(1):25-36. PubMed: 16394172 MGI: J:104171
Drel VR; Mashtalir N; Ilnytska O; Shin J; Li F; Lyzogubov VV; Obrosova IG. 2006. The leptin-deficient (ob/ob) mouse: a new animal model of peripheral neuropathy of type 2 diabetes and obesity. Diabetes 55(12):3335-43. PubMed: 17130477 MGI: J:121015
Dubuc PU. 1992. Interactions between insulin and glucocorticoids in the maintenance of genetic obesity. Am J Physiol 263(3 Pt 1):E550-5. PubMed: 1415535 MGI: J:2939
Ducy P; Amling M; Takeda S; Priemel M; Schilling AF; Beil FT; Shen J; Vinson C; Rueger JM; Karsenty G. 2000. Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell 100(2):197-207. PubMed: 10660043 MGI: J:60001
El-Salhy M. 1998. Neuroendocrine peptides of the gastrointestinal tract of an animal model of human type 2 diabetes mellitus. Acta Diabetol 35(4):194-8. PubMed: 9934817 MGI: J:55590
Elefteriou F; Ahn JD; Takeda S; Starbuck M; Yang X; Liu X; Kondo H; Richards WG; Bannon TW; Noda M; Clement K; Vaisse C; Karsenty G. 2005. Leptin regulation of bone resorption by the sympathetic nervous system and CART. Nature 434(7032):514-20. PubMed: 15724149 MGI: J:97566
Elefteriou F; Takeda S; Ebihara K; Magre J; Patano N; Kim CA; Ogawa Y; Liu X; Ware SM; Craigen WJ; Robert JJ; Vinson C; Nakao K; Capeau J; Karsenty G. 2004. Serum leptin level is a regulator of bone mass. Proc Natl Acad Sci U S A 101(9):3258-63. PubMed: 14978271 MGI: J:88655
Elinav E; Pappo O; Sklair-Levy M; Margalit M; Shibolet O; Gomori M; Alper R; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y. 2006. Adoptive transfer of regulatory NKT lymphocytes ameliorates non-alcoholic steatohepatitis and glucose intolerance in ob/ob mice and is associated with intrahepatic CD8 trapping. J Pathol 209(1):121-8. PubMed: 16482497 MGI: J:107706
Elinav E; Pappo O; Sklair-Levy M; Margalit M; Shibolet O; Gomori M; Alper R; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y. 2006. Amelioration of non-alcoholic steatohepatitis and glucose intolerance in ob/ob mice by oral immune regulation towards liver-extracted proteins is associated with elevated intrahepatic NKT lymphocytes and serum IL-10 levels. J Pathol 208(1):74-81. PubMed: 16261527 MGI: J:104032
Ellingsgaard H; Hauselmann I; Schuler B; Habib AM; Baggio LL; Meier DT; Eppler E; Bouzakri K; Wueest S; Muller YD; Hansen AM; Reinecke M; Konrad D; Gassmann M; Reimann F; Halban PA; Gromada J; Drucker DJ; Gribble FM; Ehses JA; Donath MY. 2011. Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells. Nat Med 17(11):1481-9. PubMed: 22037645 MGI: J:179825
Emanuelli B; Eberle D; Suzuki R; Kahn CR. 2008. Overexpression of the dual-specificity phosphatase MKP-4/DUSP-9 protects against stress-induced insulin resistance. Proc Natl Acad Sci U S A 105(9):3545-50. PubMed: 18296638 MGI: J:132675
Endo H; Hosono K; Uchiyama T; Sakai E; Sugiyama M; Takahashi H; Nakajima N; Wada K; Takeda K; Nakagama H; Nakajima A. 2011. Leptin acts as a growth factor for colorectal tumours at stages subsequent to tumour initiation in murine colon carcinogenesis. Gut 60(10):1363-71. PubMed: 21406387 MGI: J:194453
Erickson JC; Hollopeter G; Palmiter RD. 1996. Attenuation of the obesity syndrome of ob/ob mice by the loss of neuropeptide Y. Science 274(5293):1704-7. PubMed: 8939859 MGI: J:37106
Erickson JC; Hollopeter G; Palmiter RD. 1997. On raising energy expenditure in ob/ob mice Science 276(5315):1132-3. PubMed: 9173544 MGI: J:40381
Esterhazy D; Stutzer I; Wang H; Rechsteiner MP; Beauchamp J; Dobeli H; Hilpert H; Matile H; Prummer M; Schmidt A; Lieske N; Boehm B; Marselli L; Bosco D; Kerr-Conte J; Aebersold R; Spinas GA; Moch H; Migliorini C; Stoffel M. 2011. Bace2 Is a beta Cell-Enriched Protease that Regulates Pancreatic beta Cell Function and Mass. Cell Metab 14(3):365-77. PubMed: 21907142 MGI: J:176653
Evans AA; Hughes S; Smith ME. 1995. Delta-opioid peptide receptors in muscles from obese diabetic and normal mice. Peptides 16(2):361-4. PubMed: 7784267 MGI: J:24888
Evans ZP; Ellett JD; Schmidt MG; Schnellmann RG; Chavin KD. 2008. Mitochondrial uncoupling protein-2 mediates steatotic liver injury following ischemia/reperfusion. J Biol Chem 283(13):8573-9. PubMed: 18086675 MGI: J:135165
Evans ZP; Palanisamy AP; Sutter AG; Ellett JD; Ramshesh VK; Attaway H; Schmidt MG; Schnellmann RG; Chavin KD. 2012. Mitochondrial uncoupling protein-2 deficiency protects steatotic mouse hepatocytes from hypoxia/reoxygenation. Am J Physiol Gastrointest Liver Physiol 302(3):G336-42. PubMed: 22094601 MGI: J:183315
Everard A; Lazarevic V; Derrien M; Girard M; Muccioli GG; Neyrinck AM; Possemiers S; Van Holle A; Francois P; de Vos WM; Delzenne NM; Schrenzel J; Cani PD. 2011. Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice. Diabetes 60(11):2775-86. PubMed: 21933985 MGI: J:189479
Everitt H; Hu M; Ajmo JM; Rogers CQ; Liang X; Zhang R; Yin H; Choi A; Bennett ES; You M. 2013. Ethanol administration exacerbates the abnormalities in hepatic lipid oxidation in genetically obese mice. Am J Physiol Gastrointest Liver Physiol 304(1):G38-47. PubMed: 23139221 MGI: J:194691
Faggioni R; Fantuzzi G; Gabay C; Moser A; Dinarello CA; Feingold KR ; Grunfeld C. 1999. Leptin deficiency enhances sensitivity to endotoxin-induced lethality. Am J Physiol 276(1 Pt 2):R136-42. PubMed: 9887187 MGI: J:52477
Faggioni R; Fuller J; Moser A; Feingold KR; Grunfeld C. 1997. LPS-induced anorexia in leptin-deficient (ob/ob) and leptin receptor-deficient (db/db) mice. Am J Physiol 273(1 Pt 2):R181-6. PubMed: 9249548 MGI: J:41966
Faggioni R; Jones-Carson J; Reed DA; Dinarello CA; Feingold KR; Grunfeld C; Fantuzzi G. 2000. Leptin-deficient (ob/ob) mice are protected from T cell-mediated hepatotoxicity: role of tumor necrosis factor alpha and IL-18. Proc Natl Acad Sci U S A 97(5):2367-72. PubMed: 10681432 MGI: J:60929
Fajardo RJ; Karim L; Calley VI; Bouxsein ML. 2014. A review of rodent models of type 2 diabetic skeletal fragility. J Bone Miner Res 29(5):1025-40. PubMed: 24585709 MGI: J:233235
Fan W; Boston BA; Kesterson RA; Hruby VJ; Cone RD. 1997. Role of melanocortinergic neurons in feeding and the agouti obesity syndrome [see comments] Nature 385(6612):165-8. PubMed: 8990120 MGI: J:37848
Fauconnier J; Andersson DC; Zhang SJ; Lanner JT; Wibom R; Katz A; Bruton JD; Westerblad H. 2007. Effects of palmitate on Ca(2+) handling in adult control and ob/ob cardiomyocytes: impact of mitochondrial reactive oxygen species. Diabetes 56(4):1136-42. PubMed: 17229941 MGI: J:122121
Feng D; Youn DY; Zhao X; Gao Y; Quinn WJ 3rd; Xiaoli AM; Sun Y; Birnbaum MJ; Pessin JE; Yang F. 2015. mTORC1 Down-Regulates Cyclin-Dependent Kinase 8 (CDK8) and Cyclin C (CycC). PLoS One 10(6):e0126240. PubMed: 26042770 MGI: J:233814
Ferrante AW Jr; Thearle M; Liao T; Leibel RL. 2001. Effects of leptin deficiency and short-term repletion on hepatic gene expression in genetically obese mice. Diabetes 50(10):2268-78. PubMed: 11574408 MGI: J:71975
Ferrara CT; Wang P; Neto EC; Stevens RD; Bain JR; Wenner BR; Ilkayeva OR; Keller MP; Blasiole DA; Kendziorski C; Yandell BS; Newgard CB; Attie AD. 2008. Genetic networks of liver metabolism revealed by integration of metabolic and transcriptional profiling. PLoS Genet 4(3):e1000034. PubMed: 18369453 MGI: J:134375
Feuerer M; Herrero L; Cipolletta D; Naaz A; Wong J; Nayer A; Lee J; Goldfine AB; Benoist C; Shoelson S; Mathis D. 2009. Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nat Med 15(8):930-9. PubMed: 19633656 MGI: J:152186
Finger BC; Dinan TG; Cryan JF. 2010. Progressive ratio responding in an obese mouse model: Effects of fenfluramine. Neuropharmacology 59(7-8):619-26. PubMed: 20727362 MGI: J:178515
Flaveny CA; Griffett K; El-Gendy Bel-D; Kazantzis M; Sengupta M; Amelio AL; Chatterjee A; Walker J; Solt LA; Kamenecka TM; Burris TP. 2015. Broad Anti-tumor Activity of a Small Molecule that Selectively Targets the Warburg Effect and Lipogenesis. Cancer Cell 28(1):42-56. PubMed: 26120082 MGI: J:223001
Fleig SV; Choi SS; Yang L; Jung Y; Omenetti A; VanDongen HM; Huang J; Sicklick JK; Diehl AM. 2007. Hepatic accumulation of Hedgehog-reactive progenitors increases with severity of fatty liver damage in mice. Lab Invest 87(12):1227-39. PubMed: 17952094 MGI: J:128723
Flowers JB; Rabaglia ME; Schueler KL; Flowers MT; Lan H; Keller MP; Ntambi JM; Attie AD. 2007. Loss of stearoyl-CoA desaturase-1 improves insulin sensitivity in lean mice but worsens diabetes in leptin-deficient obese mice. Diabetes 56(5):1228-39. PubMed: 17369521 MGI: J:122081
Fontaine DA; Davis DB. 2016. Attention to Background Strain Is Essential for Metabolic Research: C57BL/6 and the International Knockout Mouse Consortium. Diabetes 65(1):25-33. PubMed: 26696638 MGI: J:231066
Frank S; Stallmeyer B; Kampfer H; Kolb N; Pfeilschifter J. 2000. Leptin enhances wound re-epithelialization and constitutes a direct function of leptin in skin repair. J Clin Invest 106(4):501-9. PubMed: 10953025 MGI: J:112351
Fransson L; Rosengren V; Saha TK; Grankvist N; Islam T; Honkanen RE; Sjoholm A; Ortsater H. 2014. Mitogen-activated protein kinases and protein phosphatase 5 mediate glucocorticoid-induced cytotoxicity in pancreatic islets and beta-cells. Mol Cell Endocrinol 383(1-2):126-36. PubMed: 24361515 MGI: J:211851
Fraser DC; Srivastava J; Woodward CJ; Simpson AE; Jones RB. 1998. A molecular investigation of the obese phenotype in the Aston University strain of ob/ob mice and the Japanese Kuo Kondo mice. Int J Obes Relat Metab Disord 22(2):193-4. PubMed: 9504329 MGI: J:45748
Frohnert BI; Long EK; Hahn WS; Bernlohr DA. 2014. Glutathionylated lipid aldehydes are products of adipocyte oxidative stress and activators of macrophage inflammation. Diabetes 63(1):89-100. PubMed: 24062247 MGI: J:208916
Fruhbeck G; Aguado M; Martinez JA. 1997. In vitro lipolytic effect of leptin on mouse adipocytes: evidence for a possible autocrine/paracrine role of leptin. Biochem Biophys Res Commun 240(3):590-4. PubMed: 9398609 MGI: J:44321
Fu L; John LM; Adams SH; Yu XX; Tomlinson E; Renz M; Williams PM; Soriano R; Corpuz R; Moffat B; Vandlen R; Simmons L; Foster J; Stephan JP; Tsai SP; Stewart TA. 2004. Fibroblast growth factor 19 increases metabolic rate and reverses dietary and leptin-deficient diabetes. Endocrinology 145(6):2594-603. PubMed: 14976145 MGI: J:133073
Fu S; Yang L; Li P; Hofmann O; Dicker L; Hide W; Lin X; Watkins SM; Ivanov AR; Hotamisligil GS. 2011. Aberrant lipid metabolism disrupts calcium homeostasis causing liver endoplasmic reticulum stress in obesity. Nature 473(7348):528-31. PubMed: 21532591 MGI: J:172129
Fujii Y; Okada A; Yasui T; Niimi K; Hamamoto S; Hirose M; Kubota Y; Tozawa K; Hayashi Y; Kohri K. 2013. Effect of adiponectin on kidney crystal formation in metabolic syndrome model mice via inhibition of inflammation and apoptosis. PLoS One 8(4):e61343. PubMed: 23630583 MGI: J:200567
Fujimoto W; Shiuchi T; Miki T; Minokoshi Y; Takahashi Y; Takeuchi A; Kimura K; Saito M; Iwanaga T; Seino S. 2007. Dmbx1 is essential in agouti-related protein action. Proc Natl Acad Sci U S A 104(39):15514-9. PubMed: 17873059 MGI: J:125193
Fujita H; Yagishita N; Aratani S; Saito-Fujita T; Morota S; Yamano Y; Hansson MJ; Inazu M; Kokuba H; Sudo K; Sato E; Kawahara K; Nakajima F; Hasegawa D; Higuchi I; Sato T; Araya N; Usui C; Nishioka K; Nakatani Y; Maruyama I; Usui M; Hara N; Uchino H; Elmer E; Nishioka K; Nakajima T. 2015. The E3 ligase synoviolin controls body weight and mitochondrial biogenesis through negative regulation of PGC-1beta. EMBO J 34(8):1042-55. PubMed: 25698262 MGI: J:220710
Fujita Y; Fujii T; Mimori T; Sato T; Nakamura T; Iwao H; Nakajima A; Miki M; Sakai T; Kawanami T; Tanaka M; Masaki Y; Fukushima T; Okazaki T; Umehara H. 2014. Deficient leptin signaling ameliorates systemic lupus erythematosus lesions in MRL/Mp-Fas lpr mice. J Immunol 192(3):979-84. PubMed: 24391210 MGI: J:207299
Fukuda D; Aikawa E; Swirski FK; Novobrantseva TI; Kotelianski V; Gorgun CZ; Chudnovskiy A; Yamazaki H; Croce K; Weissleder R; Aster JC; Hotamisligil GS; Yagita H; Aikawa M. 2012. Notch ligand Delta-like 4 blockade attenuates atherosclerosis and metabolic disorders. Proc Natl Acad Sci U S A 109(27):E1868-77. PubMed: 22699504 MGI: J:186429
Fulton S; Pissios P; Manchon RP; Stiles L; Frank L; Pothos EN; Maratos-Flier E; Flier JS. 2006. Leptin regulation of the mesoaccumbens dopamine pathway. Neuron 51(6):811-22. PubMed: 16982425 MGI: J:113646
Funato H; Tsai AL; Willie JT; Kisanuki Y; Williams SC; Sakurai T; Yanagisawa M. 2009. Enhanced orexin receptor-2 signaling prevents diet-induced obesity and improves leptin sensitivity. Cell Metab 9(1):64-76. PubMed: 19117547 MGI: J:144346
Galgani M; Procaccini C; De Rosa V; Carbone F; Chieffi P; La Cava A; Matarese G. 2010. Leptin modulates the survival of autoreactive CD4+ T cells through the nutrient/energy-sensing mammalian target of rapamycin signaling pathway. J Immunol 185(12):7474-9. PubMed: 21078910 MGI: J:167460
Galvez BG ; San Martin N ; Rodriguez C. 2009. TNF-alpha is required for the attraction of mesenchymal precursors to white adipose tissue in Ob/ob mice. PLoS One 4(2):e4444. PubMed: 19214223 MGI: J:146626
Gao D; Wei C; Chen L; Huang J; Yang S; Diehl AM. 2004. Oxidative DNA damage and DNA repair enzyme expression are inversely related in murine models of fatty liver disease. Am J Physiol Gastrointest Liver Physiol 287(5):G1070-7. PubMed: 15231485 MGI: J:96152
Gao H; Bryzgalova G; Hedman E; Khan A; Efendic S; Gustafsson JA; Dahlman-Wright K. 2006. Long-term administration of estradiol decreases expression of hepatic lipogenic genes and improves insulin sensitivity in ob/ob mice: a possible mechanism is through direct regulation of signal transducer and activator of transcription 3. Mol Endocrinol 20(6):1287-99. PubMed: 16627594 MGI: J:108950
Gao J; He J; Shi X; Stefanovic-Racic M; Xu M; O'Doherty RM; Garcia-Ocana A; Xie W. 2012. Sex-specific effect of estrogen sulfotransferase on mouse models of type 2 diabetes. Diabetes 61(6):1543-51. PubMed: 22438574 MGI: J:196848
Gao Q; Jia Y; Yang G; Zhang X; Boddu PC; Petersen B; Narsingam S; Zhu YJ; Thimmapaya B; Kanwar YS; Reddy JK. 2015. PPARalpha-Deficient ob/ob Obese Mice Become More Obese and Manifest Severe Hepatic Steatosis Due to Decreased Fatty Acid Oxidation. Am J Pathol 185(5):1396-408. PubMed: 25773177 MGI: J:220678
Gao Y; Ottaway N; Schriever SC; Legutko B; Garcia-Caceres C; de la Fuente E; Mergen C; Bour S; Thaler JP; Seeley RJ; Filosa J; Stern JE; Perez-Tilve D; Schwartz MW; Tschop MH; Yi CX. 2014. Hormones and diet, but not body weight, control hypothalamic microglial activity. Glia 62(1):17-25. PubMed: 24166765 MGI: J:203061
Garcia-Guerra L; Nieto-Vazquez I; Vila-Bedmar R; Jurado-Pueyo M; Zalba G; Diez J; Murga C; Fernandez-Veledo S; Mayor F Jr; Lorenzo M. 2010. G protein-coupled receptor kinase 2 plays a relevant role in insulin resistance and obesity. Diabetes 59(10):2407-17. PubMed: 20627936 MGI: J:169625
Garris DR. 2004. Ultrastructural analysis of progressive endometrial hypercytolipidemia induced by obese (ob/ob) and diabetes (db/db) genotype mutations: structural basis of female reproductive tract involution. Tissue Cell 36(1):19-28. PubMed: 14729450 MGI: J:102445
Garris DR; Garris BL. 2004. Genomic modulation of diabetes (db/db) and obese (ob/ob) mutation-induced hypercytolipidemia: cytochemical basis of female reproductive tract involution. Cell Tissue Res 316(2):233-41. PubMed: 15024641 MGI: J:105101
Gautam D; Gavrilova O; Jeon J; Pack S; Jou W; Cui Y; Li JH; Wess J. 2006. Beneficial metabolic effects of M3 muscarinic acetylcholine receptor deficiency. Cell Metab 4(5):363-75. PubMed: 17084710 MGI: J:129745
Gavrilescu LC; Butcher BA; Del Rio L; Taylor GA; Denkers EY. 2004. STAT1 is essential for antimicrobial effector function but dispensable for gamma interferon production during Toxoplasma gondii infection. Infect Immun 72(3):1257-64. PubMed: 14977926 MGI: J:88582
Gavrilova O; Barr V; Marcus-Samuels B; Reitman M. 1997. Hyperleptinemia of pregnancy associated with the appearance of a circulating form of the leptin receptor. J Biol Chem 272(48):30546-51. PubMed: 9374549 MGI: J:44331
Gavrilova O; Leon LR; Marcus-Samuels B; Mason MM; Castle AL; Refetoff S; Vinson C; Reitman ML. 1999. Torpor in mice is induced by both leptin-dependent and -independent mechanisms. Proc Natl Acad Sci U S A 96(25):14623-8. PubMed: 10588755 MGI: J:58946
Gazit V; Weymann A; Hartman E; Finck BN; Hruz PW; Tzekov A; Rudnick DA. 2010. Liver regeneration is impaired in lipodystrophic fatty liver dystrophy mice. Hepatology 52(6):2109-17. PubMed: 20967828 MGI: J:204049
Ge F; Zhou S; Hu C; Lobdell H th; Berk PD. 2010. Insulin- and leptin-regulated fatty acid uptake plays a key causal role in hepatic steatosis in mice with intact leptin signaling but not in ob/ob or db/db mice. Am J Physiol Gastrointest Liver Physiol 299(4):G855-66. PubMed: 20595619 MGI: J:165834
Ge H; Gardner J; Wu X; Rulifson I; Wang J; Xiong Y; Ye J; Belouski E; Cao P; Tang J; Lee KJ; Coberly S; Wu X; Gupte J; Miao L; Yang L; Nguyen N; Shan B; Yeh WC; Veniant MM; Li Y; Baribault H. 2015. Trefoil Factor 3 (TFF3) Is Regulated by Food Intake, Improves Glucose Tolerance and Induces Mucinous Metaplasia. PLoS One 10(6):e0126924. PubMed: 26083576 MGI: J:237799
Gembardt F; Bartaun C; Jarzebska N; Mayoux E; Todorov VT; Hohenstein B; Hugo C. 2014. The SGLT2 inhibitor empagliflozin ameliorates early features of diabetic nephropathy in BTBR ob/ob type 2 diabetic mice with and without hypertension. Am J Physiol Renal Physiol 307(3):F317-25. PubMed: 24944269 MGI: J:212183
Gentric G; Maillet V; Paradis V; Couton D; L'Hermitte A; Panasyuk G; Fromenty B; Celton-Morizur S; Desdouets C. 2015. Oxidative stress promotes pathologic polyploidization in nonalcoholic fatty liver disease. J Clin Invest 125(3):981-92. PubMed: 25621497 MGI: J:220381
Gerin I; Louis GW; Zhang X; Prestwich TC; Kumar TR; Myers MG Jr; Macdougald OA; Nothnick WB. 2009. Hyperphagia and obesity in female mice lacking tissue inhibitor of metalloproteinase-1. Endocrinology 150(4):1697-704. PubMed: 19036876 MGI: J:158084
Getchell TV; Kwong K; Saunders CP; Stromberg AJ; Getchell ML. 2006. Leptin regulates olfactory-mediated behavior in ob/ob mice. Physiol Behav 87(5):848-56. PubMed: 16549076 MGI: J:112820
Gettys TW; Watson PM; Seger L; Padgett M; Taylor IL. 1997. Adrenalectomy after weaning restores beta3-adrenergic receptor expression in white adipocytes from C57BL/6J-ob/ob mice. Endocrinology 138(7):2697-704. PubMed: 9202206 MGI: J:41996
Ghamari-Langroudi M; Srisai D; Cone RD. 2011. Multinodal regulation of the arcuate/paraventricular nucleus circuit by leptin. Proc Natl Acad Sci U S A 108(1):355-60. PubMed: 21169216 MGI: J:169023
Gimenez-Cassina A; Garcia-Haro L; Choi CS; Osundiji MA; Lane EA; Huang H; Yildirim MA; Szlyk B; Fisher JK; Polak K; Patton E; Wiwczar J; Godes M; Lee DH; Robertson K; Kim S; Kulkarni A; Distefano A; Samuel V; Cline G; Kim YB; Shulman GI; Danial NN. 2014. Regulation of hepatic energy metabolism and gluconeogenesis by BAD. Cell Metab 19(2):272-84. PubMed: 24506868 MGI: J:210651
Gimeno RE; Dembski M; Weng X; Deng N; Shyjan AW; Gimeno CJ; Iris F; Ellis SJ; Woolf EA; Tartaglia LA. 1997. Cloning and characterization of an uncoupling protein homolog: a potential molecular mediator of human thermogenesis. Diabetes 46(5):900-6. PubMed: 9133562 MGI: J:40062
Giordano A; Murano I; Mondini E; Perugini J; Smorlesi A; Severi I; Barazzoni R; Scherer PE; Cinti S. 2013. Obese adipocytes show ultrastructural features of stressed cells and die of pyroptosis. J Lipid Res 54(9):2423-36. PubMed: 23836106 MGI: J:200764
Gloaguen I; Costa P; Demartis A; Lazzaro D; Di Marco A; Graziani R ; Paonessa G ; Chen F ; Rosenblum CI ; Van der Ploeg LH ; Cortese R ; Ciliberto G ; Laufer R. 1997. Ciliary neurotrophic factor corrects obesity and diabetes associated with leptin deficiency and resistance. Proc Natl Acad Sci U S A 94(12):6456-61. PubMed: 9177239 MGI: J:40976
Golson ML; Bush WS; Brissova M. 2014. Automated quantification of pancreatic beta-cell mass. Am J Physiol Endocrinol Metab 306(12):E1460-7. PubMed: 24760991 MGI: J:214769
Gomez JA; Rutkowski DT. 2016. Experimental reconstitution of chronic ER stress in the liver reveals feedback suppression of BiP mRNA expression. Elife 5:. PubMed: 27938665 MGI: J:239449
Gonzalez-Periz A; Horrillo R; Ferre N; Gronert K; Dong B; Moran-Salvador E; Titos E; Martinez-Clemente M; Lopez-Parra M; Arroyo V; Claria J. 2009. Obesity-induced insulin resistance and hepatic steatosis are alleviated by omega-3 fatty acids: a role for resolvins and protectins. FASEB J 23(6):1946-57. PubMed: 19211925 MGI: J:150547
Goren I; Kampfer H; Muller E; Schiefelbein D; Pfeilschifter J; Frank S. 2006. Oncostatin M expression is functionally connected to neutrophils in the early inflammatory phase of skin repair: implications for normal and diabetes-impaired wounds. J Invest Dermatol 126(3):628-37. PubMed: 16410783 MGI: J:106761
Goren I; Kampfer H; Podda M; Pfeilschifter J; Frank S. 2003. Leptin and wound inflammation in diabetic ob/ob mice: differential regulation of neutrophil and macrophage influx and a potential role for the scab as a sink for inflammatory cells and mediators. Diabetes 52(11):2821-32. PubMed: 14578302 MGI: J:86305
Goren I; Muller E; Pfeilschifter J; Frank S. 2006. Severely impaired insulin signaling in chronic wounds of diabetic ob/ob mice: a potential role of tumor necrosis factor-alpha. Am J Pathol 168(3):765-77. PubMed: 16507892 MGI: J:106484
Goren I; Pfeilschifter J; Frank S. 2014. Uptake of neutrophil-derived ym1 protein distinguishes wound macrophages in the absence of interleukin-4 signaling in murine wound healing. Am J Pathol 184(12):3249-61. PubMed: 25307347 MGI: J:216580
Goudriaan JR; Tacken PJ; Dahlmans VE; Gijbels MJ; van Dijk KW; Havekes LM; Jong MC. 2001. Protection from obesity in mice lacking the VLDL receptor. Arterioscler Thromb Vasc Biol 21(9):1488-93. PubMed: 11557677 MGI: J:102939
Graham MJ; Lee RG; Bell TA 3rd; Fu W; Mullick AE; Alexander VJ; Singleton W; Viney N; Geary R; Su J; Baker BF; Burkey J; Crooke ST; Crooke RM. 2013. Antisense oligonucleotide inhibition of apolipoprotein C-III reduces plasma triglycerides in rodents, nonhuman primates, and humans. Circ Res 112(11):1479-90. PubMed: 23542898 MGI: J:213303
Gray SL; Nora ED; Grosse J; Manieri M; Stoeger T; Medina-Gomez G; Burling K; Wattler S; Russ A; Yeo GS; Chatterjee VK; O'Rahilly S; Voshol PJ; Cinti S; Vidal-Puig A. 2006. Leptin deficiency unmasks the deleterious effects of impaired peroxisome proliferator-activated receptor gamma function (P465L PPARgamma) in mice. Diabetes 55(10):2669-77. PubMed: 17003330 MGI: J:116568
Grefhorst A; van Dijk TH; Hammer A; van der Sluijs FH; Havinga R; Havekes LM; Romijn JA; Groot PH; Reijngoud DJ; Kuipers F. 2005. Differential effects of pharmacological liver X receptor activation on hepatic and peripheral insulin sensitivity in lean and ob/ob mice. Am J Physiol Endocrinol Metab 289(5):E829-38. PubMed: 15941783 MGI: J:102451
Gropler MC; Harris TE; Hall AM; Wolins NE; Gross RW; Han X; Chen Z; Finck BN. 2009. Lipin 2 is a liver-enriched phosphatidate phosphohydrolase enzyme that is dynamically regulated by fasting and obesity in mice. J Biol Chem 284(11):6763-72. PubMed: 19136718 MGI: J:148371
Grosbellet E; Gourmelen S; Pevet P; Criscuolo F; Challet E. 2015. Leptin normalizes photic synchronization in male ob/ob mice, via indirect effects on the suprachiasmatic nucleus. Endocrinology 156(3):1080-90. PubMed: 25521581 MGI: J:221508
Gruen ML; Plummer MR; Zhang W; Posey KA; Linton M; Fazio S; Hasty AH. 2005. Persistence of high density lipoprotein particles in obese mice lacking apolipoprotein A-I. J Lipid Res 46(9):2007-14. PubMed: 15995171 MGI: J:100492
Grueter CE; van Rooij E; Johnson BA; DeLeon SM; Sutherland LB; Qi X; Gautron L; Elmquist JK; Bassel-Duby R; Olson EN. 2012. A cardiac microRNA governs systemic energy homeostasis by regulation of MED13. Cell 149(3):671-83. PubMed: 22541436 MGI: J:186193
Gunapala KM; Gallardo CM; Hsu CT; Steele AD. 2011. Single gene deletions of orexin, leptin, neuropeptide Y, and ghrelin do not appreciably alter food anticipatory activity in mice. PLoS One 6(3):e18377. PubMed: 21464907 MGI: J:223914
Gundewar S; Calvert JW; Elrod JW; Lefer DJ. 2007. Cytoprotective effects of N,N,N-trimethylsphingosine during ischemia- reperfusion injury are lost in the setting of obesity and diabetes. Am J Physiol Heart Circ Physiol 293(4):H2462-71. PubMed: 17630348 MGI: J:126117
Guo KY; Halo P; Leibel RL; Zhang Y. 2004. Effects of obesity on the relationship of leptin mRNA expression and adipocyte size in anatomically distinct fat depots in mice. Am J Physiol Regul Integr Comp Physiol 287(1):R112-9. PubMed: 15001430 MGI: J:109323
Guo L; Zhou SR; Wei XB; Liu Y; Chang XX; Liu Y; Ge X; Dou X; Huang HY; Qian SW; Li X; Lei QY; Gao X; Tang QQ. 2016. Acetylation of Mitochondrial Trifunctional Protein alpha-Subunit Enhances Its Stability To Promote Fatty Acid Oxidation and Is Decreased in Nonalcoholic Fatty Liver Disease. Mol Cell Biol 36(20):2553-67. PubMed: 27457618 MGI: J:236308
Guo T; Bond ND; Jou W; Gavrilova O; Portas J; McPherron AC. 2012. Myostatin inhibition prevents diabetes and hyperphagia in a mouse model of lipodystrophy. Diabetes 61(10):2414-23. PubMed: 22596054 MGI: J:208455
Guo Y; Fan Y; Zhang J; Lomberk GA; Zhou Z; Sun L; Mathison AJ; Garcia-Barrio MT; Zhang J; Zeng L; Li L; Pennathur S; Willer CJ; Rader DJ; Urrutia R; Chen YE. 2015. Perhexiline activates KLF14 and reduces atherosclerosis by modulating ApoA-I production. J Clin Invest 125(10):3819-30. PubMed: 26368306 MGI: J:226403
Gupte A; Mora S. 2006. Activation of the Cbl insulin signaling pathway in cardiac muscle; dysregulation in obesity and diabetes. Biochem Biophys Res Commun 342(3):751-7. PubMed: 16494846 MGI: J:106781
Gustavsson N; Abedi G; Larsson-Nyren G; Lindstrom P. 2006. Timing of Ca2+ response in pancreatic beta-cells is related to mitochondrial mass. Biochem Biophys Res Commun 340(4):1119-24. PubMed: 16414347 MGI: J:104995
Gutierrez DA; Muralidhar S; Feyerabend TB; Herzig S; Rodewald HR. 2015. Hematopoietic Kit Deficiency, rather than Lack of Mast Cells, Protects Mice from Obesity and Insulin Resistance. Cell Metab 21(5):678-91. PubMed: 25955205 MGI: J:225848
Hahm S; Fekete C; Mizuno TM; Windsor J; Yan H; Boozer CN; Lee C; Elmquist JK; Lechan RM; Mobbs CV; Salton SR. 2002. VGF is required for obesity induced by diet, gold thioglucose treatment, and agouti and is differentially regulated in pro-opiomelanocortin- and neuropeptide Y-containing arcuate neurons in response to fasting. J Neurosci 22(16):6929-38. PubMed: 12177191 MGI: J:124244
Hajri T; Hall AM; Jensen DR; Pietka TA; Drover VA; Tao H; Eckel R; Abumrad NA. 2007. CD36-facilitated fatty acid uptake inhibits leptin production and signaling in adipose tissue. Diabetes 56(7):1872-80. PubMed: 17440173 MGI: J:126461
Hakansson-Ovesjo ML; Collin M; Meister B. 2000. Down-regulated STAT3 messenger ribonucleic acid and STAT3 protein in the hypothalamic arcuate nucleus of the obese leptin-deficient (ob/ob) mouse Endocrinology 141(11):3946-55. PubMed: 11089524 MGI: J:65568
Halaas JL; Gajiwala KS; Maffei M; Cohen SL; Chait BT; Rabinowitz D; Lallone RL; Burley SK; Friedman JM. 1995. Weight-reducing effects of the plasma protein encoded by the obese gene [see comments] Science 269(5223):543-6. PubMed: 7624777 MGI: J:29161
Hale C; Chen MM; Stanislaus S; Chinookoswong N; Hager T; Wang M; Veniant MM; Xu J. 2012. Lack of overt FGF21 resistance in two mouse models of obesity and insulin resistance. Endocrinology 153(1):69-80. PubMed: 22067317 MGI: J:181652
Hall AM; Brunt EM; Chen Z; Viswakarma N; Reddy JK; Wolins NE; Finck BN. 2010. Dynamic and differential regulation of proteins that coat lipid droplets in fatty liver dystrophic mice. J Lipid Res 51(3):554-63. PubMed: 19749180 MGI: J:159055
Hall AM; Soufi N; Chambers KT; Chen Z; Schweitzer GG; McCommis KS; Erion DM; Graham MJ; Su X; Finck BN. 2014. Abrogating monoacylglycerol acyltransferase activity in liver improves glucose tolerance and hepatic insulin signaling in obese mice. Diabetes 63(7):2284-96. PubMed: 24595352 MGI: J:229497
Haller EW; Wittmers LE Jr; Haller IV; Regal RR. 1999. The obese gene is expressed in lean littermates of the genetically obese mouse (C57BL/6J ob/ob). Am J Physiol 276(4 Pt 1):E762-5. PubMed: 10198314 MGI: J:54704
Haluzik M; Colombo C; Gavrilova O; Chua S; Wolf N; Chen M; Stannard B; Dietz KR; Le Roith D; Reitman ML. 2004. Genetic background (C57BL/6J versus FVB/N) strongly influences the severity of diabetes and insulin resistance in ob/ob mice. Endocrinology 145(7):3258-64. PubMed: 15059949 MGI: J:90742
Hamm ML; Bhat GK; Thompson WE; Mann DR. 2004. Folliculogenesis is impaired and granulosa cell apoptosis is increased in leptin-deficient mice. Biol Reprod 71(1):66-72. PubMed: 14985253 MGI: J:91001
Hamrick MW; Pennington C; Newton D; Xie D; Isales C. 2004. Leptin deficiency produces contrasting phenotypes in bones of the limb and spine. Bone 34(3):376-83. PubMed: 15003785 MGI: J:88559
Han C; Jiao Y; Zhao Q; Lu B. 2014. Mex3c mutation reduces adiposity partially through increasing physical activity. J Endocrinol 221(3):457-68. PubMed: 24741071 MGI: J:226660
Han C; Zhao Q; Lu B. 2013. The role of nitric oxide signaling in food intake; insights from the inner mitochondrial membrane peptidase 2 mutant mice. Redox Biol 1:498-507. PubMed: 24251118 MGI: J:223189
Han CY; Subramanian S; Chan CK; Omer M; Chiba T; Wight TN; Chait A. 2007. Adipocyte-derived serum amyloid A3 and hyaluronan play a role in monocyte recruitment and adhesion. Diabetes 56(9):2260-73. PubMed: 17563062 MGI: J:126587
Han YM; Kang GM; Byun K; Ko HW; Kim J; Shin MS; Kim HK; Gil SY; Yu JH; Lee B; Kim MS. 2014. Leptin-promoted cilia assembly is critical for normal energy balance. J Clin Invest 124(5):2193-7. PubMed: 24667636 MGI: J:212773
Hao M; Head WS; Gunawardana SC; Hasty AH; Piston DW. 2007. Direct effect of cholesterol on insulin secretion: a novel mechanism for pancreatic beta-cell dysfunction. Diabetes 56(9):2328-38. PubMed: 17575085 MGI: J:126584
Harris RB. 1999. Parabiosis between db/db and ob/ob or db/+ mice. Endocrinology 140(1):138-45. PubMed: 9886818 MGI: J:114258
Harris RB; Hausman DB; Bartness TJ. 2002. Compensation for partial lipectomy in mice with genetic alterations of leptin and its receptor subtypes. Am J Physiol Regul Integr Comp Physiol 283(5):R1094-103. PubMed: 12376403 MGI: J:113622
Harris RB; Zhou J; Redmann SM Jr; Smagin GN; Smith SR; Rodgers E; Zachwieja JJ. 1998. A leptin dose-response study in obese (ob/ob) and lean (+/?) mice. Endocrinology 139(1):8-19. PubMed: 9421392 MGI: J:44829
Hasan M; Gonugunta VK; Dobbs N; Ali A; Palchik G; Calvaruso MA; DeBerardinis RJ; Yan N. 2017. Chronic innate immune activation of TBK1 suppresses mTORC1 activity and dysregulates cellular metabolism. Proc Natl Acad Sci U S A 114(4):746-751. PubMed: 28069950 MGI: J:239522
Hasegawa T; Ito Y; Wijeweera J; Liu J; Malle E; Farhood A; McCuskey RS; Jaeschke H. 2007. Reduced inflammatory response and increased microcirculatory disturbances during hepatic ischemia-reperfusion injury in steatotic livers of ob/ob mice. Am J Physiol Gastrointest Liver Physiol 292(5):G1385-95. PubMed: 17307725 MGI: J:122631
Hasty AH; Shimano H; Osuga Ji; Namatame I; Takahashi A; Yahagi N; Perrey S; Iizuka Y; Tamura Y; Amemiya-Kudo M; Yoshikawa T; Okazaki H; Ohashi K; Harada K; Matsuzaka T; Sone H; Gotoda T; Nagai R; Ishibashi S; Yamada N. 2001. Severe hypercholesterolemia, hypertriglyceridemia, and atherosclerosis in mice lacking both leptin and the low density lipoprotein receptor. J Biol Chem 276(40):37402-8. PubMed: 11445560 MGI: J:72027
Hawke Z; Ivanov TR; Bechtold DA; Dhillon H; Lowell BB; Luckman SM. 2009. PACAP neurons in the hypothalamic ventromedial nucleus are targets of central leptin signaling. J Neurosci 29(47):14828-35. PubMed: 19940178 MGI: J:158472
Hayashi T; Cottam HB; Chan M; Jin G; Tawatao RI; Crain B; Ronacher L; Messer K; Carson DA; Corr M. 2008. Mast cell-dependent anorexia and hypothermia induced by mucosal activation of Toll-like receptor 7. Am J Physiol Regul Integr Comp Physiol 295(1):R123-32. PubMed: 18480244 MGI: J:148644
He J; Gao J; Xu M; Ren S; Stefanovic-Racic M; O'Doherty RM; Xie W. 2013. PXR ablation alleviates diet-induced and genetic obesity and insulin resistance in mice. Diabetes 62(6):1876-87. PubMed: 23349477 MGI: J:208575
Hedbacker K; Birsoy K; Wysocki RW; Asilmaz E; Ahima RS; Farooqi IS; Friedman JM. 2010. Antidiabetic effects of IGFBP2, a leptin-regulated gene. Cell Metab 11(1):11-22. PubMed: 20074524 MGI: J:157004
Heep H; Wedemeyer C; Wegner A; Hofmeister S; von Knoch M. 2008. Differences in trabecular bone of leptin-deficient ob/ob mice in response to biomechanical loading. Int J Biol Sci 4(3):169-75. PubMed: 18566694 MGI: J:161105
Heffernan M; Summers RJ; Thorburn A; Ogru E; Gianello R; Jiang WJ; Ng FM. 2001. The effects of human GH and its lipolytic fragment (AOD9604) on lipid metabolism following chronic treatment in obese mice and beta(3)-AR knock-out mice. Endocrinology 142(12):5182-9. PubMed: 11713213 MGI: J:115409
Hemi R; Yochananov Y; Barhod E; Kasher-Meron M; Karasik A; Tirosh A; Kanety H. 2011. p38 mitogen-activated protein kinase-dependent transactivation of ErbB receptor family: a novel common mechanism for stress-induced IRS-1 serine phosphorylation and insulin resistance. Diabetes 60(4):1134-45. PubMed: 21386087 MGI: J:171748
Henderson RB; Hobbs JA; Mathies M; Hogg N. 2003. Rapid recruitment of inflammatory monocytes is independent of neutrophil migration. Blood 102(1):328-35. PubMed: 12623845 MGI: J:115516
Henkel JS; Beers DR; Siklos L; Appel SH. 2006. The chemokine MCP-1 and the dendritic and myeloid cells it attracts are increased in the mSOD1 mouse model of ALS. Mol Cell Neurosci 31(3):427-37. PubMed: 16337133 MGI: J:106862
Henriksbo BD; Lau TC; Cavallari JF; Denou E; Chi W; Lally JS; Crane JD; Duggan BM; Foley KP; Fullerton MD; Tarnopolsky MA; Steinberg GR; Schertzer JD. 2014. Fluvastatin causes NLRP3 inflammasome-mediated adipose insulin resistance. Diabetes 63(11):3742-7. PubMed: 24917577 MGI: J:230097
Herberg L; Coleman DL. 1977. Laboratory animals exhibiting obesity and diabetes syndromes. Metabolism 26(1):59-99. PubMed: 834144 MGI: J:5759
Herrero L; Shapiro H; Nayer A; Lee J; Shoelson SE. 2010. Inflammation and adipose tissue macrophages in lipodystrophic mice. Proc Natl Acad Sci U S A 107(1):240-5. PubMed: 20007767 MGI: J:156490
Hick RW; Gruver AL; Ventevogel MS; Haynes BF; Sempowski GD. 2006. Leptin selectively augments thymopoiesis in leptin deficiency and lipopolysaccharide-induced thymic atrophy. J Immunol 177(1):169-76. PubMed: 16785512 MGI: J:134403
Hinoi E; Gao N; Jung DY; Yadav V; Yoshizawa T; Myers MG Jr; Chua SC Jr; Kim JK; Kaestner KH; Karsenty G. 2008. The sympathetic tone mediates leptin's inhibition of insulin secretion by modulating osteocalcin bioactivity. J Cell Biol 183(7):1235-42. PubMed: 19103808 MGI: J:145998
Hinoi E; Iezaki T; Ozaki K; Yoneda Y. 2014. Nuclear factor-kappaB is a common upstream signal for growth differentiation factor-5 expression in brown adipocytes exposed to pro-inflammatory cytokines and palmitate. Biochem Biophys Res Commun 452(4):974-9. PubMed: 25223801 MGI: J:220087
Hinoi E; Nakamura Y; Takada S; Fujita H; Iezaki T; Hashizume S; Takahashi S; Odaka Y; Watanabe T; Yoneda Y. 2014. Growth differentiation factor-5 promotes brown adipogenesis in systemic energy expenditure. Diabetes 63(1):162-75. PubMed: 24062245 MGI: J:208918
Hirasawa T; Ohara T; Makino S. 1997. Genetic typing of the mouse ob mutation by PCR and restriction enzyme analysis. Exp Anim 46(1):75-8. PubMed: 9027475 MGI: J:41265
Hirata A; Maeda N; Hiuge A; Hibuse T; Fujita K; Okada T; Kihara S; Funahashi T; Shimomura I. 2009. Blockade of mineralocorticoid receptor reverses adipocyte dysfunction and insulin resistance in obese mice. Cardiovasc Res 84(1):164-72. PubMed: 19505930 MGI: J:172486
Hirosumi J; Tuncman G; Chang L; Gorgun CZ; Uysal KT; Maeda K; Karin M; Hotamisligil GS. 2002. A central role for JNK in obesity and insulin resistance. Nature 420(6913):333-6. PubMed: 12447443 MGI: J:80452
Hiuge-Shimizu A; Maeda N; Hirata A; Nakatsuji H; Nakamura K; Okuno A; Kihara S; Funahashi T; Shimomura I. 2011. Dynamic changes of adiponectin and S100A8 levels by the selective peroxisome proliferator-activated receptor-gamma agonist rivoglitazone. Arterioscler Thromb Vasc Biol 31(4):792-9. PubMed: 21233451 MGI: J:184170
Hochgeschwender U; Costa JL; Reed P; Bui S; Brennan MB. 2003. Altered glucose homeostasis in proopiomelanocortin-null mouse mutants lacking central and peripheral melanocortin. Endocrinology 144(12):5194-202. PubMed: 12970157 MGI: J:87246
Hoffmann A; Manjowk GM; Wagner IV; Kloting N; Ebert T; Jessnitzer B; Lossner U; Stukenborg JB; Bluher M; Stumvoll M; Soder O; Svechnikov K; Fasshauer M; Kralisch S. 2016. Leptin Within the Subphysiological to Physiological Range Dose Dependently Improves Male Reproductive Function in an Obesity Mouse Model. Endocrinology 157(6):2461-8. PubMed: 27105383 MGI: J:235165
Hoggard N; Cruickshank M; Moar KM; Barrett P; Bashir S; Miller JD. 2009. Inhibin betaB expression in murine adipose tissue and its regulation by leptin, insulin and dexamethasone. J Mol Endocrinol 43(4):171-7. PubMed: 19491194 MGI: J:163437
Holland WL; Adams AC; Brozinick JT; Bui HH; Miyauchi Y; Kusminski CM; Bauer SM; Wade M; Singhal E; Cheng CC; Volk K; Kuo MS; Gordillo R; Kharitonenkov A; Scherer PE. 2013. An FGF21-adiponectin-ceramide axis controls energy expenditure and insulin action in mice. Cell Metab 17(5):790-7. PubMed: 23663742 MGI: J:199268
Howard JK; Lord GM; Matarese G; Vendetti S; Ghatei MA; Ritter MA; Lechler RI; Bloom SR. 1999. Leptin protects mice from starvation-induced lymphoid atrophy and increases thymic cellularity in ob/ob mice. J Clin Invest 104(8):1051-9. PubMed: 10525043 MGI: J:58102
Howell JJ; Stoffel M. 2009. Nuclear export-independent inhibition of Foxa2 by insulin. J Biol Chem 284(37):24816-24. PubMed: 19589781 MGI: J:155259
Hsu A; Aronoff DM; Phipps J; Goel D; Mancuso P. 2007. Leptin improves pulmonary bacterial clearance and survival in ob/ob mice during pneumococcal pneumonia. Clin Exp Immunol 150(2):332-9. PubMed: 17822444 MGI: J:126350
Hu X; Wu R; Jiang Z; Wang L; Chen P; Zhang L; Yang L; Wu Y; Chen H; Chen H; Xu Y; Zhou Y; Huang X; Webster KA; Yu H; Wang J. 2014. Leptin signaling is required for augmented therapeutic properties of mesenchymal stem cells conferred by hypoxia preconditioning. Stem Cells 32(10):2702-13. PubMed: 24989835 MGI: J:218496
Huang J; Jia Y; Fu T; Viswakarma N; Bai L; Rao MS; Zhu Y; Borensztajn J; Reddy JK. 2012. Sustained activation of PPARalpha by endogenous ligands increases hepatic fatty acid oxidation and prevents obesity in ob/ob mice. FASEB J 26(2):628-38. PubMed: 22009939 MGI: J:180625
Huang SL; Yu RT; Gong J; Feng Y; Dai YL; Hu F; Hu YH; Tao YD; Leng Y. 2012. Arctigenin, a natural compound, activates AMP-activated protein kinase via inhibition of mitochondria complex I and ameliorates metabolic disorders in ob/ob mice. Diabetologia 55(5):1469-81. PubMed: 22095235 MGI: J:183727
Huang W; Bansode RR; Bal NC; Mehta M; Mehta KD. 2012. Protein kinase Cbeta deficiency attenuates obesity syndrome of ob/ob mice by promoting white adipose tissue remodeling. J Lipid Res 53(3):368-78. PubMed: 22210924 MGI: J:183125
Huby AC; Antonova G; Groenendyk J; Gomez-Sanchez CE; Bollag WB; Filosa JA; Belin de Chantemele EJ. 2015. Adipocyte-Derived Hormone Leptin Is a Direct Regulator of Aldosterone Secretion, Which Promotes Endothelial Dysfunction and Cardiac Fibrosis. Circulation 132(22):2134-45. PubMed: 26362633 MGI: J:239049
Hudkins KL; Pichaiwong W; Wietecha T; Kowalewska J; Banas MC; Spencer MW; Muhlfeld A; Koelling M; Pippin JW; Shankland SJ; Askari B; Rabaglia ME; Keller MP; Attie AD; Alpers CE. 2010. BTBR Ob/Ob mutant mice model progressive diabetic nephropathy. J Am Soc Nephrol 21(9):1533-42. PubMed: 20634301 MGI: J:185261
Huh JY; Kim JI; Park YJ; Hwang IJ; Lee YS; Sohn JH; Lee SK; Alfadda AA; Kim SS; Choi SH; Lee DS; Park SH; Seong RH; Choi CS; Kim JB. 2013. A novel function of adipocytes in lipid antigen presentation to iNKT cells. Mol Cell Biol 33(2):328-39. PubMed: 23149942 MGI: J:194102
Hulsmans M; Geeraert B; Arnould T; Tsatsanis C; Holvoet P. 2013. PPAR agonist-induced reduction of Mcp1 in atherosclerotic plaques of obese, insulin-resistant mice depends on adiponectin-induced Irak3 expression. PLoS One 8(4):e62253. PubMed: 23620818 MGI: J:200636
Hwang JH; Kim DW; Jo EJ; Kim YK; Jo YS; Park JH; Yoo SK; Park MK; Kwak TH; Kho YL; Han J; Choi HS; Lee SH; Kim JM; Lee I; Kyung T; Jang C; Chung J; Kweon GR; Shong M. 2009. Pharmacological stimulation of NADH oxidation ameliorates obesity and related phenotypes in mice. Diabetes 58(4):965-74. PubMed: 19136651 MGI: J:151045
Hyogo H; Roy S; Cohen DE. 2003. Restoration of gallstone susceptibility by leptin in C57BL/6J ob/ob mice. J Lipid Res 44(6):1232-40. PubMed: 12671032 MGI: J:120674
INGALLS AM; DICKIE MM; SNELL GD. 1950. Obese, a new mutation in the house mouse. J Hered 41(12):317-8. PubMed: 14824537 MGI: J:13066
Iizuka K; Miller B; Uyeda K. 2006. Deficiency of carbohydrate-activated transcription factor ChREBP prevents obesity and improves plasma glucose control in leptin-deficient (ob/ob) mice. Am J Physiol Endocrinol Metab 291(2):E358-64. PubMed: 16705063 MGI: J:111374
Ikejima S; Sasaki S; Sashinami H; Mori F; Ogawa Y; Nakamura T; Abe Y; Wakabayashi K; Suda T; Nakane A. 2005. Impairment of host resistance to Listeria monocytogenes infection in liver of db/db and ob/ob mice. Diabetes 54(1):182-9. PubMed: 15616027 MGI: J:105107
Ikels K; Kuschel S; Fischer J; Kaisers W; Eberhard D; Ruther U. 2014. FTO is a relevant factor for the development of the metabolic syndrome in mice. PLoS One 9(8):e105349. PubMed: 25144618 MGI: J:219118
Ilan Y; Maron R; Tukpah AM; Maioli TU; Murugaiyan G; Yang K; Wu HY; Weiner HL. 2010. Induction of regulatory T cells decreases adipose inflammation and alleviates insulin resistance in ob/ob mice. Proc Natl Acad Sci U S A 107(21):9765-70. PubMed: 20445103 MGI: J:160555
Ilegems E; Dicker A; Speier S; Sharma A; Bahow A; Edlund PK; Leibiger IB; Berggren PO. 2013. Reporter islets in the eye reveal the plasticity of the endocrine pancreas. Proc Natl Acad Sci U S A 110(51):20581-6. PubMed: 24248353 MGI: J:205112
Imajo K; Fujita K; Yoneda M; Nozaki Y; Ogawa Y; Shinohara Y; Kato S; Mawatari H; Shibata W; Kitani H; Ikejima K; Kirikoshi H; Nakajima N; Saito S; Maeyama S; Watanabe S; Wada K; Nakajima A. 2012. Hyperresponsivity to low-dose endotoxin during progression to nonalcoholic steatohepatitis is regulated by leptin-mediated signaling. Cell Metab 16(1):44-54. PubMed: 22768838 MGI: J:187402
Inami Y; Yamashina S; Izumi K; Ueno T; Tanida I; Ikejima K; Watanabe S. 2011. Hepatic steatosis inhibits autophagic proteolysis via impairment of autophagosomal acidification and cathepsin expression. Biochem Biophys Res Commun 412(4):618-25. PubMed: 21856284 MGI: J:177536
Ioffe E; Moon B; Connolly E; Friedman JM. 1998. Abnormal regulation of the leptin gene in the pathogenesis of obesity. Proc Natl Acad Sci U S A 95(20):11852-7. PubMed: 9751754 MGI: J:50145
Irles E; Neco P; Lluesma M; Villar-Pazos S; Santos-Silva JC; Vettorazzi JF; Alonso-Magdalena P; Carneiro EM; Boschero AC; Nadal A; Quesada I. 2015. Enhanced glucose-induced intracellular signaling promotes insulin hypersecretion: pancreatic beta-cell functional adaptations in a model of genetic obesity and prediabetes. Mol Cell Endocrinol 404:46-55. PubMed: 25633666 MGI: J:220333
Ishii M; Fei H; Friedman JM. 2003. Targeted disruption of GPR7, the endogenous receptor for neuropeptides B and W, leads to metabolic defects and adult-onset obesity. Proc Natl Acad Sci U S A 100(18):10540-5. PubMed: 12925742 MGI: J:94820
Itateyama E; Chiba S; Sakata T; Yoshimatsu H. 2003. Hypothalamic neuronal histamine in genetically obese animals: its implication of leptin action in the brain. Exp Biol Med (Maywood) 228(10):1132-7. PubMed: 14610251 MGI: J:103056
Ito A; Suganami T; Yamauchi A; Degawa-Yamauchi M; Tanaka M; Kouyama R; Kobayashi Y; Nitta N; Yasuda K; Hirata Y; Kuziel WA; Takeya M; Kanegasaki S; Kamei Y; Ogawa Y. 2008. Role of CC chemokine receptor 2 in bone marrow cells in the recruitment of macrophages into obese adipose tissue. J Biol Chem 283(51):35715-23. PubMed: 18977759 MGI: J:143770
Iwaniec UT; Dube MG; Boghossian S; Song H; Helferich WG; Turner RT; Kalra SP. 2009. Body mass influences cortical bone mass independent of leptin signaling. Bone 44(3):404-12. PubMed: 19095090 MGI: J:146053
Jager J; Corcelle V; Gremeaux T; Laurent K; Waget A; Pages G; Binetruy B; Le Marchand-Brustel Y; Burcelin R; Bost F; Tanti JF. 2010. Deficiency in the extracellular signal-regulated kinase 1 (ERK1) protects leptin-deficient mice from insulin resistance without affecting obesity. Diabetologia :. PubMed: 20953578 MGI: J:165782
Jager J; Gremeaux T; Gonzalez T; Bonnafous S; Debard C; Laville M; Vidal H; Tran A; Gual P; Le Marchand-Brustel Y; Cormont M; Tanti JF. 2010. Tpl2 kinase is upregulated in adipose tissue in obesity and may mediate interleukin-1beta and tumor necrosis factor-{alpha} effects on extracellular signal-regulated kinase activation and lipolysis. Diabetes 59(1):61-70. PubMed: 19808894 MGI: J:164170
Jakobs HH; Mikula M; Havemeyer A; Strzalkowska A; Borowa-Chmielak M; Dzwonek A; Gajewska M; Hennig EE; Ostrowski J; Clement B. 2014. The N-reductive system composed of mitochondrial amidoxime reducing component (mARC), cytochrome b5 (CYB5B) and cytochrome b5 reductase (CYB5R) is regulated by fasting and high fat diet in mice. PLoS One 9(8):e105371. PubMed: 25144769 MGI: J:221087
Jang M; Romsos DR. 1998. Neuropeptide Y and corticotropin-releasing hormone concentrations within specific hypothalamic regions of lean but not ob/ob mice respond to food-deprivation and refeeding. J Nutr 128(12):2520-5. PubMed: 9868202 MGI: J:52175
Jansen HJ; van Essen P; Koenen T; Joosten LA; Netea MG; Tack CJ; Stienstra R. 2012. Autophagy activity is up-regulated in adipose tissue of obese individuals and modulates proinflammatory cytokine expression. Endocrinology 153(12):5866-74. PubMed: 23117929 MGI: J:192841
Jatoi A; Cleary MP; Tee CM; Nguyen PL. 2001. Weight gain does not preclude increased ubiquitin conjugation in skeletal muscle: an exploratory study in tumor-bearing mice. Ann Nutr Metab 45(3):116-20. PubMed: 11423703 MGI: J:70639
Jaworski K; Ahmadian M; Duncan RE; Sarkadi-Nagy E; Varady KA; Hellerstein MK; Lee HY; Samuel VT; Shulman GI; Kim KH; de Val S; Kang C; Sul HS. 2009. AdPLA ablation increases lipolysis and prevents obesity induced by high-fat feeding or leptin deficiency. Nat Med 15(2):159-68. PubMed: 19136964 MGI: J:239202
Jeffery E; Church CD; Holtrup B; Colman L; Rodeheffer MS. 2015. Rapid depot-specific activation of adipocyte precursor cells at the onset of obesity. Nat Cell Biol 17(4):376-85. PubMed: 25730471 MGI: J:220886
Jeon BT; Heo RW; Jeong EA; Yi CO; Lee JY; Kim KE; Kim H; Roh GS. 2016. Effects of caloric restriction on O-GlcNAcylation, Ca(2+) signaling, and learning impairment in the hippocampus of ob/ob mice. Neurobiol Aging 44:127-37. PubMed: 27318140 MGI: J:239038
Jetton TL; Liang Y; Cincotta AH. 2001. Systemic treatment with sympatholytic dopamine agonists improves aberrant beta-cell hyperplasia and GLUT2, glucokinase, and insulin immunoreactive levels in ob/ob mice. Metabolism 50(11):1377-84. PubMed: 11699060 MGI: J:72803
Jheng HF; Tsai PJ; Guo SM; Kuo LH; Chang CS; Su IJ; Chang CR; Tsai YS. 2012. Mitochondrial fission contributes to mitochondrial dysfunction and insulin resistance in skeletal muscle. Mol Cell Biol 32(2):309-19. PubMed: 22083962 MGI: J:183663
Ji Y; Sun S; Xu A; Bhargava P; Yang L; Lam KS; Gao B; Lee CH; Kersten S; Qi L. 2012. Activation of natural killer T cells promotes M2 Macrophage polarization in adipose tissue and improves systemic glucose tolerance via interleukin-4 (IL-4)/STAT6 protein signaling axis in obesity. J Biol Chem 287(17):13561-71. PubMed: 22396530 MGI: J:184470
Jiao P; Chen Q; Shah S; Du J; Tao B; Tzameli I; Yan W; Xu H. 2009. Obesity-related upregulation of monocyte chemotactic factors in adipocytes: involvement of nuclear factor-kappaB and c-Jun NH2-terminal kinase pathways. Diabetes 58(1):104-15. PubMed: 18835938 MGI: J:147249
Jiao Y; George SK; Zhao Q; Hulver MW; Hutson SM; Bishop CE; Lu B. 2012. Mex3c mutation reduces adiposity and increases energy expenditure. Mol Cell Biol 32(21):4350-62. PubMed: 22927639 MGI: J:189249
Jo YH; Chen YJ; Chua SC Jr; Talmage DA; Role LW. 2005. Integration of endocannabinoid and leptin signaling in an appetite-related neural circuit. Neuron 48(6):1055-66. PubMed: 16364907 MGI: J:107590
Johnson AM; Costanzo A; Gareau MG; Armando AM; Quehenberger O; Jameson JM; Olefsky JM. 2015. High fat diet causes depletion of intestinal eosinophils associated with intestinal permeability. PLoS One 10(4):e0122195. PubMed: 25837594 MGI: J:233418
Johnson PR; Hirsch J. 1972. Cellularity of adipose depots in six strains of genetically obese mice. J Lipid Res 13(1):2-11. PubMed: 5059196 MGI: J:5253
Joost HG; Schurmann A. 2014. The genetic basis of obesity-associated type 2 diabetes (diabesity) in polygenic mouse models. Mamm Genome 25(9-10):401-12. PubMed: 24752583 MGI: J:216848
Jurgens HS; Schurmann A; Kluge R; Ortmann S; Klaus S; Joost HG; Tschop MH. 2006. Hyperphagia, lower body temperature, and reduced running wheel activity precede development of morbid obesity in New Zealand obese mice. Physiol Genomics 25(2):234-41. PubMed: 16614459 MGI: J:144124
Kabra DG; Pfuhlmann K; Garcia-Caceres C; Schriever SC; Casquero Garcia V; Kebede AF; Fuente-Martin E; Trivedi C; Heppner K; Uhlenhaut NH; Legutko B; Kabra UD; Gao Y; Yi CX; Quarta C; Clemmensen C; Finan B; Muller TD; Meyer CW; Paez-Pereda M; Stemmer K; Woods SC; Perez-Tilve D; Schneider R; Olson EN; Tschop MH; Pfluger PT. 2016. Hypothalamic leptin action is mediated by histone deacetylase 5. Nat Commun 7:10782. PubMed: 26923837 MGI: J:234826
Kaddai V; Jager J; Gonzalez T; Najem-Lendom R; Bonnafous S; Tran A; Le Marchand-Brustel Y; Gual P; Tanti JF; Cormont M. 2009. Involvement of TNF-alpha in abnormal adipocyte and muscle sortilin expression in obese mice and humans. Diabetologia 52(5):932-40. PubMed: 19219422 MGI: J:148209
Kaiyala KJ; Morton GJ; Leroux BG; Ogimoto K; Wisse B; Schwartz MW. 2010. Identification of body fat mass as a major determinant of metabolic rate in mice. Diabetes 59(7):1657-66. PubMed: 20413511 MGI: J:169354
Kaiyala KJ; Ogimoto K; Nelson JT; Schwartz MW; Morton GJ. 2015. Leptin signaling is required for adaptive changes in food intake, but not energy expenditure, in response to different thermal conditions. PLoS One 10(3):e0119391. PubMed: 25756181 MGI: J:228336
Kajimura D; Lee HW; Riley KJ; Arteaga-Solis E; Ferron M; Zhou B; Clarke CJ; Hannun YA; DePinho RA; Guo EX; Mann JJ; Karsenty G. 2013. Adiponectin regulates bone mass via opposite central and peripheral mechanisms through FoxO1. Cell Metab 17(6):901-15. PubMed: 23684624 MGI: J:199264
Kamei N; Tobe K; Suzuki R; Ohsugi M; Watanabe T; Kubota N; Ohtsuka-Kowatari N; Kumagai K; Sakamoto K; Kobayashi M; Yamauchi T; Ueki K; Oishi Y; Nishimura S; Manabe I; Hashimoto H; Ohnishi Y; Ogata H; Tokuyama K; Tsunoda M; Ide T; Murakami K; Nagai R; Kadowaki T. 2006. Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance. J Biol Chem 281(36):26602-14. PubMed: 16809344 MGI: J:116947
Kampfer H; Pfeilschifter J; Frank S. 2003. Expression and activity of arginase isoenzymes during normal and diabetes-impaired skin repair. J Invest Dermatol 121(6):1544-51. PubMed: 14675208 MGI: J:120040
Kampfer H; Schmidt R; Geisslinger G; Pfeilschifter J; Frank S. 2005. Wound inflammation in diabetic ob/ob mice: functional coupling of prostaglandin biosynthesis to cyclooxygenase-1 activity in diabetes-impaired wound healing. Diabetes 54(5):1543-51. PubMed: 15855344 MGI: J:105193
Kaneko K; Yamada T; Tsukita S; Takahashi K; Ishigaki Y; Oka Y; Katagiri H. 2009. Obesity alters circadian expressions of molecular clock genes in the brainstem. Brain Res 1263:58-68. PubMed: 19401184 MGI: J:148090
Kaplan ML; Oh SS. 1991. Oxygen consumption of muscles from ob/ob and Ay/a strains of obese mice. Int J Obes 15(12):809-12. PubMed: 1794923 MGI: J:613
Kaplan ML; Trout JR; Leveille GA. 1976. Adipocyte size distribution in ob/ob mice during preobese and obese phases of development. Proc Soc Exp Biol Med 153(3):476-82. PubMed: 1013161 MGI: J:5765
Kapur S; Amoui M; Kesavan C; Wang X; Mohan S; Baylink DJ; Lau KH. 2010. Leptin receptor (Lepr) is a negative modulator of bone mechanosensitivity and genetic variations in Lepr may contribute to the differential osteogenic response to mechanical stimulation in the C57BL/6J and C3H/HeJ pair of mouse strains. J Biol Chem 285(48):37607-18. PubMed: 20851886 MGI: J:167342
Katiyar SK; Meeran SM. 2007. Obesity increases the risk of UV radiation-induced oxidative stress and activation of MAPK and NF-kappaB signaling. Free Radic Biol Med 42(2):299-310. PubMed: 17189835 MGI: J:117222
Ke Y; Qiu J; Ogus S; Shen WJ; Kraemer FB; Chehab FF. 2003. Overexpression of leptin in transgenic mice leads to decreased basal lipolysis, PKA activity, and perilipin levels. Biochem Biophys Res Commun 312(4):1165-70. PubMed: 14651995 MGI: J:94674
Kebede M; Favaloro J; Gunton JE; Laybutt DR; Shaw M; Wong N; Fam BC; Aston-Mourney K; Rantzau C; Zulli A; Proietto J; Andrikopoulos S. 2008. Fructose-1,6-bisphosphatase overexpression in pancreatic beta-cells results in reduced insulin secretion: a new mechanism for fat-induced impairment of beta-cell function. Diabetes 57(7):1887-95. PubMed: 18375435 MGI: J:138232
Kebede MA; Oler AT; Gregg T; Balloon AJ; Johnson A; Mitok K; Rabaglia M; Schueler K; Stapleton D; Thorstenson C; Wrighton L; Floyd BJ; Richards O; Raines S; Eliceiri K; Seidah NG; Rhodes C; Keller MP; Coon JL; Audhya A; Attie AD. 2014. SORCS1 is necessary for normal insulin secretory granule biogenesis in metabolically stressed beta cells. J Clin Invest 124(10):4240-56. PubMed: 25157818 MGI: J:217648
Keller MP; Paul PK; Rabaglia ME; Stapleton DS; Schueler KL; Broman AT; Ye SI; Leng N; Brandon CJ; Neto EC; Plaisier CL; Simonett SP; Kebede MA; Sheynkman GM; Klein MA; Baliga NS; Smith LM; Broman KW; Yandell BS; Kendziorski C; Attie AD. 2016. The Transcription Factor Nfatc2 Regulates beta-Cell Proliferation and Genes Associated with Type 2 Diabetes in Mouse and Human Islets. PLoS Genet 12(12):e1006466. PubMed: 27935966 MGI: J:237488
Kemp JG; Blazev R; Stephenson DG; Stephenson GM. 2009. Morphological and biochemical alterations of skeletal muscles from the genetically obese (ob/ob) mouse. Int J Obes (Lond) 33(8):831-41. PubMed: 19528970 MGI: J:151518
Kern TS; Tang J; Berkowitz BA. 2010. Validation of structural and functional lesions of diabetic retinopathy in mice. Mol Vis 16:2121-31. PubMed: 21139688 MGI: J:168105
Kerouz NJ; Horsch D; Pons S; Kahn CR. 1997. Differential regulation of insulin receptor substrates-1 and -2 (IRS-1 and IRS-2) and phosphatidylinositol 3-kinase isoforms in liver and muscle of the obese diabetic (ob/ob) mouse. J Clin Invest 100(12):3164-72. PubMed: 9399964 MGI: J:44906
Kesterson RA; Huszar D; Lynch CA; Simerly RB; Cone RD. 1997. Induction of neuropeptide Y gene expression in the dorsal medial hypothalamic nucleus in two models of the agouti obesity syndrome. Mol Endocrinol 11(5):630-7. PubMed: 9139806 MGI: J:40012
Khan A; Efendic S. 1995. Evidence that increased glucose cycling in islets of diabetic ob/ob mice is a primary feature of the disease. Am J Physiol 269(4 Pt 1):E623-6. PubMed: 7485473 MGI: J:29436
Khan A; Ostenson CG; Berggren PO; Efendic S. 1992. Glucocorticoid increases glucose cycling and inhibits insulin release in pancreatic islets of ob/ob mice. Am J Physiol 263(4 Pt 1):E663-6. PubMed: 1384356 MGI: J:3045
Khan A; Zong-Chao L; Efendic S; Landau BR. 1998. Glucose-6-phosphatase activity in the hypothalamus of the ob/ob mouse. Metabolism 47(6):627-9. PubMed: 9627357 MGI: J:48045
Khan T; Muise ES; Iyengar P; Wang ZV; Chandalia M; Abate N; Zhang BB; Bonaldo P; Chua S; Scherer PE. 2009. Metabolic dysregulation and adipose tissue fibrosis: role of collagen VI. Mol Cell Biol 29(6):1575-91. PubMed: 19114551 MGI: J:145762
Kharitonenkov A; Shiyanova TL; Koester A; Ford AM; Micanovic R; Galbreath EJ; Sandusky GE; Hammond LJ; Moyers JS; Owens RA; Gromada J; Brozinick JT; Hawkins ED; Wroblewski VJ; Li DS; Mehrbod F; Jaskunas SR; Shanafelt AB. 2005. FGF-21 as a novel metabolic regulator. J Clin Invest 115(6):1627-35. PubMed: 15902306 MGI: J:99202
Kiechl S; Wittmann J; Giaccari A; Knoflach M; Willeit P; Bozec A; Moschen AR; Muscogiuri G; Sorice GP; Kireva T; Summerer M; Wirtz S; Luther J; Mielenz D; Billmeier U; Egger G; Mayr A; Oberhollenzer F; Kronenberg F; Orthofer M; Penninger JM; Meigs JB; Bonora E; Tilg H; Willeit J; Schett G. 2013. Blockade of receptor activator of nuclear factor-kappaB (RANKL) signaling improves hepatic insulin resistance and prevents development of diabetes mellitus. Nat Med 19(3):358-63. PubMed: 23396210 MGI: J:196304
Kim DH; Kim J; Kwon JS; Sandhu J; Tontonoz P; Lee SK; Lee S; Lee JW. 2016. Critical Roles of the Histone Methyltransferase MLL4/KMT2D in Murine Hepatic Steatosis Directed by ABL1 and PPARgamma2. Cell Rep 17(6):1671-1682. PubMed: 27806304 MGI: J:242336
Kim HA; Park WJ; Jeong HS; Lee HE; Lee SH; Kwon NS; Baek KJ; Kim DS; Yun HY. 2012. Leucine-rich glioma inactivated 3 regulates adipogenesis through ADAM23. Biochim Biophys Acta 1821(6):914-22. PubMed: 22405860 MGI: J:184988
Kim HK; Youn BS; Shin MS; Namkoong C; Park KH; Baik JH; Kim JB; Park JY; Lee KU; Kim YB; Kim MS. 2010. Hypothalamic Angptl4/Fiaf is a novel regulator of food intake and body weight. Diabetes 59(11):2772-80. PubMed: 20798332 MGI: J:169731
Kim JY; van de Wall E; Laplante M; Azzara A; Trujillo ME; Hofmann SM; Schraw T; Durand JL; Li H; Li G; Jelicks LA; Mehler MF; Hui DY; Deshaies Y; Shulman GI; Schwartz GJ; Scherer PE. 2007. Obesity-associated improvements in metabolic profile through expansion of adipose tissue. J Clin Invest 117(9):2621-37. PubMed: 17717599 MGI: J:127420
Kim SG; Lee B; Kim DH; Kim J; Lee S; Lee SK; Lee JW. 2013. Control of energy balance by hypothalamic gene circuitry involving two nuclear receptors, neuron-derived orphan receptor 1 and glucocorticoid receptor. Mol Cell Biol 33(19):3826-34. PubMed: 23897430 MGI: J:205020
Kim SH; Kim KH; Kim HK; Kim MJ; Back SH; Konishi M; Itoh N; Lee MS. 2015. Fibroblast growth factor 21 participates in adaptation to endoplasmic reticulum stress and attenuates obesity-induced hepatic metabolic stress. Diabetologia 58(4):809-18. PubMed: 25537833 MGI: J:220750
Kim SY; Lim JH; Choi SW; Kim M; Kim ST; Kim MS; Cho YS; Chun E; Lee KY. 2010. Preferential effects of leptin on CD4 T cells in central and peripheral immune system are critically linked to the expression of leptin receptor. Biochem Biophys Res Commun 394(3):562-8. PubMed: 20227394 MGI: J:159235
Kim YD; Park KG; Lee YS; Park YY; Kim DK; Nedumaran B; Jang WG; Cho WJ; Ha J; Lee IK; Lee CH; Choi HS. 2008. Metformin inhibits hepatic gluconeogenesis through AMP-activated protein kinase-dependent regulation of the orphan nuclear receptor SHP. Diabetes 57(2):306-14. PubMed: 17909097 MGI: J:132418
Kimple ME; Keller MP; Rabaglia MR; Pasker RL; Neuman JC; Truchan NA; Brar HK; Attie AD. 2013. Prostaglandin E2 receptor, EP3, is induced in diabetic islets and negatively regulates glucose- and hormone-stimulated insulin secretion. Diabetes 62(6):1904-12. PubMed: 23349487 MGI: J:208569
Kirchner H; Heppner KM; Holland J; Kabra D; Tschop MH; Pfluger PT. 2013. Ablation of ghrelin O-acyltransferase does not improve glucose intolerance or body adiposity in mice on a leptin-deficient ob/ob background. PLoS One 8(4):e61822. PubMed: 23630616 MGI: J:200880
Kishida Y; Hirao M; Tamai N; Nampei A; Fujimoto T; Nakase T; Shimizu N; Yoshikawa H; Myoui A. 2005. Leptin regulates chondrocyte differentiation and matrix maturation during endochondral ossification. Bone 37(5):607-21. PubMed: 16039170 MGI: J:102535
Kitada Y; Kajita K; Taguchi K; Mori I; Yamauchi M; Ikeda T; Kawashima M; Asano M; Kajita T; Ishizuka T; Banno Y; Kojima I; Chun J; Kamata S; Ishii I; Morita H. 2016. Blockade of Sphingosine 1-Phosphate Receptor 2 Signaling Attenuates High-Fat Diet-Induced Adipocyte Hypertrophy and Systemic Glucose Intolerance in Mice. Endocrinology 157(5):1839-51. PubMed: 26943364 MGI: J:234354
Kitade H; Sawamoto K; Nagashimada M; Inoue H; Yamamoto Y; Sai Y; Takamura T; Yamamoto H; Miyamoto K; Ginsberg HN; Mukaida N; Kaneko S; Ota T. 2012. CCR5 plays a critical role in obesity-induced adipose tissue inflammation and insulin resistance by regulating both macrophage recruitment and M1/M2 status. Diabetes 61(7):1680-90. PubMed: 22474027 MGI: J:203177
Kleinridders A; Lauritzen HP; Ussar S; Christensen JH; Mori MA; Bross P; Kahn CR. 2013. Leptin regulation of Hsp60 impacts hypothalamic insulin signaling. J Clin Invest :. PubMed: 24084737 MGI: J:203991
Knight ZA; Hannan KS; Greenberg ML; Friedman JM. 2010. Hyperleptinemia is required for the development of leptin resistance. PLoS One 5(6):e11376. PubMed: 20613882 MGI: J:161999
Koch C; Augustine RA; Steger J; Ganjam GK; Benzler J; Pracht C; Lowe C; Schwartz MW; Shepherd PR; Anderson GM; Grattan DR; Tups A. 2010. Leptin rapidly improves glucose homeostasis in obese mice by increasing hypothalamic insulin sensitivity. J Neurosci 30(48):16180-7. PubMed: 21123564 MGI: J:166745
Koenen TB; Stienstra R; van Tits LJ; de Graaf J; Stalenhoef AF; Joosten LA; Tack CJ; Netea MG. 2011. Hyperglycemia activates caspase-1 and TXNIP-mediated IL-1beta transcription in human adipose tissue. Diabetes 60(2):517-24. PubMed: 21270263 MGI: J:169785
Komori T; Morikawa Y; Tamura S; Doi A; Nanjo K; Senba E. 2005. Subcellular localization of glucose transporter 4 in the hypothalamic arcuate nucleus of ob/ob mice under basal conditions. Brain Res 1049(1):34-42. PubMed: 15925330 MGI: J:99184
Komori T; Tanaka M; Senba E; Miyajima A; Morikawa Y. 2014. Deficiency of oncostatin M receptor beta (OSMRbeta) exacerbates high-fat diet-induced obesity and related metabolic disorders in mice. J Biol Chem 289(20):13821-37. PubMed: 24695736 MGI: J:214124
Kondo T; Kahn CR. 2004. Altered insulin signaling in retinal tissue in diabetic states. J Biol Chem 279(36):37997-8006. PubMed: 15201286 MGI: J:92558
Kong X; Banks A; Liu T; Kazak L; Rao RR; Cohen P; Wang X; Yu S; Lo JC; Tseng YH; Cypess AM; Xue R; Kleiner S; Kang S; Spiegelman BM; Rosen ED. 2014. IRF4 is a key thermogenic transcriptional partner of PGC-1alpha. Cell 158(1):69-83. PubMed: 24995979 MGI: J:214637
Konstantinides S; Schafer K; Koschnick S; Loskutoff DJ. 2001. Leptin-dependent platelet aggregation and arterial thrombosis suggests a mechanism for atherothrombotic disease in obesity. J Clin Invest 108(10):1533-40. PubMed: 11714745 MGI: J:109859
Kordonowy LL; Burg E; Lenox CC; Gauthier LM; Petty JM; Antkowiak M; Palvinskaya T; Ubags N; Rincon M; Dixon AE; Vernooy JH; Fessler MB; Poynter ME; Suratt BT. 2012. Obesity is associated with neutrophil dysfunction and attenuation of murine acute lung injury. Am J Respir Cell Mol Biol 47(1):120-7. PubMed: 22427537 MGI: J:199772
Kraus D; Yang Q; Kong D; Banks AS; Zhang L; Rodgers JT; Pirinen E; Pulinilkunnil TC; Gong F; Wang YC; Cen Y; Sauve AA; Asara JM; Peroni OD; Monia BP; Bhanot S; Alhonen L; Puigserver P; Kahn BB. 2014. Nicotinamide N-methyltransferase knockdown protects against diet-induced obesity. Nature 508(7495):258-62. PubMed: 24717514 MGI: J:208844
Krauss S; Zhang CY; Scorrano L; Dalgaard LT; St-Pierre J; Grey ST; Lowell BB. 2003. Superoxide-mediated activation of uncoupling protein 2 causes pancreatic beta cell dysfunction. J Clin Invest 112(12):1831-42. PubMed: 14679178 MGI: J:118472
Krautkramer KA; Linnemann AK; Fontaine DA; Whillock AL; Harris TW; Schleis GJ; Truchan NA; Marty-Santos L; Lavine JA; Cleaver O; Kimple ME; Davis DB. 2013. Tcf19 is a novel islet factor necessary for proliferation and survival in the INS-1 beta-cell line. Am J Physiol Endocrinol Metab 305(5):E600-10. PubMed: 23860123 MGI: J:203187
Krutzfeldt J; Stoffel M. 2010. Regulation of wingless-type MMTV integration site family (WNT) signalling in pancreatic islets from wild-type and obese mice. Diabetologia 53(1):123-7. PubMed: 19898815 MGI: J:156548
Kubota N; Terauchi Y; Kubota T; Kumagai H; Itoh S; Satoh H; Yano W; Ogata H; Tokuyama K; Takamoto I; Mineyama T; Ishikawa M; Moroi M; Sugi K; Yamauchi T; Ueki K; Tobe K; Noda T; Nagai R; Kadowaki T. 2006. Pioglitazone ameliorates insulin resistance and diabetes by both adiponectin-dependent and -independent pathways. J Biol Chem 281(13):8748-55. PubMed: 16431926 MGI: J:111576
Kubota N; Yamauchi T; Tobe K; Kadowaki T. 2006. Adiponectin-dependent and -independent pathways in insulin-sensitizing and antidiabetic actions of thiazolidinediones. Diabetes 55 Suppl 2:S32-8. MGI: J:120995
Kulkarni RN; Wang ZL; Wang RM; Hurley JD; Smith DM; Ghatei MA ; Withers DJ ; Gardiner JV ; Bailey CJ ; Bloom SR. 1997. Leptin rapidly suppresses insulin release from insulinoma cells, rat and human islets and, in vivo, in mice. J Clin Invest 100(11):2729-36. PubMed: 9389736 MGI: J:45259
Kumadaki S; Karasawa T; Matsuzaka T; Ema M; Nakagawa Y; Nakakuki M; Saito R; Yahagi N; Iwasaki H; Sone H; Takekoshi K; Yatoh S; Kobayashi K; Takahashi A; Suzuki H; Takahashi S; Yamada N; Shimano H. 2011. Inhibition of ubiquitin ligase F-box and WD repeat domain-containing 7alpha (Fbw7alpha) causes hepatosteatosis through Kruppel-like factor 5 (KLF5)/peroxisome proliferator-activated receptor gamma2 (PPARgamma2) pathway but not SREBP-1c protein in mice. J Biol Chem 286(47):40835-46. PubMed: 21911492 MGI: J:180713
Kumar KG; Trevaskis JL; Lam DD; Sutton GM; Koza RA; Chouljenko VN; Kousoulas KG; Rogers PM; Kesterson RA; Thearle M; Ferrante AW Jr; Mynatt RL; Burris TP; Dong JZ; Halem HA; Culler MD; Heisler LK; Stephens JM; Butler AA. 2008. Identification of adropin as a secreted factor linking dietary macronutrient intake with energy homeostasis and lipid metabolism. Cell Metab 8(6):468-81. PubMed: 19041763 MGI: J:144378
Kumpers P; Gueler F; Rong S; Mengel M; Tossidou I; Peters I; Haller H; Schiffer M. 2007. Leptin is a coactivator of TGF-beta in unilateral ureteral obstructive kidney disease. Am J Physiol Renal Physiol 293(4):F1355-62. PubMed: 17686962 MGI: J:145120
Kuo LE; Kitlinska JB; Tilan JU; Li L; Baker SB; Johnson MD; Lee EW; Burnett MS; Fricke ST; Kvetnansky R; Herzog H; Zukowska Z. 2007. Neuropeptide Y acts directly in the periphery on fat tissue and mediates stress-induced obesity and metabolic syndrome. Nat Med 13(7):803-11. PubMed: 17603492 MGI: J:125084
Kuo LH; Tsai PJ; Jiang MJ; Chuang YL; Yu L; Lai KT; Tsai YS. 2010. Toll-like receptor 2 deficiency improves insulin sensitivity and hepatic insulin signalling in the mouse. Diabetologia :. PubMed: 20967535 MGI: J:166051
Kurrasch DM; Cheung CC; Lee FY; Tran PV; Hata K; Ingraham HA. 2007. The neonatal ventromedial hypothalamus transcriptome reveals novel markers with spatially distinct patterning. J Neurosci 27(50):13624-34. PubMed: 18077674 MGI: J:130568
Lalloyer F; Vandewalle B; Percevault F; Torpier G; Kerr-Conte J; Oosterveer M; Paumelle R; Fruchart JC; Kuipers F; Pattou F; Fievet C; Staels B. 2006. Peroxisome Proliferator-Activated Receptor {alpha} Improves Pancreatic Adaptation to Insulin Resistance in Obese Mice and Reduces Lipotoxicity in Human Islets. Diabetes 55(6):1605-13. PubMed: 16731822 MGI: J:111882
Lalonde J; Samson P; Poulin S; Deshaies Y; Richard D. 2004. Additive effects of leptin and topiramate in reducing fat deposition in lean and obese ob/ob mice. Physiol Behav 80(4):415-20. PubMed: 14741225 MGI: J:96339
Lambert PD; Anderson KD; Sleeman MW; Wong V; Tan J; Hijarunguru A; Corcoran TL; Murray JD; Thabet KE; Yancopoulos GD; Wiegand SJ. 2001. Ciliary neurotrophic factor activates leptin-like pathways and reduces body fat, without cachexia or rebound weight gain, even in leptin-resistant obesity. Proc Natl Acad Sci U S A 98(8):4652-7. PubMed: 11259650 MGI: J:68826
Lan H; Rabaglia ME; Stoehr JP; Nadler ST; Schueler KL; Zou F; Yandell BS; Attie AD. 2003. Gene expression profiles of nondiabetic and diabetic obese mice suggest a role of hepatic lipogenic capacity in diabetes susceptibility. Diabetes 52(3):688-700. PubMed: 12606510 MGI: J:148466
Lan H; Stoehr JP; Nadler ST; Schueler KL; Yandell BS; Attie AD. 2003. Dimension reduction for mapping mRNA abundance as quantitative traits. Genetics 164(4):1607-14. PubMed: 12930764 MGI: J:119260
Lang JE; Williams ES; Mizgerd JP; Shore SA. 2008. Effect of obesity on pulmonary inflammation induced by acute ozone exposure: role of interleukin-6. Am J Physiol Lung Cell Mol Physiol 294(5):L1013-20. PubMed: 18359888 MGI: J:136626
Lanner JT; Katz A; Tavi P; Sandstrom ME; Zhang SJ; Wretman C; James S; Fauconnier J; Lannergren J; Bruton JD; Westerblad H. 2006. The role of Ca2+ influx for insulin-mediated glucose uptake in skeletal muscle. Diabetes 55(7):2077-83. PubMed: 16804078 MGI: J:111855
Laposky AD; Shelton J; Bass J; Dugovic C; Perrino N; Turek FW. 2006. Altered sleep regulation in leptin-deficient mice. Am J Physiol Regul Integr Comp Physiol 290(4):R894-903. PubMed: 16293682 MGI: J:115771
Laque A; Zhang Y; Gettys S; Nguyen TA; Bui K; Morrison CD; Munzberg H. 2013. Leptin receptor neurons in the mouse hypothalamus are colocalized with the neuropeptide galanin and mediate anorexigenic leptin action. Am J Physiol Endocrinol Metab 304(9):E999-E1011. PubMed: 23482448 MGI: J:198129
Larcher F; Del Rio M; Serrano F; Segovia JC; Ramirez A; Meana A; Page A; Abad JL; Gonzalez MA; Bueren J; Bernad A; Jorcano JL. 2001. A cutaneous gene therapy approach to human leptin deficiencies: correction of the murine ob/ob phenotype using leptin-targeted keratinocyte grafts. FASEB J 15(9):1529-38. PubMed: 11427484 MGI: J:115148
Latham JR; Pathirathna S; Jagodic MM; Joo Choe W; Levin ME; Nelson MT; Yong Lee W; Krishnan K; Covey DF; Todorovic SM; Jevtovic-Todorovic V. 2009. Selective T-type calcium channel blockade alleviates hyperalgesia in ob/ob mice. Diabetes 58(11):2656-65. PubMed: 19651818 MGI: J:154387
Lavine JA; Raess PW; Stapleton DS; Rabaglia ME; Suhonen JI; Schueler KL; Koltes JE; Dawson JA; Yandell BS; Samuelson LC; Beinfeld MC; Davis DB; Hellerstein MK; Keller MP; Attie AD. 2010. Cholecystokinin is up-regulated in obese mouse islets and expands beta-cell mass by increasing beta-cell survival. Endocrinology 151(8):3577-88. PubMed: 20534724 MGI: J:163942
Lawrence CB; Brough D; Knight EM. 2012. Obese mice exhibit an altered behavioural and inflammatory response to lipopolysaccharide. Dis Model Mech 5(5):649-59. PubMed: 22328591 MGI: J:187492
Leavens KF; Easton RM; Shulman GI; Previs SF; Birnbaum MJ. 2009. Akt2 is required for hepatic lipid accumulation in models of insulin resistance. Cell Metab 10(5):405-18. PubMed: 19883618 MGI: J:155432
Leckstrom A; Kim ER; Wong D; Mizuno TM. 2009. Xenin, a gastrointestinal peptide, regulates feeding independent of the melanocortin signaling pathway. Diabetes 58(1):87-94. PubMed: 18984739 MGI: J:149651
Leclercq IA; Field J; Enriquez A; Farrell GC; Robertson GR. 2000. Constitutive and inducible expression of hepatic CYP2E1 in leptin-deficient ob/ob mice. Biochem Biophys Res Commun 268(2):337-44. PubMed: 10679205 MGI: J:60404
Lee FY; Li Y; Yang EK; Yang SQ; Lin HZ; Trush MA; Dannenberg AJ; Diehl AM. 1999. Phenotypic abnormalities in macrophages from leptin-deficient, obese mice. Am J Physiol 276(2 Pt 1):C386-94. PubMed: 9950766 MGI: J:53122
Lee J; Liu J; Feng X; Salazar Hernandez MA; Mucka P; Ibi D; Choi JW; Ozcan U. 2016. Withaferin A is a leptin sensitizer with strong antidiabetic properties in mice. Nat Med 22(9):1023-32. PubMed: 27479085 MGI: J:240346
Lee J; Sun C; Zhou Y; Lee J; Gokalp D; Herrema H; Park SW; Davis RJ; Ozcan U. 2011. p38 MAPK-mediated regulation of Xbp1s is crucial for glucose homeostasis. Nat Med 17(10):1251-60. PubMed: 21892182 MGI: J:177561
Lee JH; Budanov AV; Talukdar S; Park EJ; Park HL; Park HW; Bandyopadhyay G; Li N; Aghajan M; Jang I; Wolfe AM; Perkins GA; Ellisman MH; Bier E; Scadeng M; Foretz M; Viollet B; Olefsky J; Karin M. 2012. Maintenance of metabolic homeostasis by Sestrin2 and Sestrin3. Cell Metab 16(3):311-21. PubMed: 22958918 MGI: J:189021
Lee JW; Romsos DR. 2001. Leptin-deficient mice commence hypersecreting insulin in response to acetylcholine between 1 and 2 weeks of age. Exp Biol Med (Maywood) 226(10):906-11. PubMed: 11682696 MGI: J:103303
Lee MH; Lee JU; Joung KH; Kim YK; Ryu MJ; Lee SE; Kim SJ; Chung HK; Choi MJ; Chang JY; Lee SH; Kweon GR; Kim HJ; Kim KS; Kim SM; Jo YS; Park J; Cheng SY; Shong M. 2015. Thyroid dysfunction associated with follicular cell steatosis in obese male mice and humans. Endocrinology 156(3):1181-93. PubMed: 25555091 MGI: J:221925
Lee SH; Huang H; Choi K; Lee DH; Shi J; Liu T; Chun KH; Seo JA; Lima IS; Zabolotny JM; Wei L; Kim YB. 2014. ROCK1 isoform-specific deletion reveals a role for diet-induced insulin resistance. Am J Physiol Endocrinol Metab 306(3):E332-43. PubMed: 24326423 MGI: J:208371
Lee YS; Park MS; Choung JS; Kim SS; Oh HH; Choi CS; Ha SY; Kang Y; Kim Y; Jun HS. 2012. Glucagon-like peptide-1 inhibits adipose tissue macrophage infiltration and inflammation in an obese mouse model of diabetes. Diabetologia 55(9):2456-68. PubMed: 22722451 MGI: J:189199
Lefebvre B; Benomar Y; Guedin A; Langlois A; Hennuyer N; Dumont J; Bouchaert E; Dacquet C; Penicaud L; Casteilla L; Pattou F; Ktorza A; Staels B; Lefebvre P. 2010. Proteasomal degradation of retinoid X receptor alpha reprograms transcriptional activity of PPARgamma in obese mice and humans. J Clin Invest 120(5):1454-68. PubMed: 20364085 MGI: J:161483
Leigh FS; Kaufman LN; Young JB. 1992. Diminished epinephrine excretion in genetically obese (ob/ob) mice and monosodium glutamate-treated rats. Int J Obes Relat Metab Disord 16(8):597-604. PubMed: 1382044 MGI: J:4033
Leinninger GM; Jo YH; Leshan RL; Louis GW; Yang H; Barrera JG; Wilson H; Opland DM; Faouzi MA; Gong Y; Jones JC; Rhodes CJ; Chua S Jr; Diano S; Horvath TL; Seeley RJ; Becker JB; Munzberg H; Myers MG Jr. 2009. Leptin acts via leptin receptor-expressing lateral hypothalamic neurons to modulate the mesolimbic dopamine system and suppress feeding. Cell Metab 10(2):89-98. PubMed: 19656487 MGI: J:151971
Leonardi R; Rock CO; Jackowski S. 2014. Pank1 deletion in leptin-deficient mice reduces hyperglycaemia and hyperinsulinaemia and modifies global metabolism without affecting insulin resistance. Diabetologia 57(7):1466-75. PubMed: 24781151 MGI: J:213743
Leppin K; Behrendt AK; Reichard M; Stachs O; Guthoff RF; Baltrusch S; Eule JC; Vollmar B. 2014. Diabetes mellitus leads to accumulation of dendritic cells and nerve fiber damage of the subbasal nerve plexus in the cornea. Invest Ophthalmol Vis Sci 55(6):3603-15. PubMed: 24781935 MGI: J:229856
Leshan RL; Opland DM; Louis GW; Leinninger GM; Patterson CM; Rhodes CJ; Munzberg H; Myers MG Jr. 2010. Ventral tegmental area leptin receptor neurons specifically project to and regulate cocaine- and amphetamine-regulated transcript neurons of the extended central amygdala. J Neurosci 30(16):5713-23. PubMed: 20410123 MGI: J:159836
Levenson AE; Haas ME; Miao J; Brown RJ; de Ferranti SD; Muniyappa R; Biddinger SB. 2016. Effect of Leptin Replacement on PCSK9 in ob/ob Mice and Female Lipodystrophic Patients. Endocrinology 157(4):1421-9. PubMed: 26824363 MGI: J:234032
Levi J; Huynh FK; Denroche HC; Neumann UH; Glavas MM; Covey SD; Kieffer TJ. 2012. Hepatic leptin signalling and subdiaphragmatic vagal efferents are not required for leptin-induced increases of plasma IGF binding protein-2 (IGFBP-2) in ob/ob mice. Diabetologia 55(3):752-62. PubMed: 22202803 MGI: J:181709
Levin N; Nelson C; Gurney A; Vandlen R; de Sauvage F. 1996. Decreased food intake does not completely account for adiposity reduction after ob protein infusion. Proc Natl Acad Sci U S A 93(4):1726-30. PubMed: 8643697 MGI: J:31728
Li D; Zhang Y; Xu L; Zhou L; Wang Y; Xue B; Wen Z; Li P; Sang J. 2010. Regulation of gene expression by FSP27 in white and brown adipose tissue. BMC Genomics 11:446. PubMed: 20649970 MGI: J:162769
Li G; Mongillo M; Chin KT; Harding H; Ron D; Marks AR; Tabas I. 2009. Role of ERO1-alpha-mediated stimulation of inositol 1,4,5-triphosphate receptor activity in endoplasmic reticulum stress-induced apoptosis. J Cell Biol 186(6):783-92. PubMed: 19752026 MGI: J:153833
Li J; Grigoryev DN; Ye SQ; Thorne L; Schwartz AR; Smith PL; O'Donnell CP; Polotsky VY. 2005. Chronic intermittent hypoxia upregulates genes of lipid biosynthesis in obese mice. J Appl Physiol 99(5):1643-8. PubMed: 16037401 MGI: J:116867
Li J; Thorne LN; Punjabi NM; Sun CK; Schwartz AR; Smith PL; Marino RL; Rodriguez A; Hubbard WC; O'Donnell CP; Polotsky VY. 2005. Intermittent hypoxia induces hyperlipidemia in lean mice. Circ Res 97(7):698-706. PubMed: 16123334 MGI: J:114630
Li L; Pan R; Li R; Niemann B; Aurich AC; Chen Y; Rohrbach S. 2011. Mitochondrial biogenesis and peroxisome proliferator-activated receptor-gamma coactivator-1alpha (PGC-1alpha) deacetylation by physical activity: intact adipocytokine signaling is required. Diabetes 60(1):157-67. PubMed: 20929977 MGI: J:170176
Li M; Kim DH; Tsenovoy PL; Peterson SJ; Rezzani R; Rodella LF; Aronow WS; Ikehara S; Abraham NG. 2008. Treatment of obese diabetic mice with a heme oxygenase inducer reduces visceral and subcutaneous adiposity, increases adiponectin levels, and improves insulin sensitivity and glucose tolerance. Diabetes 57(6):1526-35. PubMed: 18375438 MGI: J:136899
Li N; Young MM; Bailey CJ; Smith ME. 1999. NMDA and AMPA glutamate receptor subtypes in the thoracic spinal cord in lean and obese-diabetic ob/ob mice. Brain Res 849(1-2):34-44. PubMed: 10592285 MGI: J:59144
Li Q; Hosaka T; Harada N; Nakaya Y; Funaki M. 2013. Activation of Akt through 5-HT2A receptor ameliorates serotonin-induced degradation of insulin receptor substrate-1 in adipocytes. Mol Cell Endocrinol 365(1):25-35. PubMed: 22975078 MGI: J:193789
Li S; Sun Y; Liang CP; Thorp EB; Han S; Jehle AW; Saraswathi V; Pridgen B; Kanter JE; Li R; Welch CL; Hasty AH; Bornfeldt KE; Breslow JL; Tabas I; Tall AR. 2009. Defective phagocytosis of apoptotic cells by macrophages in atherosclerotic lesions of ob/ob mice and reversal by a fish oil diet. Circ Res 105(11):1072-82. PubMed: 19834009 MGI: J:170144
Li SY; Yang X; Ceylan-Isik AF; Du M; Sreejayan N; Ren J. 2006. Cardiac contractile dysfunction in Lep/Lep obesity is accompanied by NADPH oxidase activation, oxidative modification of sarco(endo)plasmic reticulum Ca(2+)-ATPase and myosin heavy chain isozyme switch. Diabetologia 49(6):1434-46. PubMed: 16612592 MGI: J:111488
Li T; Francl JM; Boehme S; Ochoa A; Zhang Y; Klaassen CD; Erickson SK; Chiang JY. 2012. Glucose and insulin induction of bile acid synthesis: mechanisms and implication in diabetes and obesity. J Biol Chem 287(3):1861-73. PubMed: 22144677 MGI: J:180806
Li X; Ge H; Weiszmann J; Hecht R; Li YS; Veniant MM; Xu J; Wu X; Lindberg R; Li Y. 2009. Inhibition of lipolysis may contribute to the acute regulation of plasma FFA and glucose by FGF21 in ob/ob mice. FEBS Lett 583(19):3230-4. PubMed: 19751733 MGI: J:153762
Li X; Grundy SM; Patel SB. 1997. Obesity in db and ob animals leads to impaired hepatic very low density lipoprotein secretion and differential secretion of apolipoprotein B-48 and B-100. J Lipid Res 38(7):1277-88. PubMed: 9254055 MGI: J:41954
Li Y; Nie Y; Helou Y; Ding G; Feng B; Xu G; Salomon A; Xu H. 2013. Identification of sucrose non-fermenting-related kinase (SNRK) as a suppressor of adipocyte inflammation. Diabetes 62(7):2396-409. PubMed: 23520131 MGI: J:208665
Li Z; Kelly L; Heiman M; Greengard P; Friedman JM. 2015. Hypothalamic Amylin Acts in Concert with Leptin to Regulate Food Intake. Cell Metab 22(6):1059-67. PubMed: 26655697 MGI: J:235897
Li Z; Lin H; Yang S; Diehl AM. 2002. Murine leptin deficiency alters Kupffer cell production of cytokines that regulate the innate immune system. Gastroenterology 123(4):1304-10. PubMed: 12360490 MGI: J:79334
Li Z; Oben JA; Yang S; Lin H; Stafford EA; Soloski MJ; Thomas SA; Diehl AM. 2004. Norepinephrine regulates hepatic innate immune system in leptin-deficient mice with nonalcoholic steatohepatitis. Hepatology 40(2):434-41. PubMed: 15368448 MGI: J:105439
Li Z; Schmidt SF; Friedman JM. 2013. Developmental role for endocannabinoid signaling in regulating glucose metabolism and growth. Diabetes 62(7):2359-67. PubMed: 23423572 MGI: J:208547
Lian K; Du C; Liu Y; Zhu D; Yan W; Zhang H; Hong Z; Liu P; Zhang L; Pei H; Zhang J; Gao C; Xin C; Cheng H; Xiong L; Tao L. 2015. Impaired adiponectin signaling contributes to disturbed catabolism of branched-chain amino acids in diabetic mice. Diabetes 64(1):49-59. PubMed: 25071024 MGI: J:230107
Liang Y; Cincotta AH. 2001. Increased responsiveness to the hyperglycemic, hyperglucagonemic and hyperinsulinemic effects of circulating norepinephrine in ob/ob mice. Int J Obes Relat Metab Disord 25(5):698-704. PubMed: 11360153 MGI: J:69134
Liew CW; Boucher J; Cheong JK; Vernochet C; Koh HJ; Mallol C; Townsend K; Langin D; Kawamori D; Hu J; Tseng YH; Hellerstein MK; Farmer SR; Goodyear L; Doria A; Bluher M; Hsu SI; Kulkarni RN. 2013. Ablation of TRIP-Br2, a regulator of fat lipolysis, thermogenesis and oxidative metabolism, prevents diet-induced obesity and insulin resistance. Nat Med 19(2):217-26. PubMed: 23291629 MGI: J:194928
Lijnen HR; Christiaens V; Scroyen I; Voros G; Tjwa M; Carmeliet P; Collen D. 2006. Impaired adipose tissue development in mice with inactivation of placental growth factor function. Diabetes 55(10):2698-704. PubMed: 17003333 MGI: J:116580
Lim G; Wang S; Zhang Y; Tian Y; Mao J. 2009. Spinal leptin contributes to the pathogenesis of neuropathic pain in rodents. J Clin Invest 119(2):295-304. PubMed: 19139561 MGI: J:146170
Lim MA; Bence KK; Sandesara I; Andreux P; Auwerx J; Ishibashi J; Seale P; Kalb RG. 2014. Genetically altering organismal metabolism by leptin-deficiency benefits a mouse model of amyotrophic lateral sclerosis. Hum Mol Genet 23(18):4995-5008. PubMed: 24833719 MGI: J:214320
Lin JE; Colon-Gonzalez F; Blomain E; Kim GW; Aing A; Stoecker B; Rock J; Snook AE; Zhan T; Hyslop TM; Tomczak M; Blumberg RS; Waldman SA. 2016. Obesity-Induced Colorectal Cancer Is Driven by Caloric Silencing of the Guanylin-GUCY2C Paracrine Signaling Axis. Cancer Res 76(2):339-46. PubMed: 26773096 MGI: J:231317
Lin JZ; Martagon AJ; Cimini SL; Gonzalez DD; Tinkey DW; Biter A; Baxter JD; Webb P; Gustafsson JA; Hartig SM; Phillips KJ. 2015. Pharmacological Activation of Thyroid Hormone Receptors Elicits a Functional Conversion of White to Brown Fat. Cell Rep 13(8):1528-37. PubMed: 26586443 MGI: J:228942
Lin MH; Romsos DR; Akera T; Leveille GA. 1979. Na+,K+-ATPase enzyme units in skeletal muscle and liver of 14-day-old lean and obese (ob/ob) mice. Proc Soc Exp Biol Med 161(3):235-8. PubMed: 223169 MGI: J:6182
Liu J; Lee J; Salazar Hernandez MA; Mazitschek R; Ozcan U. 2015. Treatment of obesity with celastrol. Cell 161(5):999-1011. PubMed: 26000480 MGI: J:223406
Liu J; Liang S; Liu X; Brown JA; Newman KE; Sunkara M; Morris AJ; Bhatnagar S; Li X; Pujol A; Graf GA. 2012. The absence of ABCD2 sensitizes mice to disruptions in lipid metabolism by dietary erucic acid. J Lipid Res 53(6):1071-9. PubMed: 22493092 MGI: J:184905
Liu Q; Bai C; Chen F; Wang R; MacDonald T; Gu M; Zhang Q; Morsy MA ; Caskey CT. 1998. Uncoupling protein-3: a muscle-specific gene upregulated by leptin in ob/ob mice. Gene 207(1):1-7. PubMed: 9511737 MGI: J:45946
Liu T; Zhang Y; Liu Y; Wang Y; Jia H; Kang M; Luo X; Caballero D; Gonzalez J; Sherwood L; Nunez V; Wang D; Woods A; Schultz PG; Wang F. 2015. Functional human antibody CDR fusions as long-acting therapeutic endocrine agonists. Proc Natl Acad Sci U S A 112(5):1356-61. PubMed: 25605877 MGI: J:219568
Liu W; Struik D; Nies VJ; Jurdzinski A; Harkema L; de Bruin A; Verkade HJ; Downes M; Evans RM; van Zutphen T; Jonker JW. 2016. Effective treatment of steatosis and steatohepatitis by fibroblast growth factor 1 in mouse models of nonalcoholic fatty liver disease. Proc Natl Acad Sci U S A 113(8):2288-93. PubMed: 26858440 MGI: J:230421
Liu X; Wang S; You Y; Meng M; Zheng Z; Dong M; Lin J; Zhao Q; Zhang C; Yuan X; Hu T; Liu L; Huang Y; Zhang L; Wang D; Zhan J; Jong Lee H; Speakman JR; Jin W. 2015. Brown Adipose Tissue Transplantation Reverses Obesity in Ob/Ob Mice. Endocrinology 156(7):2461-9. PubMed: 25830704 MGI: J:224108
Liu Y; Metzinger MN; Lewellen KA; Cripps SN; Carey KD; Harper EI; Shi Z; Tarwater L; Grisoli A; Lee E; Slusarz A; Yang J; Loughran EA; Conley K; Johnson JJ; Klymenko Y; Bruney L; Liang Z; Dovichi NJ; Cheatham B; Leevy WM; Stack MS. 2015. Obesity Contributes to Ovarian Cancer Metastatic Success through Increased Lipogenesis, Enhanced Vascularity, and Decreased Infiltration of M1 Macrophages. Cancer Res 75(23):5046-57. PubMed: 26573796 MGI: J:226830
Liu Y; Michael MD; Kash S; Bensch WR; Monia BP; Murray SF; Otto KA; Syed SK; Bhanot S; Sloop KW; Sullivan JM; Reifel-Miller A. 2007. Deficiency of adiponectin receptor 2 reduces diet-induced insulin resistance but promotes type 2 diabetes. Endocrinology 148(2):683-92. PubMed: 17068142 MGI: J:129554
Liu Y; Millar JS; Cromley DA; Graham M; Crooke R; Billheimer JT; Rader DJ. 2008. Knockdown of acyl-CoA:diacylglycerol acyltransferase 2 with antisense oligonucleotide reduces VLDL TG and ApoB secretion in mice. Biochim Biophys Acta 1781(3):97-104. PubMed: 18252207 MGI: J:133527
Liu Y; Prentice KJ; Eversley JA; Hu C; Batchuluun B; Leavey K; Hansen JB; Wei DW; Cox B; Dai FF; Jia W; Wheeler MB. 2016. Rapid Elevation in CMPF May Act As a Tipping Point in Diabetes Development. Cell Rep 14(12):2889-900. PubMed: 26997281 MGI: J:234873
Liu Y; Yu Y; Matarese G; La Cava A. 2012. Cutting edge: fasting-induced hypoleptinemia expands functional regulatory T cells in systemic lupus erythematosus. J Immunol 188(5):2070-3. PubMed: 22291185 MGI: J:181358
Liu YL; Emilsson V; Cawthorne MA. 1997. Leptin inhibits glycogen synthesis in the isolated soleus muscle of obese (ob/ob) mice. FEBS Lett 411(2-3):351-5. PubMed: 9271234 MGI: J:42130
Lloyd DJ; Helmering J; Kaufman SA; Turk J; Silva M; Vasquez S; Weinstein D; Johnston B; Hale C; Veniant MM. 2011. A Volumetric Method for Quantifying Atherosclerosis in Mice by Using MicroCT: Comparison to En Face. PLoS One 6(4):e18800. PubMed: 21533112 MGI: J:172393
Lloyd DJ; McCormick J; Helmering J; Kim KW; Wang M; Fordstrom P; Kaufman SA; Lindberg RA; Veniant MM. 2008. Generation and characterization of two novel mouse models exhibiting the phenotypes of the metabolic syndrome: Apob48-/-Lepob/ob mice devoid of ApoE or Ldlr. Am J Physiol Endocrinol Metab 294(3):E496-505. PubMed: 18160459 MGI: J:133453
Lloyd DJ; St Jean DJ Jr; Kurzeja RJ; Wahl RC; Michelsen K; Cupples R; Chen M; Wu J; Sivits G; Helmering J; Komorowski R; Ashton KS; Pennington LD; Fotsch C; Vazir M; Chen K; Chmait S; Zhang J; Liu L; Norman MH; Andrews KL; Bartberger MD; Van G; GalbreathEJ; Vonderfecht SL; Wang M; Jordan SR; Veniant MM; Hale C. 2013. Antidiabetic effects of glucokinase regulatory protein small-molecule disruptors. Nature 504(7480):437-40. PubMed: 24226772 MGI: J:207760
Loffreda S; Yang SQ; Lin HZ; Karp CL; Brengman ML; Wang DJ; Klein AS; Bulkley GB; Bao C; Noble PW; Lane MD; Diehl AM. 1998. Leptin regulates proinflammatory immune responses. FASEB J 12(1):57-65. PubMed: 9438411 MGI: J:115105
Loftus TM; Kuhajda FP; Lane MD. 1998. Insulin depletion leads to adipose-specific cell death in obese but not lean mice. Proc Natl Acad Sci U S A 95(24):14168-72. PubMed: 9826672 MGI: J:51283
Loh K; Fukushima A; Zhang X; Galic S; Briggs D; Enriori PJ; Simonds S; Wiede F; Reichenbach A; Hauser C; Sims NA; Bence KK; Zhang S; Zhang ZY; Kahn BB; Neel BG; Andrews ZB; Cowley MA; Tiganis T. 2011. Elevated hypothalamic TCPTP in obesity contributes to cellular leptin resistance. Cell Metab 14(5):684-99. PubMed: 22000926 MGI: J:179621
Long EK; Hellberg K; Foncea R; Hertzel AV; Suttles J; Bernlohr DA. 2013. Fatty acids induce leukotriene C4 synthesis in macrophages in a fatty acid binding protein-dependent manner. Biochim Biophys Acta 1831(7):1199-207. PubMed: 23583845 MGI: J:202397
Long EK; Olson DM; Bernlohr DA. 2013. High-fat diet induces changes in adipose tissue trans-4-oxo-2-nonenal and trans-4-hydroxy-2-nonenal levels in a depot-specific manner. Free Radic Biol Med 63:390-8. PubMed: 23726997 MGI: J:205169
Lopez-Parra M; Titos E; Horrillo R; Ferre N; Gonzalez-Periz A; Martinez-Clemente M; Planaguma A; Masferrer J; Arroyo V; Claria J. 2008. Regulatory effects of arachidonate 5-lipoxygenase on hepatic microsomal TG transfer protein activity and VLDL-triglyceride and apoB secretion in obese mice. J Lipid Res 49(12):2513-23. PubMed: 18645210 MGI: J:142866
Lord GM; Matarese G; Howard JK; Baker RJ; Bloom SR; Lechler RI. 1998. Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature 394(6696):897-901. PubMed: 9732873 MGI: J:49623
Louis GW; Leinninger GM; Rhodes CJ; Myers MG Jr. 2010. Direct innervation and modulation of orexin neurons by lateral hypothalamic LepRb neurons. J Neurosci 30(34):11278-87. PubMed: 20739548 MGI: J:163528
Lourenco EV; Liu A; Matarese G; La Cava A. 2016. Leptin promotes systemic lupus erythematosus by increasing autoantibody production and inhibiting immune regulation. Proc Natl Acad Sci U S A 113(38):10637-42. PubMed: 27588900 MGI: J:235573
Lu FL; Johnston RA; Flynt L; Theman TA; Terry RD; Schwartzman IN; Lee A; Shore SA. 2006. Increased pulmonary responses to acute ozone exposure in obese db/db mice. Am J Physiol Lung Cell Mol Physiol 290(5):L856-65. PubMed: 16373670 MGI: J:115772
Lu Y; Liu X; Jiao Y; Xiong X; Wang E; Wang X; Zhang Z; Zhang H; Pan L; Guan Y; Cai D; Ning G; Li X. 2014. Periostin promotes liver steatosis and hypertriglyceridemia through downregulation of PPARalpha. J Clin Invest 124(8):3501-13. PubMed: 25003192 MGI: J:213849
Luan B; Yoon YS; Le Lay J; Kaestner KH; Hedrick S; Montminy M. 2015. CREB pathway links PGE2 signaling with macrophage polarization. Proc Natl Acad Sci U S A 112(51):15642-7. PubMed: 26644581 MGI: J:228308
Lubitz I; Haroutunian V; Katsel P; Leroith D; Landa N; Castel D; Shaish A; Shnerb R; Schnaider-Beeri M. 2014. Non-viability of crossing the Alzheimer mouse model Tg2576 with the type 2 diabetes mouse model ob/ob. Neurobiol Aging 35(7):e19-20. PubMed: 24581479 MGI: J:213837
Lucas E; Jurado-Pueyo M; Fortuno MA; Fernandez-Veledo S; Vila-Bedmar R; Jimenez-Borreguero LJ; Lazcano JJ; Gao E; Gomez-Ambrosi J; Fruhbeck G; Koch WJ; Diez J; Mayor F Jr; Murga C. 2014. Downregulation of G protein-coupled receptor kinase 2 levels enhances cardiac insulin sensitivity and switches on cardioprotective gene expression patterns. Biochim Biophys Acta 1842(12 Pt A):2448-56. PubMed: 25239306 MGI: J:230473
Lumeng CN; Bodzin JL; Saltiel AR. 2007. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest 117(1):175-84. PubMed: 17200717 MGI: J:117438
Luo P; Wang PX; Li ZZ; Zhang XJ; Jiang X; Gong J; Qin JJ; Guo J; Zhu X; Yang S; Li H. 2016. Hepatic Oncostatin M Receptor beta Regulates Obesity-Induced Steatosis and Insulin Resistance. Am J Pathol 186(5):1278-92. PubMed: 26976243 MGI: J:232048
Luo X; Hutley LJ; Webster JA; Kim YH; Liu DF; Newell FS; Widberg CH; Bachmann A; Turner N; Schmitz-Peiffer C; Prins JB; Yang GS; Whitehead JP. 2012. Identification of BMP and activin membrane-bound inhibitor (BAMBI) as a potent negative regulator of adipogenesis and modulator of autocrine/paracrine adipogenic factors. Diabetes 61(1):124-36. PubMed: 22187378 MGI: J:191512
Luque RM; Huang ZH; Shah B; Mazzone T; Kineman RD. 2007. Effects of leptin replacement on hypothalamic-pituitary growth hormone axis function and circulating ghrelin levels in ob/ob mice. Am J Physiol Endocrinol Metab 292(3):E891-9. PubMed: 17122091 MGI: J:118904
Luque RM; Kineman RD. 2006. Impact of obesity on the growth hormone axis: evidence for a direct inhibitory effect of hyperinsulinemia on pituitary function. Endocrinology 147(6):2754-63. PubMed: 16513828 MGI: J:129482
Luque RM; Kineman RD; Tena-Sempere M. 2007. Regulation of hypothalamic expression of KiSS-1 and GPR54 genes by metabolic factors: analyses using mouse models and a cell line. Endocrinology 148(10):4601-11. PubMed: 17595226 MGI: J:129475
Lustig Y; Barhod E; Ashwal-Fluss R; Gordin R; Shomron N; Baruch-Umansky K; Hemi R; Karasik A; Kanety H. 2014. RNA-binding protein PTB and microRNA-221 coregulate AdipoR1 translation and adiponectin signaling. Diabetes 63(2):433-45. PubMed: 24130336 MGI: J:209020
Lynch CJ; Zhou Q; Shyng SL; Heal DJ; Cheetham SC; Dickinson K; Gregory P; Firnges M; Nordheim U; Goshorn S; Reiche D; Turski L; Antel J. 2012. Some cannabinoid receptor ligands and their distomers are direct-acting openers of SUR1 K(ATP) channels. Am J Physiol Endocrinol Metab 302(5):E540-51. PubMed: 22167524 MGI: J:184649
MAYER J; BATES MW; DICKIE MM. 1951. Hereditary diabetes in genetically obese mice. Science 113(2948):746-7. PubMed: 14854871 MGI: J:236845
MAYER J; DICKIE MM; BATES MW; VITALE JJ. 1951. Free selection of nutrients by hereditarily obese mice. Science 113(2948):745-6. PubMed: 14854870 MGI: J:236846
Ma C; Kesarwala AH; Eggert T; Medina-Echeverz J; Kleiner DE; Jin P; Stroncek DF; Terabe M; Kapoor V; ElGindi M; Han M; Thornton AM; Zhang H; Egger M; Luo J; Felsher DW; McVicar DW; Weber A; Heikenwalder M; Greten TF. 2016. NAFLD causes selective CD4(+) T lymphocyte loss and promotes hepatocarcinogenesis. Nature 531(7593):253-7. PubMed: 26934227 MGI: J:229665
Ma X; Lin Y; Lin L; Qin G; Pereira FA; Haymond MW; Butte NF; Sun Y. 2012. Ablation of ghrelin receptor in leptin-deficient ob/ob mice has paradoxical effects on glucose homeostasis when compared with ablation of ghrelin in ob/ob mice. Am J Physiol Endocrinol Metab 303(3):E422-31. PubMed: 22669248 MGI: J:187287
MacDonald S; Smith ME; Bailey CJ. 1998. Expression of beta-endorphin and its receptors in the spinal cord of obese-diabetic ob/ob mice. Neurosci Lett 248(2):85-8. PubMed: 9654348 MGI: J:107948
MacDougald OA; Hwang CS; Fan H; Lane MD. 1995. Regulated expression of the obese gene product (leptin) in white adipose tissue and 3T3-L1 adipocytes. Proc Natl Acad Sci U S A 92(20):9034-7. PubMed: 7568067 MGI: J:29081
Macia L; Delacre M; Abboud G; Ouk TS; Delanoye A; Verwaerde C; Saule P; Wolowczuk I. 2006. Impairment of dendritic cell functionality and steady-state number in obese mice. J Immunol 177(9):5997-6006. PubMed: 17056524 MGI: J:140529
Maeda K; Uysal KT; Makowski L; Gorgun CZ; Atsumi G; Parker RA; Bruning J; Hertzel AV; Bernlohr DA; Hotamisligil GS. 2003. Role of the fatty acid binding protein mal1 in obesity and insulin resistance. Diabetes 52(2):300-7. PubMed: 12540600 MGI: J:81609
Maeda T; Kiguchi N; Kobayashi Y; Ikuta T; Ozaki M; Kishioka S. 2009. Leptin derived from adipocytes in injured peripheral nerves facilitates development of neuropathic pain via macrophage stimulation. Proc Natl Acad Sci U S A 106(31):13076-81. PubMed: 19620723 MGI: J:152019
Maglich JM; Lobe DC; Moore JT. 2009. The nuclear receptor CAR (NR1I3) regulates serum triglyceride levels under conditions of metabolic stress. J Lipid Res 50(3):439-45. PubMed: 18941143 MGI: J:149091
Makimura H; Mizuno TM; Roberts J; Silverstein J; Beasley J; Mobbs CV. 2000. Adrenalectomy reverses obese phenotype and restores hypothalamic melanocortin tone in leptin-deficient ob/ob mice Diabetes 49(11):1917-23. PubMed: 11078460 MGI: J:65482
Mancuso P; Gottschalk A; Phare SM; Peters-Golden M; Lukacs NW; Huffnagle GB. 2002. Leptin-deficient mice exhibit impaired host defense in gram-negative pneumonia. J Immunol 168(8):4018-24. PubMed: 11937559 MGI: J:75906
Maness LM; Banks WA; Kastin AJ. 2000. Persistence of blood-to-brain transport of leptin in obese leptin-deficient and leptin receptor-deficient mice Brain Res 873(1):165-7. PubMed: 10915826 MGI: J:63732
Manolescu DC; Sima A; Bhat PV. 2010. All-trans retinoic acid lowers serum retinol-binding protein 4 concentrations and increases insulin sensitivity in diabetic mice. J Nutr 140(2):311-6. PubMed: 20032483 MGI: J:156441
Mansuy-Aubert V; Zhou QL; Xie X; Gong Z; Huang JY; Khan AR; Aubert G; Candelaria K; Thomas S; Shin DJ; Booth S; Baig SM; Bilal A; Hwang D; Zhang H; Lovell-Badge R; Smith SR; Awan FR; Jiang ZY. 2013. Imbalance between neutrophil elastase and its inhibitor alpha1-antitrypsin in obesity alters insulin sensitivity, inflammation, and energy expenditure. Cell Metab 17(4):534-48. PubMed: 23562077 MGI: J:198973
Marcelin G; Liu SM; Li X; Schwartz GJ; Chua S. 2012. Genetic control of ATGL-mediated lipolysis modulates adipose triglyceride stores in leptin-deficient mice. J Lipid Res 53(5):964-72. PubMed: 22383686 MGI: J:184915
Mari M; Caballero F; Colell A; Morales A; Caballeria J; Fernandez A; Enrich C; Fernandez-Checa JC; Garcia-Ruiz C. 2006. Mitochondrial free cholesterol loading sensitizes to TNF- and Fas-mediated steatohepatitis. Cell Metab 4(3):185-98. PubMed: 16950136 MGI: J:129725
Marion V; Mockel A; De Melo C; Obringer C; Claussmann A; Simon A; Messaddeq N; Durand M; Dupuis L; Loeffler JP; King P; Mutter-Schmidt C; Petrovsky N; Stoetzel C; Dollfus H. 2012. BBS-induced ciliary defect enhances adipogenesis, causing paradoxical higher-insulin sensitivity, glucose usage, and decreased inflammatory response. Cell Metab 16(3):363-77. PubMed: 22958920 MGI: J:189019
Mark AL; Shaffer RA; Correia ML; Morgan DA; Sigmund CD; Haynes WG. 1999. Contrasting blood pressure effects of obesity in leptin-deficient ob/ob mice and agouti yellow obese mice. J Hypertens 17(12 Pt 2):1949-53. PubMed: 10703894 MGI: J:61305
Marsh DJ; Hollopeter G; Kafer KE; Palmiter RD. 1998. Role of the Y5 neuropeptide Y receptor in feeding and obesity. Nat Med 4(6):718-21. PubMed: 9623983 MGI: J:87803
Marti A; Novo FJ; Martinez-Anso E; Zaratiegui M; Aguado M; Martinez JA. 1998. Leptin gene transfer into muscle increases lipolysis and oxygen consumption in white fat tissue in ob/ob mice. Biochem Biophys Res Commun 246(3):859-62. PubMed: 9618302 MGI: J:47997
Martinez-Garcia C; Izquierdo A; Velagapudi V; Vivas Y; Velasco I; Campbell M; Burling K; Cava F; Ros M; Oresic M; Vidal-Puig A; Medina-Gomez G. 2012. Accelerated renal disease is associated with the development of metabolic syndrome in a glucolipotoxic mouse model. Dis Model Mech 5(5):636-48. PubMed: 22773754 MGI: J:186778
Masjkur J; Arps-Forker C; Poser SW; Nikolakopoulou P; Toutouna L; Chenna R; Chavakis T; Chatzigeorgiou A; Chen LS; Dubrovska A; Choudhary P; Uphues I; Mark M; Bornstein SR; Androutsellis-Theotokis A. 2014. Hes3 is expressed in the adult pancreatic islet and regulates gene expression, cell growth, and insulin release. J Biol Chem 289(51):35503-16. PubMed: 25371201 MGI: J:218260
Matarese G; Di Giacomo A; Sanna V; Lord GM; Howard JK; Di Tuoro A; Bloom SR; Lechler RI; Zappacosta S; Fontana S. 2001. Requirement for leptin in the induction and progression of autoimmune encephalomyelitis. J Immunol 166(10):5909-16. PubMed: 11342605 MGI: J:69350
Matsubara T; Mita A; Minami K; Hosooka T; Kitazawa S; Takahashi K; Tamori Y; Yokoi N; Watanabe M; Matsuo E; Nishimura O; Seino S. 2012. PGRN is a key adipokine mediating high fat diet-induced insulin resistance and obesity through IL-6 in adipose tissue. Cell Metab 15(1):38-50. PubMed: 22225875 MGI: J:182323
Matsunuma A; Horiuchi N. 2007. Leptin attenuates gene expression for renal 25-hydroxyvitamin D3-1alpha-hydroxylase in mice via the long form of the leptin receptor. Arch Biochem Biophys 463(1):118-27. PubMed: 17400175 MGI: J:123347
Matsusue K; Aibara D; Hayafuchi R; Matsuo K; Takiguchi S; Gonzalez FJ; Yamano S. 2014. Hepatic PPARgamma and LXRalpha independently regulate lipid accumulation in the livers of genetically obese mice. FEBS Lett 588(14):2277-81. PubMed: 24857376 MGI: J:211650
Matsusue K; Gavrilova O; Lambert G; Brewer HB Jr; Ward JM; Inoue Y; LeRoith D; Gonzalez FJ. 2004. Hepatic CCAAT/enhancer binding protein alpha mediates induction of lipogenesis and regulation of glucose homeostasis in leptin-deficient mice. Mol Endocrinol 18(11):2751-64. PubMed: 15319454 MGI: J:93579
Matsusue K; Haluzik M; Lambert G; Yim SH; Gavrilova O; Ward JM; Brewer B Jr; Reitman ML; Gonzalez FJ. 2003. Liver-specific disruption of PPARgamma in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes. J Clin Invest 111(5):737-47. PubMed: 12618528 MGI: J:82439
Matsusue K; Kusakabe T; Noguchi T; Takiguchi S; Suzuki T; Yamano S; Gonzalez FJ. 2008. Hepatic steatosis in leptin-deficient mice is promoted by the PPARgamma target gene Fsp27. Cell Metab 7(4):302-11. PubMed: 18396136 MGI: J:134335
Matsuzaka T; Shimano H; Yahagi N; Kato T; Atsumi A; Yamamoto T; Inoue N; Ishikawa M; Okada S; Ishigaki N; Iwasaki H; Iwasaki Y; Karasawa T; Kumadaki S; Matsui T; Sekiya M; Ohashi K; Hasty AH; Nakagawa Y; Takahashi A; Suzuki H; Yatoh S; Sone H; Toyoshima H; Osuga J; Yamada N. 2007. Crucial role of a long-chain fatty acid elongase, Elovl6, in obesity-induced insulin resistance. Nat Med 13(10):1193-202. PubMed: 17906635 MGI: J:130031
Mazumder PK; O'Neill BT; Roberts MW; Buchanan J; Yun UJ; Cooksey RC; Boudina S; Abel ED. 2004. Impaired cardiac efficiency and increased fatty acid oxidation in insulin-resistant ob/ob mouse hearts. Diabetes 53(9):2366-74. PubMed: 15331547 MGI: J:107188
McGaffin KR; Sun CK; Rager JJ; Romano LC; Zou B; Mathier MA; O'Doherty RM; McTiernan CF; O'Donnell CP. 2008. Leptin signalling reduces the severity of cardiac dysfunction and remodelling after chronic ischaemic injury. Cardiovasc Res 77(1):54-63. PubMed: 18006469 MGI: J:161919
McNay DE; Briancon N; Kokoeva MV; Maratos-Flier E; Flier JS. 2012. Remodeling of the arcuate nucleus energy-balance circuit is inhibited in obese mice. J Clin Invest 122(1):142-52. PubMed: 22201680 MGI: J:184391
McPherron AC; Lee SJ. 2002. Suppression of body fat accumulation in myostatin-deficient mice. J Clin Invest 109(5):595-601. PubMed: 11877467 MGI: J:75344
McQuaid TS; Saleh MC; Joseph JW; Gyulkhandanyan A; Manning-Fox JE; Maclellan JD; Wheeler MB; Chan CB. 2006. cAMP-mediated signaling normalizes glucose-stimulated insulin secretion in uncoupling protein-2 overexpressing {beta}-cells. J Endocrinol 190(3):669-80. PubMed: 17003268 MGI: J:112890
Mcginnis R; Walker J; Margules D; Aird F; Redei E. 1992. Dysregulation of the hypothalamus-pituitary-adrenal axis in male and female, genetically obese (ob/ob) mice J Neuroendocrinol 4(6):765-771. MGI: J:13151
Medina-Gomez G; Gray SL; Yetukuri L; Shimomura K; Virtue S; Campbell M; Curtis RK; Jimenez-Linan M; Blount M; Yeo GS; Lopez M; Seppanen-Laakso T; Ashcroft FM; Oresic M; Vidal-Puig A. 2007. PPAR gamma 2 prevents lipotoxicity by controlling adipose tissue expandability and peripheral lipid metabolism. PLoS Genet 3(4):e64. PubMed: 17465682 MGI: J:121534
Melia HP; Andrews JF; McBennett SM; Porter RK. 1999. Effects of acute leptin administration on the differences in proton leak rate in liver mitochondria from ob/ob mice compared to lean controls. FEBS Lett 458(2):261-4. PubMed: 10481077 MGI: J:57725
Memon RA; Grunfeld C; Moser AH; Feingold KR. 1994. Fatty acid synthesis in obese insulin resistant diabetic mice. Horm Metab Res 26(2):85-7. PubMed: 8200619 MGI: J:17499
Memon RA; Tecott LH; Nonogaki K; Beigneux A; Moser AH; Grunfeld C; Feingold KR. 2000. Up-regulation of peroxisome proliferator-activated receptors (PPAR-alpha) and PPAR-gamma messenger ribonucleic acid expression in the liver in murine obesity: troglitazone induces expression of PPAR-gamma-responsive adipose tissue-specific genes in the liver of obese diabetic mice [In Process Citation] Endocrinology 141(11):4021-31. PubMed: 11089532 MGI: J:65569
Meng ZX; Wang L; Xiao Y; Lin JD. 2014. The Baf60c/Deptor pathway links skeletal muscle inflammation to glucose homeostasis in obesity. Diabetes 63(5):1533-45. PubMed: 24458360 MGI: J:229282
Mercer JG; Moar KM; Hoggard N. 1998. Localization of leptin receptor (Ob-R) messenger ribonucleic acid in the rodent hindbrain. Endocrinology 139(1):29-34. PubMed: 9421394 MGI: J:44828
Mercer JG; Moar KM; Rayner DV; Trayhurn P; Hoggard N. 1997. Regulation of leptin receptor and NPY gene expression in hypothalamus of leptin-treated obese (ob/ob) and cold-exposed lean mice. FEBS Lett 402(2-3):185-8. PubMed: 9037192 MGI: J:38333
Mertens A; Verhamme P; Bielicki JK; Phillips MC; Quarck R; Verreth W; Stengel D; Ninio E; Navab M; Mackness B; Mackness M; Holvoet P. 2003. Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice: LCAT gene transfer decreases atherosclerosis. Circulation 107(12):1640-6. PubMed: 12668499 MGI: J:234614
Metzger JM; Gagen K; Raustad KA; Yang L; White A; Wang SP; Craw S; Liu P; Lanza T; Lin LS; Nargund RP; Guan XM; Strack AM; Reitman ML. 2010. Body temperature as a mouse pharmacodynamic response to bombesin receptor subtype-3 agonists and other potential obesity treatments. Am J Physiol Endocrinol Metab 299(5):E816-24. PubMed: 20807840 MGI: J:171384
Miao J; Ling AV; Manthena PV; Gearing ME; Graham MJ; Crooke RM; Croce KJ; Esquejo RM; Clish CB; Vicent D; Biddinger SB. 2015. Flavin-containing monooxygenase 3 as a potential player in diabetes-associated atherosclerosis. Nat Commun 6:6498. PubMed: 25849138 MGI: J:222740
Miao J; Xiao Z; Kanamaluru D; Min G; Yau PM; Veenstra TD; Ellis E; Strom S; Suino-Powell K; Xu HE; Kemper JK. 2009. Bile acid signaling pathways increase stability of Small Heterodimer Partner (SHP) by inhibiting ubiquitin-proteasomal degradation. Genes Dev 23(8):986-96. PubMed: 19390091 MGI: J:147941
Miller AM; Asquith DL; Hueber AJ; Anderson LA; Holmes WM; McKenzie AN; Xu D; Sattar N; McInnes IB; Liew FY. 2010. Interleukin-33 induces protective effects in adipose tissue inflammation during obesity in mice. Circ Res 107(5):650-8. PubMed: 20634488 MGI: J:175027
Minhas KM; Khan SA; Raju SV; Phan AC; Gonzalez DR; Skaf MW; Lee K; Tejani AD; Saliaris AP; Barouch LA; O'Donnell CP; Emala CW; Berkowitz DE; Hare JM. 2005. Leptin repletion restores depressed {beta}-adrenergic contractility in ob/ob mice independently of cardiac hypertrophy. J Physiol 565(Pt 2):463-74. PubMed: 15760936 MGI: J:112489
Minn AH; Lan H; Rabaglia ME; Harlan DM; Peculis BA; Attie AD; Shalev A. 2005. Increased insulin translation from an insulin splice-variant overexpressed in diabetes, obesity, and insulin resistance. Mol Endocrinol 19(3):794-803. PubMed: 15550470 MGI: J:96491
Miranda DA; Kim JH; Nguyen LN; Cheng W; Tan BC; Goh VJ; Tan JS; Yaligar J; Kn BP; Velan SS; Wang H; Silver DL. 2014. Fat storage-inducing transmembrane protein 2 is required for normal fat storage in adipose tissue. J Biol Chem 289(14):9560-72. PubMed: 24519944 MGI: J:212437
Mistry AM; Helferich W; Romsos DR. 1994. Elevated neuronal c-Fos-like immunoreactivity and messenger ribonucleic acid (mRNA) in genetically obese (ob/ob) mice. Brain Res 666(1):53-60. PubMed: 7889367 MGI: J:21819
Mistry AM; Swick AG; Romsos DR. 1997. Leptin rapidly lowers food intake and elevates metabolic rates in lean and ob/ob mice. J Nutr 127(10):2065-72. PubMed: 9311966 MGI: J:43304
Mitra R; Nogee DP; Zechner JF; Yea K; Gierasch CM; Kovacs A; Medeiros DM; Kelly DP; Duncan JG. 2012. The transcriptional coactivators, PGC-1alpha and beta, cooperate to maintain cardiac mitochondrial function during the early stages of insulin resistance. J Mol Cell Cardiol 52(3):701-10. PubMed: 22080103 MGI: J:183668
Mitsutake S; Zama K; Yokota H; Yoshida T; Tanaka M; Mitsui M; Ikawa M; Okabe M; Tanaka Y; Yamashita T; Takemoto H; Okazaki T; Watanabe K; Igarashi Y. 2011. Dynamic modification of sphingomyelin in lipid microdomains controls development of obesity, Fatty liver, and type 2 diabetes. J Biol Chem 286(32):28544-55. PubMed: 21669879 MGI: J:175924
Miyawaki K; Yamada Y; Ban N; Ihara Y; Tsukiyama K; Zhou H; Fujimoto S; Oku A; Tsuda K; Toyokuni S; Hiai H; Mizunoya W; Fushiki T; Holst JJ; Makino M; Tashita A; Kobara Y; Tsubamoto Y; Jinnouchi T; Jomori T; Seino Y. 2002. Inhibition of gastric inhibitory polypeptide signaling prevents obesity. Nat Med 8(7):738-42. PubMed: 12068290 MGI: J:77483
Miyazaki M; Sampath H; Liu X; Flowers MT; Chu K; Dobrzyn A; Ntambi JM. 2009. Stearoyl-CoA desaturase-1 deficiency attenuates obesity and insulin resistance in leptin-resistant obese mice. Biochem Biophys Res Commun 380(4):818-22. PubMed: 19338759 MGI: J:147343
Mizuno TM; Kelley KA; Pasinetti GM; Roberts JL; Mobbs CV. 2003. Transgenic neuronal expression of proopiomelanocortin attenuates hyperphagic response to fasting and reverses metabolic impairments in leptin-deficient obese mice. Diabetes 52(11):2675-83. PubMed: 14578285 MGI: J:86303
Mizuno TM; Kleopoulos SP; Bergen HT; Roberts JL; Priest CA; Mobbs CV. 1998. Hypothalamic pro-opiomelanocortin mRNA is reduced by fasting in ob/ob and db/db mice, but is stimulated by leptin. Diabetes 47(2):294-7. PubMed: 9519731 MGI: J:45531
Moloney F; Toomey S; Noone E; Nugent A; Allan B; Loscher CE; Roche HM. 2007. Antidiabetic effects of cis-9, trans-11-conjugated linoleic acid may be mediated via anti-inflammatory effects in white adipose tissue. Diabetes 56(3):574-82. PubMed: 17327424 MGI: J:122028
Moon YA; Liang G; Xie X; Frank-Kamenetsky M; Fitzgerald K; Koteliansky V; Brown MS; Goldstein JL; Horton JD. 2012. The Scap/SREBP pathway is essential for developing diabetic fatty liver and carbohydrate-induced hypertriglyceridemia in animals. Cell Metab 15(2):240-6. PubMed: 22326225 MGI: J:182284
Mooney MH; Abdel-Wahab YH; McKillop AM; O'Harte FP; Flatt PR. 2002. Evaluation of glycated glucagon-like peptide-1(7-36)amide in intestinal tissue of normal and diabetic animal models. Biochim Biophys Acta 1569(1-3):75-80. PubMed: 11853960 MGI: J:75727
Moraes-Vieira PM; Larocca RA; Bassi EJ; Peron JP; Andrade-Oliveira V; Wasinski F; Araujo R; Thornley T; Quintana FJ; Basso AS; Strom TB; Camara NO. 2014. Leptin deficiency impairs maturation of dendritic cells and enhances induction of regulatory T and Th17 cells. Eur J Immunol 44(3):794-806. PubMed: 24271843 MGI: J:209083
Morais RL; Hilzendeger AM; Visniauskas B; Todiras M; Alenina N; Mori MA; Araujo RC; Nakaie CR; Chagas JR; Carmona AK; Bader M; Pesquero JB. 2017. High aminopeptidase A activity contributes to blood pressure control in ob/ob mice by AT2 receptor-dependent mechanism. Am J Physiol Heart Circ Physiol 312(3):H437-H445. PubMed: 27940965 MGI: J:239954
Mori A; Sakurai H; Choo MK; Obi R; Koizumi K; Yoshida C; Shimada Y; Saiki I. 2006. Severe pulmonary metastasis in obese and diabetic mice. Int J Cancer 119(12):2760-7. PubMed: 16998795 MGI: J:117826
Mori MA; Araujo RC; Reis FC; Sgai DG; Fonseca RG; Barros CC; Merino VF; Passadore M; Barbosa AM; Ferrari B; Carayon P; Castro CH; Shimuta SI; Luz J; Bascands JL; Schanstra JP; Even PC; Oliveira SM; Bader M; Pesquero JB. 2008. Kinin B1 receptor deficiency leads to leptin hypersensitivity and resistance to obesity. Diabetes 57(6):1491-500. PubMed: 18332096 MGI: J:136924
Morita M; Oike Y; Nagashima T; Kadomatsu T; Tabata M; Suzuki T; Nakamura T; Yoshida N; Okada M; Yamamoto T. 2011. Obesity resistance and increased hepatic expression of catabolism-related mRNAs in Cnot3+/- mice. EMBO J 30(22):4678-91. PubMed: 21897366 MGI: J:180033
Morton GJ; Kaiyala KJ; Fisher JD; Ogimoto K; Schwartz MW; Wisse BE. 2011. Identification of a physiological role for leptin in the regulation of ambulatory activity and wheel running in mice. Am J Physiol Endocrinol Metab 300(2):E392-401. PubMed: 21062956 MGI: J:172324
Morton GJ; Matsen ME; Bracy DP; Meek TH; Nguyen HT; Stefanovski D; Bergman RN; Wasserman DH; Schwartz MW. 2013. FGF19 action in the brain induces insulin-independent glucose lowering. J Clin Invest :. PubMed: 24084738 MGI: J:203990
Morton NM; Beltram J; Carter RN; Michailidou Z; Gorjanc G; McFadden C; Barrios-Llerena ME; Rodriguez-Cuenca S; Gibbins MT; Aird RE; Moreno-Navarrete JM; Munger SC; Svenson KL; Gastaldello A; Ramage L; Naredo G; Zeyda M; Wang ZV; Howie AF; Saari A; Sipila P; Stulnig TM; Gudnason V; Kenyon CJ; Seckl JR; Walker BR; Webster SP; Dunbar DR; Churchill GA; Vidal-Puig A; Fernandez-Real JM; Emilsson V; Horvat S. 2016. Genetic identification of thiosulfate sulfurtransferase as an adipocyte-expressed antidiabetic target in mice selected for leanness. Nat Med 22(7):771-9. PubMed: 27270587 MGI: J:236030
Mu J; Qureshi SA; Brady EJ; Muise ES; Candelore MR; Jiang G; Li Z; Wu MS; Yang X; Dallas-Yang Q; Miller C; Xiong Y; Langdon RB; Parmee ER; Zhang BB. 2012. Anti-diabetic efficacy and impact on amino acid metabolism of GRA1, a novel small-molecule glucagon receptor antagonist. PLoS One 7(11):e49572. PubMed: 23185367 MGI: J:194789
Muurling M; van den Hoek AM; Mensink RP; Pijl H; Romijn JA; Havekes LM; Voshol PJ. 2004. Overexpression of APOC1 in obob mice leads to hepatic steatosis and severe hepatic insulin resistance. J Lipid Res 45(1):9-16. PubMed: 14523051 MGI: J:87976
Muzzin P; Eisensmith RC; Copeland KC; Woo SL. 1996. Correction of obesity and diabetes in genetically obese mice by leptin gene therapy. Proc Natl Acad Sci U S A 93(25):14804-8. PubMed: 8962136 MGI: J:37249
Nadeau JH. 2003. Modifier genes and protective alleles in humans and mice. Curr Opin Genet Dev 13(3):290-5. PubMed: 12787792 MGI: J:88012
Nagareddy PR; Kraakman M; Masters SL; Stirzaker RA; Gorman DJ; Grant RW; Dragoljevic D; Hong ES; Abdel-Latif A; Smyth SS; Choi SH; Korner J; Bornfeldt KE; Fisher EA; Dixit VD; Tall AR; Goldberg IJ; Murphy AJ. 2014. Adipose tissue macrophages promote myelopoiesis and monocytosis in obesity. Cell Metab 19(5):821-35. PubMed: 24807222 MGI: J:215261
Najjar SM; Yang Y; Fernstrom MA; Lee SJ; Deangelis AM; Rjaily GA; Al-Share QY; Dai T; Miller TA; Ratnam S; Ruch RJ; Smith S; Lin SH; Beauchemin N; Oyarce AM. 2005. Insulin acutely decreases hepatic fatty acid synthase activity. Cell Metab 2(1):43-53. PubMed: 16054098 MGI: J:129840
Nakagawa Y; Satoh A; Yabe S; Furusawa M; Tokushige N; Tezuka H; Mikami M; Iwata W; Shingyouchi A; Matsuzaka T; Kiwata S; Fujimoto Y; Shimizu H; Danno H; Yamamoto T; Ishii K; Karasawa T; Takeuchi Y; Iwasaki H; Shimada M; Kawakami Y; Urayama O; Sone H; Takekoshi K; Kobayashi K; Yatoh S; Takahashi A; Yahagi N; Suzuki H; Yamada N; Shimano H. 2014. Hepatic CREB3L3 controls whole-body energy homeostasis and improves obesity and diabetes. Endocrinology 155(12):4706-19. PubMed: 25233440 MGI: J:219686
Nakagawa Y; Shimano H; Yoshikawa T; Ide T; Tamura M; Furusawa M; Yamamoto T; Inoue N; Matsuzaka T; Takahashi A; Hasty AH; Suzuki H; Sone H; Toyoshima H; Yahagi N; Yamada N. 2006. TFE3 transcriptionally activates hepatic IRS-2, participates in insulin signaling and ameliorates diabetes. Nat Med 12(1):107-113. PubMed: 16327801 MGI: J:104468
Nakahara K; Bannai M; Maruyama K; Suzuki Y; Okame R; Murakami N. 2013. Characterization of a novel genetically obese mouse model demonstrating early onset hyperphagia and hyperleptinemia. Am J Physiol Endocrinol Metab 305(3):E451-63. PubMed: 23736543 MGI: J:203210
Nakamura T; Arduini A; Baccaro B; Furuhashi M; Hotamisligil GS. 2014. Small-molecule inhibitors of PKR improve glucose homeostasis in obese diabetic mice. Diabetes 63(2):526-34. PubMed: 24150608 MGI: J:209018
Nakamura T; Kunz RC; Zhang C; Kimura T; Yuan CL; Baccaro B; Namiki Y; Gygi SP; Hotamisligil GS. 2015. A critical role for PKR complexes with TRBP in Immunometabolic regulation and eIF2alpha phosphorylation in obesity. Cell Rep 11(2):295-307. PubMed: 25843719 MGI: J:228250
Nakanishi N; Nakagawa Y; Tokushige N; Aoki N; Matsuzaka T; Ishii K; Yahagi N; Kobayashi K; Yatoh S; Takahashi A; Suzuki H; Urayama O; Yamada N; Shimano H. 2009. The up-regulation of microRNA-335 is associated with lipid metabolism in liver and white adipose tissue of genetically obese mice. Biochem Biophys Res Commun 385(4):492-6. PubMed: 19460359 MGI: J:151242
Narvekar P; Berriel Diaz M; Krones-Herzig A; Hardeland U; Strzoda D; Stohr S; Frohme M; Herzig S. 2009. Liver-specific loss of lipolysis-stimulated lipoprotein receptor triggers systemic hyperlipidemia in mice. Diabetes 58(5):1040-9. PubMed: 19188430 MGI: J:151130
Nassir F; Adewole OL; Brunt EM; Abumrad NA. 2013. CD36 deletion reduces VLDL secretion, modulates liver prostaglandins, and exacerbates hepatic steatosis in ob/ob mice. J Lipid Res 54(11):2988-97. PubMed: 23964120 MGI: J:203442
Naveilhan P; Svensson L; Nystrom S; Ekstrand AJ; Ernfors P. 2002. Attenuation of hypercholesterolemia and hyperglycemia in ob/ob mice by NPY Y2 receptor ablation. Peptides 23(6):1087-91. PubMed: 12126735 MGI: J:102651
Nawrocki AR; Rajala MW; Tomas E; Pajvani UB; Saha AK; Trumbauer ME; Pang Z; Chen AS; Ruderman NB; Chen H; Rossetti L; Scherer PE. 2006. Mice lacking adiponectin show decreased hepatic insulin sensitivity and reduced responsiveness to peroxisome proliferator-activated receptor gamma agonists. J Biol Chem 281(5):2654-60. PubMed: 16326714 MGI: J:107486
Neels JG; Badeanlou L; Hester KD; Samad F. 2009. Keratinocyte-derived chemokine in obesity: expression, regulation, and role in adipose macrophage infiltration and glucose homeostasis. J Biol Chem 284(31):20692-8. PubMed: 19494115 MGI: J:153182
Neels JG; Pandey M; Hotamisligil GS; Samad F. 2006. Autoamplification of tumor necrosis factor-alpha: a potential mechanism for the maintenance of elevated tumor necrosis factor-alpha in male but not female obese mice. Am J Pathol 168(2):435-44. PubMed: 16436658 MGI: J:106303
Nelson JD; LeBoeuf RC; Bomsztyk K. 2011. Direct recruitment of insulin receptor and ERK signaling cascade to insulin-inducible gene loci. Diabetes 60(1):127-37. PubMed: 20929976 MGI: J:170177
Nemazanyy I; Montagnac G; Russell RC; Morzyglod L; Burnol AF; Guan KL; Pende M; Panasyuk G. 2015. Class III PI3K regulates organismal glucose homeostasis by providing negative feedback on hepatic insulin signalling. Nat Commun 6:8283. PubMed: 26387534 MGI: J:226982
Neumann UH; Chen S; Tam YY; Baker RK; Covey SD; Cullis PR; Kieffer TJ. 2014. IGFBP2 is neither sufficient nor necessary for the physiological actions of leptin on glucose homeostasis in male ob/ob mice. Endocrinology 155(3):716-25. PubMed: 24424049 MGI: J:208807
Newberry EP; Kennedy SM; Xie Y; Luo J; Crooke RM; Graham MJ; Fu J; Piomelli D; Davidson NO. 2012. Decreased body weight and hepatic steatosis with altered fatty acid ethanolamide metabolism in aged L-Fabp -/- mice. J Lipid Res 53(4):744-54. PubMed: 22327204 MGI: J:184941
Newhall KJ; Cummings DE; Nolan MA; McKnight GS. 2005. Deletion of the RIIbeta-subunit of protein kinase A decreases body weight and increases energy expenditure in the obese, leptin-deficient ob/ob mouse. Mol Endocrinol 19(4):982-91. PubMed: 15618289 MGI: J:97181
Nishimura S; Manabe I; Nagasaki M; Seo K; Yamashita H; Hosoya Y; Ohsugi M; Tobe K; Kadowaki T; Nagai R; Sugiura S. 2008. In vivo imaging in mice reveals local cell dynamics and inflammation in obese adipose tissue. J Clin Invest 118(2):710-21. PubMed: 18202748 MGI: J:131401
Nishina PM; Lowe S; Wang J; Paigen B. 1994. Characterization of plasma lipids in genetically obese mice: the mutants obese, diabetes, fat, tubby, and lethal yellow. Metabolism 43(5):549-53. PubMed: 8177042 MGI: J:18161
Nishina PM; Naggert JK; Verstuyft J; Paigen B. 1994. Atherosclerosis in genetically obese mice: the mutants obese, diabetes, fat, tubby, and lethal yellow. Metabolism 43(5):554-8. PubMed: 8177043 MGI: J:19043
Nisoli E; Briscini L; Giordano A; Tonello C; Wiesbrock SM; Uysal KT; Cinti S; Carruba MO; Hotamisligil GS. 2000. Tumor necrosis factor alpha mediates apoptosis of brown adipocytes and defective brown adipocyte function in obesity. Proc Natl Acad Sci U S A 97(14):8033-8. PubMed: 10884431 MGI: J:126631
Nutter CA; Jaworski EA; Verma SK; Deshmukh V; Wang Q; Botvinnik OB; Lozano MJ; Abass IJ; Ijaz T; Brasier AR; Garg NJ; Wehrens XH; Yeo GW; Kuyumcu-Martinez MN. 2016. Dysregulation of RBFOX2 Is an Early Event in Cardiac Pathogenesis of Diabetes. Cell Rep 15(10):2200-13. PubMed: 27239029 MGI: J:238102
O'Donnell CP; Tankersley CG; Polotsky VP; Schwartz AR; Smith PL. 2000. Leptin, obesity, and respiratory function. Respir Physiol 119(2-3):163-70. PubMed: 10722859 MGI: J:61254
Oben JA; Roskams T; Yang S; Lin H; Sinelli N; Li Z; Torbenson M; Thomas SA; Diehl AM. 2003. Norepinephrine induces hepatic fibrogenesis in leptin deficient ob/ob mice. Biochem Biophys Res Commun 308(2):284-92. PubMed: 12901866 MGI: J:85049
Obstfeld AE; Sugaru E; Thearle M; Francisco AM; Gayet C; Ginsberg HN; Ables EV; Ferrante AW Jr. 2010. C-C chemokine receptor 2 (CCR2) regulates the hepatic recruitment of myeloid cells that promote obesity-induced hepatic steatosis. Diabetes 59(4):916-25. PubMed: 20103702 MGI: J:164331
Odle AK; Allensworth-James M; Haney A; Akhter N; Syed M; Childs GV. 2016. Adipocyte versus Somatotrope Leptin: Regulation of Metabolic Functions in the Mouse. Endocrinology :en20151811. PubMed: 26859333 MGI: J:228862
Oh CM; Namkung J; Go Y; Shong KE; Kim K; Kim H; Park BY; Lee HW; Jeon YH; Song J; Shong M; Yadav VK; Karsenty G; Kajimura S; Lee IK; Park S; Kim H. 2015. Regulation of systemic energy homeostasis by serotonin in adipose tissues. Nat Commun 6:6794. PubMed: 25864946 MGI: J:222728
Oh SS; Kaplan ML. 1994. Early treatment of obese (ob/ob) mice with triiodothyronine increases oxygen consumption and temperature and decreases body fat content. Proc Soc Exp Biol Med 207(3):260-7. PubMed: 7800681 MGI: J:22025
Oh SS; Kaplan ML. 1995. Early treatment of obese (ob/ob) mice with triiodothyronine increases oxidative metabolism in muscle but not in brown adipose tissue or liver. J Nutr 125(1):112-24. PubMed: 7815168 MGI: J:22377
Oh YS; Khil LY; Cho KA; Ryu SJ; Ha MK; Cheon GJ; Lee TS; Yoon JW; Jun HS; Park SC. 2008. A potential role for skeletal muscle caveolin-1 as an insulin sensitivity modulator in ageing-dependent non-obese type 2 diabetes: studies in a new mouse model. Diabetologia 51(6):1025-34. PubMed: 18408913 MGI: J:137899
Ohman MK; Shen Y; Obimba CI; Wright AP; Warnock M; Lawrence DA; Eitzman DT. 2008. Visceral adipose tissue inflammation accelerates atherosclerosis in apolipoprotein E-deficient mice. Circulation 117(6):798-805. PubMed: 18212290 MGI: J:145083
Ohnishi M; Kato S; Akiyoshi J; Atfi A; Razzaque MS. 2011. Dietary and genetic evidence for enhancing glucose metabolism and reducing obesity by inhibiting klotho functions. FASEB J 25(6):2031-9. PubMed: 21382979 MGI: J:172880
Ohnishi M; Kato S; Razzaque MS. 2011. Genetic induction of phosphate toxicity significantly reduces the survival of hypercholesterolemic obese mice. Biochem Biophys Res Commun 415(3):434-8. PubMed: 22037453 MGI: J:178747
Oishi K; Ohkura N; Wakabayashi M; Shirai H; Sato K; Matsuda J; Atsumi G; Ishida N. 2006. CLOCK is involved in obesity-induced disordered fibrinolysis in ob/ob mice by regulating PAI-1 gene expression. J Thromb Haemost 4(8):1774-80. PubMed: 16879220 MGI: J:135847
Okada T; Nishizawa H; Kurata A; Tamba S; Sonoda M; Yasui A; Kuroda Y; Hibuse T; Maeda N; Kihara S; Hadama T; Tobita K; Akamatsu S; Maeda K; Shimomura I; Funahashi T. 2008. URB is abundantly expressed in adipose tissue and dysregulated in obesity. Biochem Biophys Res Commun 367(2):370-6. PubMed: 18178152 MGI: J:131031
Okamoto K; Kakuma T; Fukuchi S; Masaki T; Sakata T; Yoshimatsu H. 2006. Sterol regulatory element binding protein (SREBP)-1 expression in brain is affected by age but not by hormones or metabolic changes. Brain Res 1081(1):19-27. PubMed: 16554040 MGI: J:108103
Olson DP; Pulinilkunnil T; Cline GW; Shulman GI; Lowell BB. 2010. Gene knockout of Acc2 has little effect on body weight, fat mass, or food intake. Proc Natl Acad Sci U S A 107(16):7598-603. PubMed: 20368432 MGI: J:159285
Ordway D; Henao-Tamayo M; Smith E; Shanley C; Harton M; Troudt J; Bai X; Basaraba RJ; Orme IM; Chan ED. 2008. Animal model of Mycobacterium abscessus lung infection. J Leukoc Biol 83(6):1502-11. PubMed: 18310351 MGI: J:136571
Ostertag A; Jones A; Rose AJ; Liebert M; Kleinsorg S; Reimann A; Vegiopoulos A; Berriel Diaz M; Strzoda D; Yamamoto M; Satoh T; Akira S; Herzig S. 2010. Control of adipose tissue inflammation through TRB1. Diabetes 59(8):1991-2000. PubMed: 20522600 MGI: J:169640
Otoda T; Takamura T; Misu H; Ota T; Murata S; Hayashi H; Takayama H; Kikuchi A; Kanamori T; Shima KR; Lan F; Takeda T; Kurita S; Ishikura K; Kita Y; Iwayama K; Kato K; Uno M; Takeshita Y; Yamamoto M; Tokuyama K; Iseki S; Tanaka K; Kaneko S. 2013. Proteasome dysfunction mediates obesity-induced endoplasmic reticulum stress and insulin resistance in the liver. Diabetes 62(3):811-24. PubMed: 23209186 MGI: J:208595
Ottaway N; Mahbod P; Rivero B; Norman LA; Gertler A; D'Alessio DA; Perez-Tilve D. 2015. Diet-induced obese mice retain endogenous leptin action. Cell Metab 21(6):877-82. PubMed: 25980347 MGI: J:226133
Oury F; Khrimian L; Denny CA; Gardin A; Chamouni A; Goeden N; Huang YY; Lee H; Srinivas P; Gao XB; Suyama S; Langer T; Mann JJ; Horvath TL; Bonnin A; Karsenty G. 2013. Maternal and offspring pools of osteocalcin influence brain development and functions. Cell 155(1):228-41. PubMed: 24074871 MGI: J:205218
Ozcan L; Cristina de Souza J; Harari AA; Backs J; Olson EN; Tabas I. 2013. Activation of calcium/calmodulin-dependent protein kinase II in obesity mediates suppression of hepatic insulin signaling. Cell Metab 18(6):803-15. PubMed: 24268736 MGI: J:206150
Ozcan L; Ergin AS; Lu A; Chung J; Sarkar S; Nie D; Myers MG Jr; Ozcan U. 2009. Endoplasmic reticulum stress plays a central role in development of leptin resistance. Cell Metab 9(1):35-51. PubMed: 19117545 MGI: J:144347
Ozcan L; Ghorpade DS; Zheng Z; de Souza JC; Chen K; Bessler M; Bagloo M; Schrope B; Pestell R; Tabas I. 2016. Hepatocyte DACH1 Is Increased in Obesity via Nuclear Exclusion of HDAC4 and Promotes Hepatic Insulin Resistance. Cell Rep 15(10):2214-25. PubMed: 27239042 MGI: J:238165
Ozcan L; Wong CC; Li G; Xu T; Pajvani U; Park SK; Wronska A; Chen BX; Marks AR; Fukamizu A; Backs J; Singer HA; Yates JR 3rd; Accili D; Tabas I. 2012. Calcium signaling through CaMKII regulates hepatic glucose production in fasting and obesity. Cell Metab 15(5):739-51. PubMed: 22503562 MGI: J:184607
Padmalayam I; Hasham S; Saxena U; Pillarisetti S. 2009. Lipoic acid synthase (LASY): a novel role in inflammation, mitochondrial function, and insulin resistance. Diabetes 58(3):600-8. PubMed: 19074983 MGI: J:146930
Paglialunga S; Fisette A; Yan Y; Deshaies Y; Brouillette JF; Pekna M; Cianflone K. 2008. Acylation-stimulating protein deficiency and altered adipose tissue in alternative complement pathway knockout mice. Am J Physiol Endocrinol Metab 294(3):E521-9. PubMed: 18160458 MGI: J:133454
Pajvani UB; Qiang L; Kangsamaksin T; Kitajewski J; Ginsberg HN; Accili D. 2013. Inhibition of Notch uncouples Akt activation from hepatic lipid accumulation by decreasing mTorc1 stability. Nat Med 19(8):1054-60. PubMed: 23832089 MGI: J:199992
Pajvani UB; Shawber CJ; Samuel VT; Birkenfeld AL; Shulman GI; Kitajewski J; Accili D. 2011. Inhibition of Notch signaling ameliorates insulin resistance in a FoxO1-dependent manner. Nat Med 17(8):961-7. PubMed: 21804540 MGI: J:174593
Pajvani UB; Trujillo ME; Combs TP; Iyengar P; Jelicks L; Roth KA; Kitsis RN; Scherer PE. 2005. Fat apoptosis through targeted activation of caspase 8: a new mouse model of inducible and reversible lipoatrophy. Nat Med 11(7):797-803. PubMed: 15965483 MGI: J:99639
Pan D; Mao C; Zou T; Yao AY; Cooper MP; Boyartchuk V; Wang YX. 2012. The histone demethylase Jhdm1a regulates hepatic gluconeogenesis. PLoS Genet 8(6):e1002761. PubMed: 22719268 MGI: J:187067
Pang Z; Nakagami H; Osako MK; Koriyama H; Nakagami F; Tomioka H; Shimamura M; Kurinami H; Takami Y; Morishita R; Rakugi H. 2014. Therapeutic vaccine against DPP4 improves glucose metabolism in mice. Proc Natl Acad Sci U S A 111(13):E1256-63. PubMed: 24639549 MGI: J:207292
Panzhinskiy E; Hua Y; Culver B; Ren J; Nair S. 2013. Endoplasmic reticulum stress upregulates protein tyrosine phosphatase 1B and impairs glucose uptake in cultured myotubes. Diabetologia 56(3):598-607. PubMed: 23178931 MGI: J:194636
Park HW; Park H; Ro SH; Jang I; Semple IA; Kim DN; Kim M; Nam M; Zhang D; Yin L; Lee JH. 2014. Hepatoprotective role of Sestrin2 against chronic ER stress. Nat Commun 5:4233. PubMed: 24947615 MGI: J:224583
Park J; Rho HK; Kim KH; Choe SS; Lee YS; Kim JB. 2005. Overexpression of glucose-6-phosphate dehydrogenase is associated with lipid dysregulation and insulin resistance in obesity. Mol Cell Biol 25(12):5146-57. PubMed: 15923630 MGI: J:99224
Park KW; Waki H; Villanueva CJ; Monticelli LA; Hong C; Kang S; Macdougald OA; Goldrath AW; Tontonoz P. 2008. Inhibitor of DNA Binding 2 Is a Small Molecule-Inducible Modulator of Peroxisome Proliferator-Activated Receptor-{gamma} Expression and Adipocyte Differentiation. Mol Endocrinol 22(9):2038-48. PubMed: 18562627 MGI: J:138276
Park SW; Zhou Y; Lee J; Lu A; Sun C; Chung J; Ueki K; Ozcan U. 2010. The regulatory subunits of PI3K, p85alpha and p85beta, interact with XBP-1 and increase its nuclear translocation. Nat Med 16(4):429-37. PubMed: 20348926 MGI: J:159304
Park SY; Kim KH; Seo KW; Bae JU; Kim YH; Lee SJ; Lee WS; Kim CD. 2014. Resistin derived from diabetic perivascular adipose tissue up-regulates vascular expression of osteopontin via the AP-1 signalling pathway. J Pathol 232(1):87-97. PubMed: 24089355 MGI: J:203984
Parker JC; Lavery KS; Irwin N; Green BD; Greer B; Harriott P; O'Harte FP; Gault VA; Flatt PR. 2006. Effects of sub-chronic exposure to naturally occurring N-terminally truncated metabolites of glucose-dependent insulinotrophic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1), GIP(3-42) and GLP-1(9-36)amide, on insulin secretion and glucose homeostasis in ob/ob mice. J Endocrinol 191(1):93-100. PubMed: 17065392 MGI: J:114957
Parker JC; VanVolkenburg MA; Nardone NA; Hargrove DM; Andrews KM. 1997. Modulation of insulin secretion and glycemia by selective inhibition of cyclic AMP phosphodiesterase III. Biochem Biophys Res Commun 236(3):665-9. PubMed: 9245710 MGI: J:42064
Parton LE; Ye CP; Coppari R; Enriori PJ; Choi B; Zhang CY; Xu C; Vianna CR; Balthasar N; Lee CE; Elmquist JK; Cowley MA; Lowell BB. 2007. Glucose sensing by POMC neurons regulates glucose homeostasis and is impaired in obesity. Nature 449(7159):228-32. PubMed: 17728716 MGI: J:125165
Patel K; Trivedi RN; Durgampudi C; Noel P; Cline RA; DeLany JP; Navina S; Singh VP. 2015. Lipolysis of visceral adipocyte triglyceride by pancreatic lipases converts mild acute pancreatitis to severe pancreatitis independent of necrosis and inflammation. Am J Pathol 185(3):808-19. PubMed: 25579844 MGI: J:219279
Patel M; Gleason A; O'Malley S; Connolly B; Suresch D; Virostko J; Phillips N; Lin SA; Chen TB; Klimas M; Hargreaves RJ; Sur C; Williams DL Jr; Powers AC; Bednar B. 2014. Non-invasive bioluminescence imaging of beta-cell function in obese-hyperglycemic [ob/ob] mice. PLoS One 9(9):e106693. PubMed: 25198535 MGI: J:221524
Patsouris D; Cao JJ; Vial G; Bravard A; Lefai E; Durand A; Durand C; Chauvin MA; Laugerette F; Debard C; Michalski MC; Laville M; Vidal H; Rieusset J. 2014. Insulin resistance is associated with MCP1-mediated macrophage accumulation in skeletal muscle in mice and humans. PLoS One 9(10):e110653. PubMed: 25337938 MGI: J:222449
Patsouris D; Li PP; Thapar D; Chapman J; Olefsky JM; Neels JG. 2008. Ablation of CD11c-positive cells normalizes insulin sensitivity in obese insulin resistant animals. Cell Metab 8(4):301-9. PubMed: 18840360 MGI: J:143426
Paz JC; Park SH; Phillips N; Matsumura S; Tsai WW; Kasper L; Brindle PK; Zhang G; Zhou MM; Wright PE; Montminy M. 2014. Combinatorial regulation of a signal-dependent activator by phosphorylation and acetylation. Proc Natl Acad Sci U S A 111(48):17116-21. PubMed: 25404345 MGI: J:216728
Pelleymounter MA; Cullen MJ; Baker MB; Hecht R; Winters D; Boone T; Collins F. 1995. Effects of the obese gene product on body weight regulation in ob/ob mice [see comments] Science 269(5223):540-3. PubMed: 7624776 MGI: J:29162
Peng XG; Ju S; Fang F; Wang Y; Fang K; Cui X; Liu G; Li P; Mao H; Teng GJ. 2013. Comparison of brown and white adipose tissue fat fractions in ob, seipin, and Fsp27 gene knockout mice by chemical shift-selective imaging and (1)H-MR spectroscopy. Am J Physiol Endocrinol Metab 304(2):E160-7. PubMed: 23149622 MGI: J:195942
Peng XG; X5f6d X65b0 X6842; Ju S; X5c45 X80dc X7ea2; Qin Y; X79e6 X96e8 X59e3; Fang F; X65b9 X82b3; Cui X; X5d14 X946b; Liu G; X5218 X56fd X5e86; Ni Y; X502a X4ee5 X6210; Teng GJ; X6ed5 X768b X519b. 2011. Quantification of liver fat in mice: comparing dual-echo Dixon imaging, chemical shift imaging, and 1H-MR spectroscopy. J Lipid Res 52(10):1847-1855. PubMed: 21737754 MGI: J:176075
Perera HK; Caldwell ME; Hayes-Patterson D; Teng L; Peshavaria M; Jetton TL; Labosky PA. 2006. Expression and shifting subcellular localization of the transcription factor, Foxd3, in embryonic and adult pancreas. Gene Expr Patterns 6(8):971-7. PubMed: 16750430 MGI: J:112316
Pessentheiner AR; Pelzmann HJ; Walenta E; Schweiger M; Groschner LN; Graier WF; Kolb D; Uno K; Miyazaki T; Nitta A; Rieder D; Prokesch A; Bogner-Strauss JG. 2013. NAT8L (N-acetyltransferase 8-like) accelerates lipid turnover and increases energy expenditure in brown adipocytes. J Biol Chem 288(50):36040-51. PubMed: 24155240 MGI: J:207207
Petrolonis AJ; Yang Q; Tummino PJ; Fish SM; Prack AE; Jain S; Parsons TF; Li P; Dales NA; Ge L; Langston SP; Schuller AG; An WF; Tartaglia LA; Chen H; Hong SB. 2004. Enzymatic characterization of the pancreatic islet-specific glucose-6-phosphatase-related protein (IGRP). J Biol Chem 279(14):13976-83. PubMed: 14722102 MGI: J:124542
Phan LK; Chung WK; Leibel RL. 2006. The mahoganoid mutation (Mgrn1md) improves insulin sensitivity in mice with mutations in the melanocortin signaling pathway independently of effects on adiposity. Am J Physiol Endocrinol Metab 291(3):E611-20. PubMed: 16638826 MGI: J:112364
Phan LK; Lin F; LeDuc CA; Chung WK; Leibel RL. 2002. The mouse mahoganoid coat color mutation disrupts a novel C3HC4 RING domain protein. J Clin Invest 110(10):1449-59. PubMed: 12438443 MGI: J:80182
Philbrick KA; Turner RT; Branscum AJ; Wong CP; Iwaniec UT. 2015. Paradoxical Effects of Partial Leptin Deficiency on Bone in Growing Female Mice. Anat Rec (Hoboken) 298(12):2018-29. PubMed: 26370912 MGI: J:226850
Pini M; Rhodes DH; Castellanos KJ; Hall AR; Cabay RJ; Chennuri R; Grady EF; Fantuzzi G. 2012. Role of IL-6 in the resolution of pancreatitis in obese mice. J Leukoc Biol 91(6):957-66. PubMed: 22427681 MGI: J:184912
Pinto S; Roseberry AG; Liu H; Diano S; Shanabrough M; Cai X; Friedman JM; Horvath TL. 2004. Rapid rewiring of arcuate nucleus feeding circuits by leptin. Science 304(5667):110-5. PubMed: 15064421 MGI: J:90242
Pisani DF; Beranger GE; Corinus A; Giroud M; Ghandour RA; Altirriba J; Chambard JC; Mazure NM; Bendahhou S; Duranton C; Michiels JF; Frontini A; Rohner-Jeanrenaud F; Cinti S; Christian M; Barhanin J; Amri EZ. 2016. The K+ channel TASK1 modulates beta-adrenergic response in brown adipose tissue through the mineralocorticoid receptor pathway. FASEB J 30(2):909-22. PubMed: 26527067 MGI: J:230841
Plaisancie P; Ducroc R; El Homsi M; Tsocas A; Guilmeau S; Zoghbi S; Thibaudeau O; Bado A. 2006. Luminal leptin activates mucin-secreting goblet cells in the large bowel. Am J Physiol Gastrointest Liver Physiol 290(4):G805-12. PubMed: 16455789 MGI: J:109110
Polotsky VY; Li J; Punjabi NM; Rubin AE; Smith PL; Schwartz AR; O'Donnell CP. 2003. Intermittent hypoxia increases insulin resistance in genetically obese mice. J Physiol 552(Pt 1):253-64. PubMed: 12878760 MGI: J:105382
Polotsky VY; Wilson JA; Smaldone MC; Haines AS; Hurn PD; Tankersley CG; Smith PL; Schwartz AR; O'Donnell CP. 2001. Female gender exacerbates respiratory depression in leptin-deficient obesity. Am J Respir Crit Care Med 164(8 Pt 1):1470-5. PubMed: 11704598 MGI: J:94673
Pons S; Martin V; Portal L; Zini R; Morin D; Berdeaux A; Ghaleh B. 2013. Regular treadmill exercise restores cardioprotective signaling pathways in obese mice independently from improvement in associated co-morbidities. J Mol Cell Cardiol 54:82-9. PubMed: 23201226 MGI: J:194190
Popescu IR; Helleboid-Chapman A; Lucas A; Vandewalle B; Dumont J; Bouchaert E; Derudas B; Kerr-Conte J; Caron S; Pattou F; Staels B. 2010. The nuclear receptor FXR is expressed in pancreatic beta-cells and protects human islets from lipotoxicity. FEBS Lett 584(13):2845-51. PubMed: 20447400 MGI: J:161322
Popineau L; Morzyglod L; Carre N; Cauzac M; Bossard P; Prip-Buus C; Lenoir V; Ragazzon B; Fauveau V; Robert L; Guilmeau S; Postic C; Komatsu M; Canonne-Hergaux F; Guillou H; Burnol AF. 2016. Novel Grb14-Mediated Cross Talk between Insulin and p62/Nrf2 Pathways Regulates Liver Lipogenesis and Selective Insulin Resistance. Mol Cell Biol 36(16):2168-81. PubMed: 27215388 MGI: J:236174
Pourhoseini S; Seth RK; Das S; Dattaroy D; Kadiiska MB; Xie G; Michelotti GA; Nagarkatti M; Diehl AM; Chatterjee S. 2015. Upregulation of miR21 and repression of Grhl3 by leptin mediates sinusoidal endothelial injury in experimental nonalcoholic steatohepatitis. PLoS One 10(2):e0116780. PubMed: 25658689 MGI: J:242398
Poy MN; Hausser J; Trajkovski M; Braun M; Collins S; Rorsman P; Zavolan M; Stoffel M. 2009. miR-375 maintains normal pancreatic alpha- and beta-cell mass. Proc Natl Acad Sci U S A 106(14):5813-8. PubMed: 19289822 MGI: J:147572
Pralong FP; Gonzales C; Voirol MJ; Palmiter RD; Brunner HR; Gaillard RC; Seydoux J; Pedrazzini T. 2002. The neuropeptide Y Y1 receptor regulates leptin-mediated control of energy homeostasis and reproductive functions. FASEB J 16(7):712-4. PubMed: 11978737 MGI: J:120451
Prawitt J; Abdelkarim M; Stroeve JH; Popescu I; Duez H; Velagapudi VR; Dumont J; Bouchaert E; van Dijk TH; Lucas A; Dorchies E; Daoudi M; Lestavel S; Gonzalez FJ; Oresic M; Cariou B; Kuipers F; Caron S; Staels B. 2011. Farnesoid X receptor deficiency improves glucose homeostasis in mouse models of obesity. Diabetes 60(7):1861-71. PubMed: 21593203 MGI: J:186756
Prieur X; Mok CY; Velagapudi VR; Nunez V; Fuentes L; Montaner D; Ishikawa K; Camacho A; Barbarroja N; O'Rahilly S; Sethi JK; Dopazo J; Oresic M; Ricote M; Vidal-Puig A. 2011. Differential lipid partitioning between adipocytes and tissue macrophages modulates macrophage lipotoxicity and M2/M1 polarization in obese mice. Diabetes 60(3):797-809. PubMed: 21266330 MGI: J:170128
Procaccini C; De Rosa V; Galgani M; Abanni L; Cali G; Porcellini A; Carbone F; Fontana S; Horvath TL; La Cava A; Matarese G. 2010. An oscillatory switch in mTOR kinase activity sets regulatory T cell responsiveness. Immunity 33(6):929-41. PubMed: 21145759 MGI: J:167293
Procaccini C; De Rosa V; Galgani M; Carbone F; Cassano S; Greco D; Qian K; Auvinen P; Cali G; Stallone G; Formisano L; La Cava A; Matarese G. 2012. Leptin-induced mTOR activation defines a specific molecular and transcriptional signature controlling CD4+ effector T cell responses. J Immunol 189(6):2941-53. PubMed: 22904304 MGI: J:189915
Purushotham A; Wendel AA; Liu LF; Belury MA. 2007. Maintenance of adiponectin attenuates insulin resistance induced by dietary conjugated linoleic acid in mice. J Lipid Res 48(2):444-52. PubMed: 17050906 MGI: J:118228
Qi L; Saberi M; Zmuda E; Wang Y; Altarejos J; Zhang X; Dentin R; Hedrick S; Bandyopadhyay G; Hai T; Olefsky J; Montminy M. 2009. Adipocyte CREB promotes insulin resistance in obesity. Cell Metab 9(3):277-86. PubMed: 19254572 MGI: J:147096
Qi Y; Nie Z; Lee YS; Singhal NS; Scherer PE; Lazar MA; Ahima RS. 2006. Loss of resistin improves glucose homeostasis in leptin deficiency. Diabetes 55(11):3083-90. PubMed: 17065346 MGI: J:116550
Qiang L; Kon N; Zhao W; Jiang L; Knight CM; Welch C; Pajvani U; Gu W; Accili D. 2015. Hepatic SirT1-Dependent Gain of Function of Stearoyl-CoA Desaturase-1 Conveys Dysmetabolic and Tumor Progression Functions. Cell Rep 11(11):1797-808. PubMed: 26074075 MGI: J:228688
Qiang L; Lin HV; Kim-Muller JY; Welch CL; Gu W; Accili D. 2011. Proatherogenic abnormalities of lipid metabolism in SirT1 transgenic mice are mediated through Creb deacetylation. Cell Metab 14(6):758-67. PubMed: 22078933 MGI: J:179674
Qiao L; Lee B; Kinney B; Yoo HS; Shao J. 2011. Energy intake and adiponectin gene expression. Am J Physiol Endocrinol Metab 300(5):E809-16. PubMed: 21325106 MGI: J:172309
Qiu J; Ogus S; Mounzih K; Ewart-Toland A; Chehab FF. 2001. Leptin-deficient mice backcrossed to the BALB/cJ genetic background have reduced adiposity, enhanced fertility, normal body temperature, and severe diabetes. Endocrinology 142(8):3421-5. PubMed: 11459786 MGI: J:94784
Quan W; Hur KY; Lim Y; Oh SH; Lee JC; Kim KH; Kim GH; Kim SW; Kim HL; Lee MK; Kim KW; Kim J; Komatsu M; Lee MS. 2012. Autophagy deficiency in beta cells leads to compromised unfolded protein response and progression from obesity to diabetes in mice. Diabetologia 55(2):392-403. PubMed: 22075916 MGI: J:181812
Quennell JH; Howell CS; Roa J; Augustine RA; Grattan DR; Anderson GM. 2011. Leptin deficiency and diet-induced obesity reduce hypothalamic kisspeptin expression in mice. Endocrinology 152(4):1541-50. PubMed: 21325051 MGI: J:173859
Rafael J; Herling AW. 2000. Leptin effect in ob/ob mice under thermoneutral conditions depends not necessarily on central satiation. Am J Physiol Regul Integr Comp Physiol 278(3):R790-5. PubMed: 10712302 MGI: J:60885
Raines SM; Richards OC; Schneider LR; Schueler KL; Rabaglia ME; Oler AT; Stapleton DS; Genove G; Dawson JA; Betsholtz C; Attie AD. 2011. Loss of PDGF-B activity increases hepatic vascular permeability and enhances insulin sensitivity. Am J Physiol Endocrinol Metab 301(3):E517-26. PubMed: 21673305 MGI: J:182196
Rajala MW; Qi Y; Patel HR; Takahashi N; Banerjee R; Pajvani UB; Sinha MK; Gingerich RL; Scherer PE; Ahima RS. 2004. Regulation of resistin expression and circulating levels in obesity, diabetes, and fasting. Diabetes 53(7):1671-9. PubMed: 15220189 MGI: J:107202
Raju SV; Zheng M; Schuleri KH; Phan AC; Bedja D; Saraiva RM; Yiginer O; Vandegaer K; Gabrielson KL; O'donnell CP; Berkowitz DE; Barouch LA; Hare JM. 2006. Activation of the cardiac ciliary neurotrophic factor receptor reverses left ventricular hypertrophy in leptin-deficient and leptin-resistant obesity. Proc Natl Acad Sci U S A 103(11):4222-7. PubMed: 16537512 MGI: J:107586
Ramadori G; Lee CE; Bookout AL; Lee S; Williams KW; Anderson J; Elmquist JK; Coppari R. 2008. Brain SIRT1: anatomical distribution and regulation by energy availability. J Neurosci 28(40):9989-96. PubMed: 18829956 MGI: J:143464
Ranieri SC; Fusco S; Panieri E; Labate V; Mele M; Tesori V; Ferrara AM; Maulucci G; De Spirito M; Martorana GE; Galeotti T; Pani G. 2010. Mammalian life-span determinant p66shcA mediates obesity-induced insulin resistance. Proc Natl Acad Sci U S A 107(30):13420-5. PubMed: 20624962 MGI: J:162570
Rashid A; Wu TC; Huang CC; Chen CH; Lin HZ; Yang SQ; Lee FY; Diehl AM. 1999. Mitochondrial proteins that regulate apoptosis and necrosis are induced in mouse fatty liver. Hepatology 29(4):1131-8. PubMed: 10094957 MGI: J:55979
Rentsch J; Levens N; Chiesi M. 1995. Recombinant ob-gene product reduces food intake in fasted mice. Biochem Biophys Res Commun 214(1):131-6. PubMed: 7669033 MGI: J:28578
Rezai-Zadeh K; Yu S; Jiang Y; Laque A; Schwartzenburg C; Morrison CD; Derbenev AV; Zsombok A; Munzberg H. 2014. Leptin receptor neurons in the dorsomedial hypothalamus are key regulators of energy expenditure and body weight, but not food intake. Mol Metab 3(7):681-93. PubMed: 25352997 MGI: J:234889
Ribas V; Drew BG; Le JA; Soleymani T; Daraei P; Sitz D; Mohammad L; Henstridge DC; Febbraio MA; Hewitt SC; Korach KS; Bensinger SJ; Hevener AL. 2011. Myeloid-specific estrogen receptor {alpha} deficiency impairs metabolic homeostasis and accelerates atherosclerotic lesion development. Proc Natl Acad Sci U S A 108(39):16457-62. PubMed: 21900603 MGI: J:176674
Ribeiro AC; Ceccarini G; Dupre C; Friedman JM; Pfaff DW; Mark AL. 2011. Contrasting effects of leptin on food anticipatory and total locomotor activity. PLoS One 6(8):e23364. PubMed: 21853117 MGI: J:176508
Riser BL; Najmabadi F; Garchow K; Barnes JL; Peterson DR; Sukowski EJ. 2014. Treatment with the Matricellular Protein CCN3 Blocks and/or Reverses Fibrosis Development in Obesity with Diabetic Nephropathy. Am J Pathol 184(11):2908-21. PubMed: 25193594 MGI: J:216375
Ro S; Park C; Jin J; Zheng H; Blair PJ; Redelman D; Ward SM; Yan W; Sanders KM. 2010. A model to study the phenotypic changes of interstitial cells of Cajal in gastrointestinal diseases. Gastroenterology 138(3):1068-78.e1-2. PubMed: 19917283 MGI: J:168676
Robertson S; Ishida-Takahashi R; Tawara I; Hu J; Patterson CM; Jones JC; Kulkarni RN; Myers MG Jr. 2010. Insufficiency of Janus kinase 2-autonomous leptin receptor signals for most physiologic leptin actions. Diabetes 59(4):782-90. PubMed: 20068132 MGI: J:164339
Rodero MP; Hodgson SS; Hollier B; Combadiere C; Khosrotehrani K. 2013. Reduced Il17a expression distinguishes a Ly6c(lo)MHCII(hi) macrophage population promoting wound healing. J Invest Dermatol 133(3):783-92. PubMed: 23235530 MGI: J:196510
Rodriguez-Cuenca S; Carobbio S; Velagapudi VR; Barbarroja N; Moreno-Navarrete JM; Tinahones FJ; Fernandez-Real JM; Oresic M; Vidal-Puig A. 2012. Peroxisome proliferator-activated receptor gamma-dependent regulation of lipolytic nodes and metabolic flexibility. Mol Cell Biol 32(8):1555-65. PubMed: 22310664 MGI: J:183680
Rogove AD; Lu W; Tsirka SE. 2002. Microglial activation and recruitment, but not proliferation, suffice to mediate neurodegeneration. Cell Death Differ 9(8):801-6. PubMed: 12107823 MGI: J:115569
Romere C; Duerrschmid C; Bournat J; Constable P; Jain M; Xia F; Saha PK; Del Solar M; Zhu B; York B; Sarkar P; Rendon DA; Gaber MW; LeMaire SA; Coselli JS; Milewicz DM; Sutton VR; Butte NF; Moore DD; Chopra AR. 2016. Asprosin, a Fasting-Induced Glucogenic Protein Hormone. Cell 165(3):566-79. PubMed: 27087445 MGI: J:234498
Rong X; Albert CJ; Hong C; Duerr MA; Chamberlain BT; Tarling EJ; Ito A; Gao J; Wang B; Edwards PA; Jung ME; Ford DA; Tontonoz P. 2013. LXRs regulate ER stress and inflammation through dynamic modulation of membrane phospholipid composition. Cell Metab 18(5):685-97. PubMed: 24206663 MGI: J:206173
Ropelle ER; Flores MB; Cintra DE; Rocha GZ; Pauli JR; Morari J; de Souza CT; Moraes JC; Prada PO; Guadagnini D; Marin RM; Oliveira AG; Augusto TM; Carvalho HF; Velloso LA; Saad MJ; Carvalheira JB. 2010. IL-6 and IL-10 anti-inflammatory activity links exercise to hypothalamic insulin and leptin sensitivity through IKKbeta and ER stress inhibition. PLoS Biol 8(8):. PubMed: 20808781 MGI: J:166779
Ropelle ER; Pauli JR; Fernandes MF; Rocco SA; Marin RM; Morari J; Souza KK; Dias MM; Gomes-Marcondes MC; Gontijo JA; Franchini KG; Velloso LA; Saad MJ; Carvalheira JB. 2008. A central role for neuronal AMP-activated protein kinase (AMPK) and mammalian target of rapamycin (mTOR) in high-protein diet-induced weight loss. Diabetes 57(3):594-605. PubMed: 18057094 MGI: J:132294
Roqueta-Rivera M; Esquejo RM; Phelan PE; Sandor K; Daniel B; Foufelle F; Ding J; Li X; Khorasanizadeh S; Osborne TF. 2016. SETDB2 Links Glucocorticoid to Lipid Metabolism through Insig2a Regulation. Cell Metab 24(3):474-84. PubMed: 27568546 MGI: J:240519
Roseberry AG; Liu H; Jackson AC; Cai X; Friedman JM. 2004. Neuropeptide Y-mediated inhibition of proopiomelanocortin neurons in the arcuate nucleus shows enhanced desensitization in ob/ob mice. Neuron 41(5):711-22. PubMed: 15003171 MGI: J:88691
Roseberry AG; Painter T; Mark GP; Williams JT. 2007. Decreased vesicular somatodendritic dopamine stores in leptin-deficient mice. J Neurosci 27(26):7021-7. PubMed: 17596451 MGI: J:122961
Ruddle NH; Conta BS; Leinwand L; Kozak C; Ruddle F; Besmer P; Baltimore D. 1978. Assignment of the receptor for ecotropic murine leukemia virus to mouse chromosome 5. J Exp Med 148(2):451-65. PubMed: 212501 MGI: J:6045
Rulifson IC; Collins P; Miao L; Nojima D; Lee KJ; Hardy M; Gupte J; Hensley K; Samayoa K; Cam C; Rottman JB; Ollmann M; Richards WG; Li Y. 2017. In Vitro and in Vivo Analyses Reveal Profound Effects of Fibroblast Growth Factor 16 as a Metabolic Regulator. J Biol Chem 292(5):1951-1969. PubMed: 28011645 MGI: J:240710
Rulifson IC; Majeti JZ; Xiong Y; Hamburger A; Lee KJ; Miao L; Lu M; Gardner J; Gong Y; Wu H; Case R; Yeh WC; Richards WG; Baribault H; Li Y. 2014. Inhibition of secreted frizzled-related protein 5 improves glucose metabolism. Am J Physiol Endocrinol Metab 307(12):E1144-52. PubMed: 25370851 MGI: J:218529
Ruschke K; Ebelt H; Kloting N; Boettger T; Raum K; Bluher M; Braun T. 2009. Defective peripheral nerve development is linked to abnormal architecture and metabolic activity of adipose tissue in Nscl-2 mutant mice. PLoS One 4(5):e5516. PubMed: 19436734 MGI: J:148882
Russell ST; Tisdale MJ. 2012. Role of beta-adrenergic receptors in the anti-obesity and anti-diabetic effects of zinc-alpha2-glycoprotien (ZAG). Biochim Biophys Acta 1821(4):590-9. PubMed: 22227600 MGI: J:182566
Sabeva NS; Rouse EJ; Graf GA. 2007. Defects in the leptin axis reduce abundance of the ABCG5-ABCG8 sterol transporter in liver. J Biol Chem 282(31):22397-405. PubMed: 17561514 MGI: J:124801
Sahai A; Malladi P; Pan X; Paul R; Melin-Aldana H; Green RM; Whitington PF. 2004. Obese and diabetic db/db mice develop marked liver fibrosis in a model of nonalcoholic steatohepatitis: role of short-form leptin receptors and osteopontin. Am J Physiol Gastrointest Liver Physiol 287(5):G1035-43. PubMed: 15256362 MGI: J:96143
Sainsbury A; Schwarzer C; Couzens M; Herzog H. 2002. Y2 receptor deletion attenuates the type 2 diabetic syndrome of ob/ob mice. Diabetes 51(12):3420-7. PubMed: 12453895 MGI: J:107169
Sainsbury A; Schwarzer C; Couzens M; Jenkins A; Oakes SR; Ormandy CJ; Herzog H. 2002. Y4 receptor knockout rescues fertility in ob/ob mice. Genes Dev 16(9):1077-88. PubMed: 12000791 MGI: J:76479
Sainz N; Rodriguez A; Catalan V; Becerril S; Ramirez B; Lancha A; Burgos-Ramos E; Gomez-Ambrosi J; Fruhbeck G. 2012. Leptin reduces the expression and increases the phosphorylation of the negative regulators of GLUT4 traffic TBC1D1 and TBC1D4 in muscle of ob/ob mice. PLoS One 7(1):e29389. PubMed: 22253718 MGI: J:184323
Sajan MP; Ivey RA; Lee MC; Farese RV. 2015. Hepatic insulin resistance in ob/ob mice involves increases in ceramide, aPKC activity, and selective impairment of Akt-dependent FoxO1 phosphorylation. J Lipid Res 56(1):70-80. PubMed: 25395359 MGI: J:217398
Sakamaki J; Fu A; Reeks C; Baird S; Depatie C; Al Azzabi M; Bardeesy N; Gingras AC; Yee SP; Screaton RA. 2014. Role of the SIK2-p35-PJA2 complex in pancreatic beta-cell functional compensation. Nat Cell Biol 16(3):234-44. PubMed: 24561619 MGI: J:212985
Sakkou M; Wiedmer P; Anlag K; Hamm A; Seuntjens E; Ettwiller L; Tschop MH; Treier M. 2007. A role for brain-specific homeobox factor bsx in the control of hyperphagia and locomotory behavior. Cell Metab 5(6):450-63. PubMed: 17550780 MGI: J:122746
Saleh J; Blevins JE; Havel PJ; Barrett JA; Gietzen DW; Cianflone K. 2001. Acylation stimulating protein (ASP) acute effects on postprandial lipemia and food intake in rodents. Int J Obes Relat Metab Disord 25(5):705-13. PubMed: 11360154 MGI: J:69140
Saleh MC; Wheeler MB; Chan CB. 2006. Endogenous islet uncoupling protein-2 expression and loss of glucose homeostasis in ob/ob mice. J Endocrinol 190(3):659-67. PubMed: 17003267 MGI: J:112889
Samad F; Hester KD; Yang G; Hannun YA; Bielawski J. 2006. Altered adipose and plasma sphingolipid metabolism in obesity: a potential mechanism for cardiovascular and metabolic risk. Diabetes 55(9):2579-87. PubMed: 16936207 MGI: J:116590
Samad F; Pandey M; Loskutoff DJ. 1998. Tissue factor gene expression in the adipose tissues of obese mice. Proc Natl Acad Sci U S A 95(13):7591-6. PubMed: 9636194 MGI: J:48272
Samad F; Uysal KT; Wiesbrock SM; Pandey M; Hotamisligil GS; Loskutoff DJ. 1999. Tumor necrosis factor alpha is a key component in the obesity-linked elevation of plasminogen activator inhibitor 1. Proc Natl Acad Sci U S A 96(12):6902-7. PubMed: 10359811 MGI: J:55722
Santulli G; Pagano G; Sardu C; Xie W; Reiken S; D'Ascia SL; Cannone M; Marziliano N; Trimarco B; Guise TA; Lacampagne A; Marks AR. 2015. Calcium release channel RyR2 regulates insulin release and glucose homeostasis. J Clin Invest 125(5):1968-78. PubMed: 25844899 MGI: J:222412
Saraiva RM; Minhas KM; Zheng M; Pitz E; Treuer A; Gonzalez D; Schuleri KH; Vandegaer KM; Barouch LA; Hare JM. 2007. Reduced neuronal nitric oxide synthase expression contributes to cardiac oxidative stress and nitroso-redox imbalance in ob/ob mice. Nitric Oxide 16(3):331-8. PubMed: 17307368 MGI: J:124484
Saraswathi V; Morrow JD; Hasty AH. 2009. Dietary fish oil exerts hypolipidemic effects in lean and insulin sensitizing effects in obese LDLR-/- mice. J Nutr 139(12):2380-6. PubMed: 19864403 MGI: J:154774
Sasaki M; Shinozaki S; Shimokado K. 2016. Sulforaphane promotes murine hair growth by accelerating the degradation of dihydrotestosterone. Biochem Biophys Res Commun 472(1):250-4. PubMed: 26923074 MGI: J:234368
Sato H; Taketomi Y; Ushida A; Isogai Y; Kojima T; Hirabayashi T; Miki Y; Yamamoto K; Nishito Y; Kobayashi T; Ikeda K; Taguchi R; Hara S; Ida S; Miyamoto Y; Watanabe M; Baba H; Miyata K; Oike Y; Gelb MH; Murakami M. 2014. The adipocyte-inducible secreted phospholipases PLA2G5 and PLA2G2E play distinct roles in obesity. Cell Metab 20(1):119-32. PubMed: 24910243 MGI: J:215319
Sato S; Hanada R; Kimura A; Abe T; Matsumoto T; Iwasaki M; Inose H; Ida T; Mieda M; Takeuchi Y; Fukumoto S; Fujita T; Kato S; Kangawa K; Kojima M; Shinomiya K; Takeda S. 2007. Central control of bone remodeling by neuromedin U. Nat Med 13(10):1234-40. PubMed: 17873881 MGI: J:129930
Sato S; Ogura Y; Tajrishi MM; Kumar A. 2015. Elevated levels of TWEAK in skeletal muscle promote visceral obesity, insulin resistance, and metabolic dysfunction. FASEB J 29(3):988-1002. PubMed: 25466899 MGI: J:219637
Sato S; Sakurai T; Ogasawara J; Takahashi M; Izawa T; Imaizumi K; Taniguchi N; Ohno H; Kizaki T. 2014. A circadian clock gene, Rev-erbalpha, modulates the inflammatory function of macrophages through the negative regulation of Ccl2 expression. J Immunol 192(1):407-17. PubMed: 24307731 MGI: J:207168
Sawada N; Jiang A; Takizawa F; Safdar A; Manika A; Tesmenitsky Y; Kang KT; Bischoff J; Kalwa H; Sartoretto JL; Kamei Y; Benjamin LE; Watada H; Ogawa Y; Higashikuni Y; Kessinger CW; Jaffer FA; Michel T; Sata M; Croce K; Tanaka R; Arany Z. 2014. Endothelial PGC-1alpha mediates vascular dysfunction in diabetes. Cell Metab 19(2):246-58. PubMed: 24506866 MGI: J:210653
Scarlett JM; Rojas JM; Matsen ME; Kaiyala KJ; Stefanovski D; Bergman RN; Nguyen HT; Dorfman MD; Lantier L; Wasserman DH; Mirzadeh Z; Unterman TG; Morton GJ; Schwartz MW. 2016. Central injection of fibroblast growth factor 1 induces sustained remission of diabetic hyperglycemia in rodents. Nat Med 22(7):800-6. PubMed: 27213816 MGI: J:239768
Schafer K; Fujisawa K; Konstantinides S; Loskutoff DJ. 2001. Disruption of the plasminogen activator inhibitor 1 gene reduces the adiposity and improves the metabolic profile of genetically obese and diabetic ob/ob mice. FASEB J 15(10):1840-2. PubMed: 11481248 MGI: J:70695
Schneider JG; Finck BN; Ren J; Standley KN; Takagi M; Maclean KH; Bernal-Mizrachi C; Muslin AJ; Kastan MB; Semenkovich CF. 2006. ATM-dependent suppression of stress signaling reduces vascular disease in metabolic syndrome. Cell Metab 4(5):377-89. PubMed: 17084711 MGI: J:129761
Schurmann C; Goren I; Linke A; Pfeilschifter J; Frank S. 2014. Deregulated unfolded protein response in chronic wounds of diabetic ob/ob mice: a potential connection to inflammatory and angiogenic disorders in diabetes-impaired wound healing. Biochem Biophys Res Commun 446(1):195-200. PubMed: 24583133 MGI: J:219132
Schwartz MW; Baskin DG; Bukowski TR; Kuijper JL; Foster D; Lasser G; Prunkard DE; Porte D Jr; Woods SC; Seeley RJ; Weigle DS. 1996. Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide Y gene expression in ob/ob mice. Diabetes 45(4):531-5. PubMed: 8603777 MGI: J:32265
Schwartz MW; Erickson JC; Baskin DG; Palmiter RD. 1998. Effect of fasting and leptin deficiency on hypothalamic neuropeptide Y gene transcription in vivo revealed by expression of a lacZ reporter gene. Endocrinology 139(5):2629-35. PubMed: 9564880 MGI: J:114273
Scrocchi LA; Hill ME; Saleh J; Perkins B; Drucker DJ. 2000. Elimination of glucagon-like peptide 1R signaling does not modify weight gain and islet adaptation in mice with combined disruption of leptin and GLP-1 action. Diabetes 49(9):1552-60. PubMed: 10969840 MGI: J:64159
Segal-Lieberman G; Bradley RL; Kokkotou E; Carlson M; Trombly DJ; Wang X; Bates S; Myers MG Jr; Flier JS; Maratos-Flier E. 2003. Melanin-concentrating hormone is a critical mediator of the leptin-deficient phenotype. Proc Natl Acad Sci U S A 100(17):10085-90. PubMed: 12897241 MGI: J:85176
Seimon TA; Nadolski MJ; Liao X; Magallon J; Nguyen M; Feric NT; Koschinsky ML; Harkewicz R; Witztum JL; Tsimikas S; Golenbock D; Moore KJ; Tabas I. 2010. Atherogenic lipids and lipoproteins trigger CD36-TLR2-dependent apoptosis in macrophages undergoing endoplasmic reticulum stress. Cell Metab 12(5):467-82. PubMed: 21035758 MGI: J:167910
Sekiya M; Osuga J; Okazaki H; Yahagi N; Harada K; Shen WJ; Tamura Y; Tomita S; Iizuka Y; Ohashi K; Okazaki M; Sata M; Nagai R; Fujita T; Shimano H; Kraemer FB; Yamada N; Ishibashi S. 2004. Absence of hormone-sensitive lipase inhibits obesity and adipogenesis in Lep ob/ob mice. J Biol Chem 279(15):15084-90. PubMed: 14752112 MGI: J:89519
Sekiya M; Osuga J; Yahagi N; Okazaki H; Tamura Y; Igarashi M; Takase S; Harada K; Okazaki S; Iizuka Y; Ohashi K; Yagyu H; Okazaki M; Gotoda T; Nagai R; Kadowaki T; Shimano H; Yamada N; Ishibashi S. 2008. Hormone-sensitive lipase is involved in hepatic cholesteryl ester hydrolysis. J Lipid Res 49(8):1829-38. PubMed: 18480494 MGI: J:138444
Sekiya M; Yahagi N; Matsuzaka T; Najima Y; Nakakuki M; Nagai R; Ishibashi S; Osuga J; Yamada N; Shimano H. 2003. Polyunsaturated fatty acids ameliorate hepatic steatosis in obese mice by SREBP-1 suppression. Hepatology 38(6):1529-39. PubMed: 14647064 MGI: J:106018
Sekiya M; Yahagi N; Tamura Y; Okazaki H; Igarashi M; Ohta K; Takanashi M; Kumagai M; Takase S; Nishi M; Takeuchi Y; Izumida Y; Kubota M; Ohashi K; Iizuka Y; Yagyu H; Gotoda T; Nagai R; Shimano H; Yamada N; Kadowaki T; Ishibashi S; Osuga J. 2009. Hormone-sensitive lipase deficiency suppresses insulin secretion from pancreatic islets of Lep ob/ob mice. Biochem Biophys Res Commun 387(3):511-5. PubMed: 19619509 MGI: J:152537
Sell H; Berger JP; Samson P; Castriota G; Lalonde J; Deshaies Y; Richard D. 2004. Peroxisome proliferator-activated receptor gamma agonism increases the capacity for sympathetically mediated thermogenesis in lean and ob/ob mice. Endocrinology 145(8):3925-34. PubMed: 15131020 MGI: J:105624
Sennello JA; Fayad R; Morris AM; Eckel RH; Asilmaz E; Montez J; Friedman JM; Dinarello CA; Fantuzzi G. 2005. Regulation of T cell-mediated hepatic inflammation by adiponectin and leptin. Endocrinology 146(5):2157-64. PubMed: 15677756 MGI: J:109480
Sennello JA; Fayad R; Pini M; Gove ME; Ponemone V; Cabay RJ; Siegmund B; Dinarello CA; Fantuzzi G. 2008. Interleukin-18, together with interleukin-12, induces severe acute pancreatitis in obese but not in nonobese leptin-deficient mice. Proc Natl Acad Sci U S A 105(23):8085-90. PubMed: 18515422 MGI: J:137046
Senokuchi T; Liang CP; Seimon TA; Han S; Matsumoto M; Banks AS; Paik JH; DePinho RA; Accili D; Tabas I; Tall AR. 2008. Forkhead transcription factors (FoxOs) promote apoptosis of insulin-resistant macrophages during cholesterol-induced endoplasmic reticulum stress. Diabetes 57(11):2967-76. PubMed: 18728232 MGI: J:142468
Seth RK; Kumar A; Das S; Kadiiska MB; Michelotti G; Diehl AM; Chatterjee S. 2013. Environmental toxin-linked nonalcoholic steatohepatitis and hepatic metabolic reprogramming in obese mice. Toxicol Sci 134(2):291-303. PubMed: 23640861 MGI: J:206893
Sha H; He Y; Chen H; Wang C; Zenno A; Shi H; Yang X; Zhang X; Qi L. 2009. The IRE1alpha-XBP1 pathway of the unfolded protein response is required for adipogenesis. Cell Metab 9(6):556-64. PubMed: 19490910 MGI: J:149823
Sha H; Yang L; Liu M; Xia S; Liu Y; Liu F; Kersten S; Qi L. 2014. Adipocyte spliced form of X-box-binding protein 1 promotes adiponectin multimerization and systemic glucose homeostasis. Diabetes 63(3):867-79. PubMed: 24241534 MGI: J:208982
Shafrir E; Ziv E. 2009. A useful list of spontaneously arising animal models of obesity and diabetes. Am J Physiol Endocrinol Metab 296(6):E1450-2. PubMed: 19468077 MGI: J:149667
Shao J; Zeng S; Zhou B; Xu H; Bian Y; Xu Y. 2017. Angiogenic factor with G patch and FHA domains 1 (Aggf1) promotes hepatic steatosis in mice. Biochem Biophys Res Commun 482(1):134-140. PubMed: 27865839 MGI: J:241251
Sharma A; Bartell SM; Baile CA; Chen B; Podolsky RH; McIndoe RA; She JX. 2010. Hepatic gene expression profiling reveals key pathways involved in leptin-mediated weight loss in ob/ob mice. PLoS One 5(8):. PubMed: 20808936 MGI: J:164008
Sharma SD; Katiyar SK. 2010. Leptin deficiency-induced obesity exacerbates ultraviolet B radiation-induced cyclooxygenase-2 expression and cell survival signals in ultraviolet B-irradiated mouse skin. Toxicol Appl Pharmacol 244(3):328-35. PubMed: 20122948 MGI: J:160387
Shaw RJ; Lamia KA; Vasquez D; Koo SH; Bardeesy N; Depinho RA; Montminy M; Cantley LC. 2005. The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin. Science 310(5754):1642-6. PubMed: 16308421 MGI: J:104202
Shemesh A; Abdulla A; Yang F; Chua SC; Pessin JE; Zong H. 2014. The antidepressant trans-2-phenylcyclopropylamine protects mice from high-fat-diet-induced obesity. PLoS One 9(2):e89199. PubMed: 24586592 MGI: J:213762
Shen L; Tso P; Woods SC; Clegg DJ; Barber KL; Carey K; Liu M. 2008. Brain apolipoprotein E: an important regulator of food intake in rats. Diabetes 57(8):2092-8. PubMed: 18559657 MGI: J:141777
Sheng L; Cho KW; Zhou Y; Shen H; Rui L. 2011. Lipocalin 13 protein protects against hepatic steatosis by both inhibiting lipogenesis and stimulating fatty acid beta-oxidation. J Biol Chem 286(44):38128-35. PubMed: 21908604 MGI: J:178167
Sheng L; Zhou Y; Chen Z; Ren D; Cho KW; Jiang L; Shen H; Sasaki Y; Rui L. 2012. NF-kappaB-inducing kinase (NIK) promotes hyperglycemia and glucose intolerance in obesity by augmenting glucagon action. Nat Med 18(6):943-9. PubMed: 22581287 MGI: J:187458
Shi H; Kokoeva MV; Inouye K; Tzameli I; Yin H; Flier JS. 2006. TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 116(11):3015-25. PubMed: 17053832 MGI: J:114608
Shi H; Tzameli I; Bjorbaek C; Flier JS. 2004. Suppressor of cytokine signaling 3 is a physiological regulator of adipocyte insulin signaling. J Biol Chem 279(33):34733-40. PubMed: 15181014 MGI: J:121205
Shi SY; Lu SY; Sivasubramaniyam T; Revelo XS; Cai EP; Luk CT; Schroer SA; Patel P; Kim RH; Bombardier E; Quadrilatero J; Tupling AR; Mak TW; Winer DA; Woo M. 2015. DJ-1 links muscle ROS production with metabolic reprogramming and systemic energy homeostasis in mice. Nat Commun 6:7415. PubMed: 26077864 MGI: J:223024
Shigemura N; Ohta R; Kusakabe Y; Miura H; Hino A; Koyano K; Nakashima K; Ninomiya Y. 2004. Leptin modulates behavioral responses to sweet substances by influencing peripheral taste structures. Endocrinology 145(2):839-47. PubMed: 14592964 MGI: J:96388
Shimomura I; Bashmakov Y; Horton JD. 1999. Increased levels of nuclear SREBP-1c associated with fatty livers in two mouse models of diabetes mellitus. J Biol Chem 274(42):30028-32. PubMed: 10514488 MGI: J:58018
Shimomura I; Matsuda M; Hammer RE; Bashmakov Y; Brown MS; Goldstein JL. 2000. Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice. Mol Cell 6(1):77-86. PubMed: 10949029 MGI: J:63895
Shutter JR; Graham M; Kinsey AC; Scully S; Luthy R; Stark KL. 1997. Hypothalamic expression of ART, a novel gene related to agouti, is up-regulated in obese and diabetic mutant mice. Genes Dev 11(5):593-602. PubMed: 9119224 MGI: J:39234
Siegmund B; Lehr HA; Fantuzzi G. 2002. Leptin: a pivotal mediator of intestinal inflammation in mice. Gastroenterology 122(7):2011-25. PubMed: 12055606 MGI: J:109852
Siegmund B; Sennello JA; Lehr HA; Batra A; Fedke I; Zeitz M; Fantuzzi G. 2004. Development of intestinal inflammation in double IL-10- and leptin-deficient mice. J Leukoc Biol 76(4):782-6. PubMed: 15240754 MGI: J:93117
Silvani A; Bastianini S; Berteotti C; Franzini C; Lenzi P; Lo Martire V; Zoccoli G. 2009. Sleep modulates hypertension in leptin-deficient obese mice. Hypertension 53(2):251-5. PubMed: 19114642 MGI: J:164998
Silver DL; Jiang XC; Tall AR. 1999. Increased high density lipoprotein (HDL), defective hepatic catabolism of ApoA-I and ApoA-II, and decreased ApoA-I mRNA in ob/ob mice. Possible role of leptin in stimulation of HDL turnover. J Biol Chem 274(7):4140-6. PubMed: 9933608 MGI: J:115228
Silver DL; Wang N; Tall AR. 2000. Defective HDL particle uptake in ob/ob hepatocytes causes decreased recycling, degradation, and selective lipid uptake. J Clin Invest 105(2):151-9. PubMed: 10642593 MGI: J:124840
Sims-Robinson C; Bakeman A; Glasser R; Boggs J; Pacut C; Feldman EL. 2016. The role of endoplasmic reticulum stress in hippocampal insulin resistance. Exp Neurol 277:261-7. PubMed: 26775176 MGI: J:229542
Singh A; Wirtz M; Parker N; Hogan M; Strahler J; Michailidis G; Schmidt S; Vidal-Puig A; Diano S; Andrews P; Brand MD; Friedman J. 2009. Leptin-mediated changes in hepatic mitochondrial metabolism, structure, and protein levels. Proc Natl Acad Sci U S A 106(31):13100-5. PubMed: 19622746 MGI: J:152013
Singhal NS; Patel RT; Qi Y; Lee YS; Ahima RS. 2008. Loss of resistin ameliorates hyperlipidemia and hepatic steatosis in leptin-deficient mice. Am J Physiol Endocrinol Metab 295(2):E331-8. PubMed: 18505833 MGI: J:139905
Sjoholm A; Arkhammar P; Berggren PO; Andersson A. 2001. Polyamines in pancreatic islets of obese-hyperglycemic (ob/ob) mice of different ages. Am J Physiol Cell Physiol 280(2):C317-23. PubMed: 11208527 MGI: J:68066
Sloan C; Tuinei J; Nemetz K; Frandsen J; Soto J; Wride N; Sempokuya T; Alegria L; Bugger H; Abel ED. 2011. Central Leptin Signaling Is Required to Normalize Myocardial Fatty Acid Oxidation Rates in Caloric-Restricted ob/ob Mice. Diabetes 60(5):1424-34. PubMed: 21441440 MGI: J:171744
Snell GD. 1951. Mutant stock V Mouse News Lett 5:29. MGI: J:178288
So JS; Hur KY; Tarrio M; Ruda V; Frank-Kamenetsky M; Fitzgerald K; Koteliansky V; Lichtman AH; Iwawaki T; Glimcher LH; Lee AH. 2012. Silencing of lipid metabolism genes through IRE1alpha-mediated mRNA decay lowers plasma lipids in mice. Cell Metab 16(4):487-99. PubMed: 23040070 MGI: J:190921
Solinas G; Naugler W; Galimi F; Lee MS; Karin M. 2006. Saturated fatty acids inhibit induction of insulin gene transcription by JNK-mediated phosphorylation of insulin-receptor substrates. Proc Natl Acad Sci U S A 103(44):16454-9. PubMed: 17050683 MGI: J:116088
Song DD; Chen Y; Li ZY; Guan YF; Zou DJ; Miao CY. 2013. Protein tyrosine phosphatase 1B inhibits adipocyte differentiation and mediates TNFalpha action in obesity. Biochim Biophys Acta 1831(8):1368-76. PubMed: 23711960 MGI: J:202539
Sorensen H; Brand CL; Neschen S; Holst JJ; Fosgerau K; Nishimura E; Shulman GI. 2006. Immunoneutralization of endogenous glucagon reduces hepatic glucose output and improves long-term glycemic control in diabetic ob/ob mice. Diabetes 55(10):2843-8. PubMed: 17003351 MGI: J:116540
Soukas A; Cohen P; Socci ND; Friedman JM. 2000. Leptin-specific patterns of gene expression in white adipose tissue. Genes Dev 14(8):963-80. PubMed: 10783168 MGI: J:61962
Steinberg GR; Michell BJ; van Denderen BJ; Watt MJ; Carey AL; Fam BC; Andrikopoulos S; Proietto J; Gorgun CZ; Carling D; Hotamisligil GS; Febbraio MA; Kay TW; Kemp BE. 2006. Tumor necrosis factor alpha-induced skeletal muscle insulin resistance involves suppression of AMP-kinase signaling. Cell Metab 4(6):465-74. PubMed: 17141630 MGI: J:129774
Steinberg GR; Watt MJ; Ernst M; Birnbaum MJ; Kemp BE; Jorgensen SB. 2009. Ciliary neurotrophic factor stimulates muscle glucose uptake by a PI3-kinase-dependent pathway that is impaired with obesity. Diabetes 58(4):829-39. PubMed: 19136654 MGI: J:151044
Stern JH; Rutkowski JM; Scherer PE. 2016. Adiponectin, Leptin, and Fatty Acids in the Maintenance of Metabolic Homeostasis through Adipose Tissue Crosstalk. Cell Metab 23(5):770-84. PubMed: 27166942 MGI: J:235373
Stienstra R; Joosten LA; Koenen T; van Tits B; van Diepen JA; van den Berg SA; Rensen PC; Voshol PJ; Fantuzzi G; Hijmans A; Kersten S; Muller M; van den Berg WB; van Rooijen N; Wabitsch M; Kullberg BJ; van der Meer JW; Kanneganti T; Tack CJ; Netea MG. 2010. The inflammasome-mediated caspase-1 activation controls adipocyte differentiation and insulin sensitivity. Cell Metab 12(6):593-605. PubMed: 21109192 MGI: J:168117
Stockebrand M; Sauter K; Neu A; Isbrandt D; Choe CU. 2013. Differential regulation of AMPK activation in leptin- and creatine-deficient mice. FASEB J 27(10):4147-4156. PubMed: 23825223 MGI: J:201173
Stoehr JP; Nadler ST; Schueler KL; Rabaglia ME; Yandell BS; Metz SA; Attie AD. 2000. Genetic obesity unmasks nonlinear interactions between murine type 2 diabetes susceptibility loci Diabetes 49(11):1946-54. PubMed: 11078464 MGI: J:65486
Stratigopoulos G; Padilla SL; Leduc CA; Watson E; Hattersley AT; McCarthy MI; Zeltser LM; Chung WK; Leibel RL. 2008. Regulation of Fto/Ftm gene expression in mice and humans. Am J Physiol Regul Integr Comp Physiol 294(4):R1185-96. PubMed: 18256137 MGI: J:133509
Suganami E; Takagi H; Ohashi H; Suzuma K; Suzuma I; Oh H; Watanabe D; Ojima T; Suganami T; Fujio Y; Nakao K; Ogawa Y; Yoshimura N. 2004. Leptin stimulates ischemia-induced retinal neovascularization: possible role of vascular endothelial growth factor expressed in retinal endothelial cells. Diabetes 53(9):2443-8. PubMed: 15331557 MGI: J:92072
Suganami T; Yuan X; Shimoda Y; Uchio-Yamada K; Nakagawa N; Shirakawa I; Usami T; Tsukahara T; Nakayama K; Miyamoto Y; Yasuda K; Matsuda J; Kamei Y; Kitajima S; Ogawa Y. 2009. Activating transcription factor 3 constitutes a negative feedback mechanism that attenuates saturated Fatty acid/toll-like receptor 4 signaling and macrophage activation in obese adipose tissue. Circ Res 105(1):25-32. PubMed: 19478204 MGI: J:164755
Sugita H; Fujimoto M; Yasukawa T; Shimizu N; Sugita M; Yasuhara S; Martyn JA; Kaneki M. 2005. Inducible nitric-oxide synthase and NO donor induce insulin receptor substrate-1 degradation in skeletal muscle cells. J Biol Chem 280(14):14203-11. PubMed: 15805118 MGI: J:98746
Suh JM; Jonker JW; Ahmadian M; Goetz R; Lackey D; Osborn O; Huang Z; Liu W; Yoshihara E; van Dijk TH; Havinga R; Fan W; Yin YQ; Yu RT; Liddle C; Atkins AR; Olefsky JM; Mohammadi M; Downes M; Evans RM. 2014. Endocrinization of FGF1 produces a neomorphic and potent insulin sensitizer. Nature 513(7518):436-9. PubMed: 25043058 MGI: J:217106
Sun L; Xie H; Mori MA; Alexander R; Yuan B; Hattangadi SM; Liu Q; Kahn CR; Lodish HF. 2011. Mir193b-365 is essential for brown fat differentiation. Nat Cell Biol 13(8):958-65. PubMed: 21743466 MGI: J:174421
Sun S; Xia S; Ji Y; Kersten S; Qi L. 2012. The ATP-P2X7 signaling axis is dispensable for obesity-associated inflammasome activation in adipose tissue. Diabetes 61(6):1471-8. PubMed: 22415881 MGI: J:196855
Sun XY; Hayashi Y; Xu S; Kanou Y; Takagishi Y; Tang YP; Murata Y. 2011. Inactivation of the Rcan2 gene in mice ameliorates the age- and diet-induced obesity by causing a reduction in food intake. PLoS One 6(1):e14605. PubMed: 21298050 MGI: J:169558
Sun Y; Asnicar M; Saha PK; Chan L; Smith RG. 2006. Ablation of ghrelin improves the diabetic but not obese phenotype of ob/ob mice. Cell Metab 3(5):379-86. PubMed: 16679295 MGI: J:129645
Sunadome K; Suzuki T; Usui M; Ashida Y; Nishida E. 2014. Antagonism between the master regulators of differentiation ensures the discreteness and robustness of cell fates. Mol Cell 54(3):526-35. PubMed: 24703953 MGI: J:213621
Suto J. 2007. The A y allele at the agouti locus enhances sensitivity to endotoxin-induced lethality in mice. J Vet Med Sci 69(9):931-7. PubMed: 17917378 MGI: J:141486
Suzuki R; Lee K; Jing E; Biddinger SB; McDonald JG; Montine TJ; Craft S; Kahn CR. 2010. Diabetes and insulin in regulation of brain cholesterol metabolism. Cell Metab 12(6):567-79. PubMed: 21109190 MGI: J:168119
Swoap SJ. 2001. Altered leptin signaling is sufficient, but not required, for hypotension associated with caloric restriction. Am J Physiol Heart Circ Physiol 281(6):H2473-9. PubMed: 11709414 MGI: J:108672
Swoap SJ; Weinshenker D. 2008. Norepinephrine controls both torpor initiation and emergence via distinct mechanisms in the mouse. PLoS One 3(12):e4038. PubMed: 19107190 MGI: J:144352
Sylow L; Long JZ; Lokurkar IA; Zeng X; Richter EA; Spiegelman BM. 2016. The Cancer Drug Dasatinib Increases PGC-1alpha in Adipose Tissue but Has Adverse Effects on Glucose Tolerance in Obese Mice. Endocrinology 157(11):4184-4191. PubMed: 27589085 MGI: J:240433
Szczypka MS; Rainey MA; Palmiter RD. 2000. Dopamine is required for hyperphagia in Lep(ob/ob) mice. Nat Genet 25(1):102-4. PubMed: 10802666 MGI: J:61883
Taguchi K; Kobayashi T; Matsumoto T; Kamata K. 2011. Dysfunction of endothelium-dependent relaxation to insulin via PKC-mediated GRK2/ Akt activation in aortas of ob/ob mice. Am J Physiol Heart Circ Physiol :. PubMed: 21572010 MGI: J:173236
Taguchi K; Matsumoto T; Kamata K; Kobayashi T. 2012. Inhibitor of G protein-coupled receptor kinase 2 normalizes vascular endothelial function in type 2 diabetic mice by improving beta-arrestin 2 translocation and ameliorating Akt/eNOS signal dysfunction. Endocrinology 153(7):2985-96. PubMed: 22581458 MGI: J:189042
Takahashi A; Morita M; Yokoyama K; Suzuki T; Yamamoto T. 2012. Tob2 inhibits peroxisome proliferator-activated receptor gamma2 expression by sequestering Smads and C/EBPalpha during adipocyte differentiation. Mol Cell Biol 32(24):5067-77. PubMed: 23071089 MGI: J:192861
Takahashi N; Waelput W; Guisez Y. 1999. Leptin is an endogenous protective protein against the toxicity exerted by tumor necrosis factor. J Exp Med 189(1):207-12. PubMed: 9874578 MGI: J:52060
Takeda S; Elefteriou F; Levasseur R; Liu X; Zhao L; Parker KL; Armstrong D; Ducy P; Karsenty G. 2002. Leptin regulates bone formation via the sympathetic nervous system. Cell 111(3):305-17. PubMed: 12419242 MGI: J:79873
Takeda S; Sato N; Uchio-Yamada K; Sawada K; Kunieda T; Takeuchi D; Kurinami H; Shinohara M; Rakugi H; Morishita R. 2010. Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and Abeta deposition in an Alzheimer mouse model with diabetes. Proc Natl Acad Sci U S A 107(15):7036-41. PubMed: 20231468 MGI: J:159328
Takeuchi Y; Yahagi N; Aita Y; Murayama Y; Sawada Y; Piao X; Toya N; Oya Y; Shikama A; Takarada A; Masuda Y; Nishi M; Kubota M; Izumida Y; Yamamoto T; Sekiya M; Matsuzaka T; Nakagawa Y; Urayama O; Kawakami Y; Iizuka Y; Gotoda T; Itaka K; Kataoka K; Nagai R; Kadowaki T; Yamada N; Lu Y; Jain MK; Shimano H. 2016. KLF15 Enables Rapid Switching between Lipogenesis and Gluconeogenesis during Fasting. Cell Rep 16(9):2373-86. PubMed: 27545894 MGI: J:239032
Taleb S; Herbin O; Ait-Oufella H; Verreth W; Gourdy P; Barateau V; Merval R; Esposito B; Clement K; Holvoet P; Tedgui A; Mallat Z. 2007. Defective leptin/leptin receptor signaling improves regulatory T cell immune response and protects mice from atherosclerosis. Arterioscler Thromb Vasc Biol 27(12):2691-8. PubMed: 17690315 MGI: J:147531
Tam J; Vemuri VK; Liu J; Batkai S; Mukhopadhyay B; Godlewski G; Osei-Hyiaman D; Ohnuma S; Ambudkar SV; Pickel J; Makriyannis A; Kunos G. 2010. Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity. J Clin Invest 120(8):2953-66. PubMed: 20664173 MGI: J:163760
Tanaka T; Yamamoto J; Iwasaki S; Asaba H; Hamura H; Ikeda Y; Watanabe M; Magoori K; Ioka RX; Tachibana K; Watanabe Y; Uchiyama Y; Sumi K; Iguchi H; Ito S; Doi T; Hamakubo T; Naito M; Auwerx J; Yanagisawa M; Kodama T; Sakai J. 2003. Activation of peroxisome proliferator-activated receptor delta induces fatty acid beta-oxidation in skeletal muscle and attenuates metabolic syndrome. Proc Natl Acad Sci U S A 100(26):15924-9. PubMed: 14676330 MGI: J:114135
Tang Y; Chen A. 2014. Curcumin eliminates the effect of advanced glycation end-products (AGEs) on the divergent regulation of gene expression of receptors of AGEs by interrupting leptin signaling. Lab Invest 94(5):503-16. PubMed: 24614199 MGI: J:208133
Tanii M; Yonemitsu Y; Fujii T; Shikada Y; Kohno R; Onimaru M; Okano S; Inoue M; Hasegawa M; Onohara T; Maehara Y; Sueishi K. 2006. Diabetic microangiopathy in ischemic limb is a disease of disturbance of the platelet-derived growth factor-BB/protein kinase C axis but not of impaired expression of angiogenic factors. Circ Res 98(1):55-62. PubMed: 16306442 MGI: J:118090
Tarzi RM; Cook HT; Jackson I; Pusey CD; Lord GM. 2004. Leptin-deficient mice are protected from accelerated nephrotoxic nephritis. Am J Pathol 164(2):385-90. PubMed: 14742244 MGI: J:88373
Tattikota SG; Rathjen T; McAnulty SJ; Wessels HH; Akerman I; van de Bunt M; Hausser J; Esguerra JL; Musahl A; Pandey AK; You X; Chen W; Herrera PL; Johnson PR; O'Carroll D; Eliasson L; Zavolan M; Gloyn AL; Ferrer J; Shalom-Feuerstein R; Aberdam D; Poy MN. 2014. Argonaute2 mediates compensatory expansion of the pancreatic beta cell. Cell Metab 19(1):122-34. PubMed: 24361012 MGI: J:210552
Taylor IL; Garcia R. 1985. Effects of pancreatic polypeptide, caerulein, and bombesin on satiety in obese mice. Am J Physiol 248(3 Pt 1):G277-80. PubMed: 3976886 MGI: J:7767
Teng R; Gavrilova O; Suzuki N; Chanturiya T; Schimel D; Hugendubler L; Mammen S; Yver DR; Cushman SW; Mueller E; Yamamoto M; Hsu LL; Noguchi CT. 2011. Disrupted erythropoietin signalling promotes obesity and alters hypothalamus proopiomelanocortin production. Nat Commun 2:520. PubMed: 22044999 MGI: J:220935
Thrybom T; Rooth P; Lindstrom P. 2001. Effect of serotonin reuptake inhibitor on syndrome development in obese hyperglycemic mice (Umea ob/ob). Metabolism 50(2):144-50. PubMed: 11229420 MGI: J:68407
Thurlby PL; Trayhurn P. 1979. The role of thermoregulatory thermogenesis in the development of obesity in genetically-obese (ob/ob) mice pair-fed with lean siblings. Br J Nutr 42(3):377-85. PubMed: 508700 MGI: J:6236
Tian J; Keller MP; Oler AT; Rabaglia ME; Schueler KL; Stapleton DS; Broman AT; Zhao W; Kendziorski C; Yandell BS; Hagenbuch B; Broman KW; Attie AD. 2015. Identification of the Bile Acid Transporter Slco1a6 as a Candidate Gene That Broadly Affects Gene Expression in Mouse Pancreatic Islets. Genetics 201(3):1253-62. PubMed: 26385979 MGI: J:227551
Togliatto G; Trombetta A; Dentelli P; Baragli A; Rosso A; Granata R; Ghigo D; Pegoraro L; Ghigo E; Brizzi MF. 2010. Unacylated ghrelin rescues endothelial progenitor cell function in individuals with type 2 diabetes. Diabetes 59(4):1016-25. PubMed: 20068135 MGI: J:164337
Toh SY; Gong J; Du G; Li JZ; Yang S; Ye J; Yao H; Zhang Y; Xue B; Li Q; Yang H; Wen Z; Li P. 2008. Up-regulation of mitochondrial activity and acquirement of brown adipose tissue-like property in the white adipose tissue of fsp27 deficient mice. PLoS One 3(8):e2890. PubMed: 18682832 MGI: J:140122
Torre-Villalvazo I; Gonzalez F; Aguilar-Salinas CA; Tovar AR; Torres N. 2009. Dietary soy protein reduces cardiac lipid accumulation and the ceramide concentration in high-fat diet-fed rats and ob/ob mice. J Nutr 139(12):2237-43. PubMed: 19828684 MGI: J:154693
Trabelsi MS; Daoudi M; Prawitt J; Ducastel S; Touche V; Sayin SI; Perino A; Brighton CA; Sebti Y; Kluza J; Briand O; Dehondt H; Vallez E; Dorchies E; Baud G; Spinelli V; Hennuyer N; Caron S; Bantubungi K; Caiazzo R; Reimann F; Marchetti P; Lefebvre P; Backhed F; Gribble FM; Schoonjans K; Pattou F; Tailleux A; Staels B; Lestavel S. 2015. Farnesoid X receptor inhibits glucagon-like peptide-1 production by enteroendocrine L cells. Nat Commun 6:7629. PubMed: 26134028 MGI: J:224384
Trayhurn P; James WP. 1978. Thermoregulation and non-shivering thermogenesis in the genetically obese (ob/ob) mouse. Pflugers Arch 373(2):189-93. PubMed: 565045 MGI: J:5958
Trayhurn P; Thomas ME; Duncan JS; Rayner DV. 1995. Effects of fasting and refeeding on ob gene expression in white adipose tissue of lean and obese (oblob) mice. FEBS Lett 368(3):488-90. PubMed: 7635205 MGI: J:27455
Trayhurn P; Thurlby PL; James WP. 1977. Thermogenic defect in pre-obese ob/ob mice. Nature 266(5597):60-2. PubMed: 840297 MGI: J:12010
Trevaskis JL; Butler AA. 2005. Double leptin and melanocortin-4 receptor gene mutations have an additive effect on fat mass and are associated with reduced effects of leptin on weight loss and food intake. Endocrinology 146(10):4257-65. PubMed: 15994342 MGI: J:101555
Trevaskis JL; Griffin PS; Wittmer C; Neuschwander-Tetri BA; Brunt EM; Dolman CS; Erickson MR; Napora J; Parkes DG; Roth JD. 2012. Glucagon-like peptide-1 receptor agonism improves metabolic, biochemical, and histopathological indices of nonalcoholic steatohepatitis in mice. Am J Physiol Gastrointest Liver Physiol 302(8):G762-72. PubMed: 22268099 MGI: J:185386
Trevaskis JL; Meyer EA; Galgani JE; Butler AA. 2008. Counterintuitive effects of double-heterozygous null melanocortin-4 receptor and leptin genes on diet-induced obesity and insulin resistance in C57BL/6J mice. Endocrinology 149(1):174-84. PubMed: 17932216 MGI: J:141477
Trotter-Mayo RN; Roberts MR. 2008. Leptin acts in the periphery to protect thymocytes from glucocorticoid-mediated apoptosis in the absence of weight loss. Endocrinology 149(10):5209-18. PubMed: 18583419 MGI: J:145495
Tsai WW; Niessen S; Goebel N; Yates JR 3rd; Guccione E; Montminy M. 2013. PRMT5 modulates the metabolic response to fasting signals. Proc Natl Acad Sci U S A 110(22):8870-5. PubMed: 23671120 MGI: J:197425
Tschop J; Nogueiras R; Haas-Lockie S; Kasten KR; Castaneda TR; Huber N; Guanciale K; Perez-Tilve D; Habegger K; Ottaway N; Woods SC; Oldfield B; Clarke I; Chua S Jr; Farooqi IS; O'Rahilly S; Caldwell CC; Tschop MH. 2010. CNS leptin action modulates immune response and survival in sepsis. J Neurosci 30(17):6036-47. PubMed: 20427662 MGI: J:159827
Tsurutani Y; Fujimoto M; Takemoto M; Irisuna H; Koshizaka M; Onishi S; Ishikawa T; Mezawa M; He P; Honjo S; Maezawa Y; Saito Y; Yokote K. 2011. The roles of transforming growth factor-beta and Smad3 signaling in adipocyte differentiation and obesity. Biochem Biophys Res Commun 407(1):68-73. PubMed: 21356196 MGI: J:171952
Tsutsumi A; Motoshima H; Kondo T; Kawasaki S; Matsumura T; Hanatani S; Igata M; Ishii N; Kinoshita H; Kawashima J; Taketa K; Furukawa N; Tsuruzoe K; Nishikawa T; Araki E. 2011. Caloric restriction decreases ER stress in liver and adipose tissue in ob/ob mice. Biochem Biophys Res Commun 404(1):339-44. PubMed: 21134353 MGI: J:167445
Tu Z; Keller MP; Zhang C; Rabaglia ME; Greenawalt DM; Yang X; Wang IM; Dai H; Bruss MD; Lum PY; Zhou YP; Kemp DM; Kendziorski C; Yandell BS; Attie AD; Schadt EE; Zhu J. 2012. Integrative analysis of a cross-loci regulation network identifies App as a gene regulating insulin secretion from pancreatic islets. PLoS Genet 8(12):e1003107. PubMed: 23236292 MGI: J:194853
Tubbs E; Theurey P; Vial G; Bendridi N; Bravard A; Chauvin MA; Ji-Cao J; Zoulim F; Bartosch B; Ovize M; Vidal H; Rieusset J. 2014. Mitochondria-associated endoplasmic reticulum membrane (MAM) integrity is required for insulin signaling and is implicated in hepatic insulin resistance. Diabetes 63(10):3279-94. PubMed: 24947355 MGI: J:230176
Turner RT; Kalra SP; Wong CP; Philbrick KA; Lindenmaier LB; Boghossian S; Iwaniec UT. 2013. Peripheral leptin regulates bone formation. J Bone Miner Res 28(1):22-34. PubMed: 22887758 MGI: J:233261
Turner SM; Roy S; Sul HS; Neese RA; Murphy EJ; Samandi W; Roohk DJ; Hellerstein MK. 2007. Dissociation between adipose tissue fluxes and lipogenic gene expression in ob/ob mice. Am J Physiol Endocrinol Metab 292(4):E1101-9. PubMed: 17164440 MGI: J:120374
Turpin SM; Hoy AJ; Brown RD; Garcia Rudaz C; Honeyman J; Matzaris M; Watt MJ. 2010. Adipose triacylglycerol lipase is a major regulator of hepatic lipid metabolism but not insulin sensitivity in mice. Diabetologia :. PubMed: 20842343 MGI: J:164672
Turpin SM; Ryall JG; Southgate R; Darby I; Hevener AL; Febbraio MA; Kemp BE; Lynch GS; Watt MJ. 2009. Examination of 'lipotoxicity' in skeletal muscle of high-fat fed and ob/ob mice. J Physiol 587(Pt 7):1593-605. PubMed: 19204053 MGI: J:176545
Udagawa J; Hashimoto R; Hioki K; Otani H. 2006. The role of leptin in the development of the cortical neuron in mouse embryos. Brain Res 1120(1):74-82. PubMed: 17020752 MGI: J:116065
Udagawa J; Hashimoto R; Suzuki H; Hatta T; Sotomaru Y; Hioki K; Kagohashi Y; Nomura T; Minami Y; Otani H. 2006. The role of leptin in the development of the cerebral cortex in mouse embryos. Endocrinology 147(2):647-58. PubMed: 16282354 MGI: J:105139
Udagawa J; Nimura M; Kagohashi Y; Otani H. 2006. Leptin deficiency causes pycnotic change in fetal cingulate cortical cells. Congenit Anom (Kyoto) 46(1):16-20. PubMed: 16643594 MGI: J:111445
Ueno N; Oh-ishi S; Segawa M; Nishida M; Fukuwatari Y; Kizaki T; Ookawara T; Ohno H. 1998. Effect of age on brown adipose tissue activity in the obese (ob/ob) mouse. Mech Ageing Dev 100(1):67-76. PubMed: 9509396 MGI: J:46004
Ukropec J; Anunciado RV; Ravussin Y; Kozak LP. 2006. Leptin is required for uncoupling protein-1-independent thermogenesis during cold stress. Endocrinology 147(5):2468-80. PubMed: 16469807 MGI: J:129662
Um SH; Frigerio F; Watanabe M; Picard F; Joaquin M; Sticker M; Fumagalli S; Allegrini PR; Kozma SC; Auwerx J; Thomas G. 2004. Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity. Nature 431(7005):200-5. PubMed: 15306821 MGI: J:92663
Uno K; Yamada T; Ishigaki Y; Imai J; Hasegawa Y; Sawada S; Kaneko K; Ono H; Asano T; Oka Y; Katagiri H. 2015. A hepatic amino acid/mTOR/S6K-dependent signalling pathway modulates systemic lipid metabolism via neuronal signals. Nat Commun 6:7940. PubMed: 26268630 MGI: J:224994
Uysal KT; Scheja L; Wiesbrock SM; Bonner-Weir S; Hotamisligil GS. 2000. Improved glucose and lipid metabolism in genetically obese mice lacking aP2. Endocrinology 141(9):3388-96. PubMed: 10965911 MGI: J:108811
Uysal KT; Wiesbrock SM; Hotamisligil GS. 1998. Functional analysis of tumor necrosis factor (TNF) receptors in TNF-alpha-mediated insulin resistance in genetic obesity. Endocrinology 139(12):4832-8. PubMed: 9832419 MGI: J:110666
Vachharajani V; Russell JM; Scott KL; Conrad S; Stokes KY; Tallam L; Hall J; Granger DN. 2005. Obesity exacerbates sepsis-induced inflammation and microvascular dysfunction in mouse brain. Microcirculation 12(2):183-94. PubMed: 15828130 MGI: J:114228
Valerio A; Cardile A; Cozzi V; Bracale R; Tedesco L; Pisconti A; Palomba L; Cantoni O; Clementi E; Moncada S; Carruba MO; Nisoli E. 2006. TNF-alpha downregulates eNOS expression and mitochondrial biogenesis in fat and muscle of obese rodents. J Clin Invest 116(10):2791-8. PubMed: 16981010 MGI: J:115008
Van den Bergh A; Vanderper A; Vangheluwe P; Desjardins F; Nevelsteen I; Verreth W; Wuytack F; Holvoet P; Flameng W; Balligand JL; Herijgers P. 2008. Dyslipidaemia in type II diabetic mice does not aggravate contractile impairment but increases ventricular stiffness. Cardiovasc Res 77(2):371-9. PubMed: 18006491 MGI: J:161915
Vegiopoulos A; Muller-Decker K; Strzoda D; Schmitt I; Chichelnitskiy E; Ostertag A; Berriel Diaz M; Rozman J; Hrabe de Angelis M; Nusing RM; Meyer CW; Wahli W; Klingenspor M; Herzig S. 2010. Cyclooxygenase-2 controls energy homeostasis in mice by de novo recruitment of brown adipocytes. Science 328(5982):1158-61. PubMed: 20448152 MGI: J:160553
Vergnes L; Beigneux AP; Davis R; Watkins SM; Young SG; Reue K. 2006. Agpat6 deficiency causes subdermal lipodystrophy and resistance to obesity. J Lipid Res 47(4):745-54. PubMed: 16436371 MGI: J:108332
Vernia S; Edwards YJ; Han MS; Cavanagh-Kyros J; Barrett T; Kim JK; Davis RJ. 2016. An alternative splicing program promotes adipose tissue thermogenesis. Elife 5:. PubMed: 27635635 MGI: J:236975
Vernooy JH; Bracke KR; Drummen NE; Pauwels NS; Zabeau L; van Suylen RJ; Tavernier J; Joos GF; Wouters EF; Brusselle GG. 2010. Leptin modulates innate and adaptive immune cell recruitment after cigarette smoke exposure in mice. J Immunol 184(12):7169-77. PubMed: 20488786 MGI: J:161133
Verreth W; De Keyzer D; Pelat M; Verhamme P; Ganame J; Bielicki JK; Mertens A; Quarck R; Benhabiles N; Marguerie G; Mackness B; Mackness M; Ninio E; Herregods MC; Balligand JL; Holvoet P. 2004. Weight-loss-associated induction of peroxisome proliferator-activated receptor-alpha and peroxisome proliferator-activated receptor-gamma correlate with reduced atherosclerosis and improved cardiovascular function in obese insulin-resistant mice. Circulation 110(20):3259-69. PubMed: 15533870 MGI: J:234613
Vicent D; Maratos-Flier E; Kahn CR. 2000. The branch point enzyme of the mevalonate pathway for protein prenylation is overexpressed in the ob/ob mouse and induced by adipogenesis. Mol Cell Biol 20(6):2158-66. PubMed: 10688662 MGI: J:60599
Vicent D; Piper M; Gammeltoft S; Maratos-Flier E; Kahn CR. 1998. Alterations in skeletal muscle gene expression of ob/ob mice by mRNA differential display [published erratum appears in Diabetes 1998 Dec;47(12):1978] Diabetes 47(9):1451-8. PubMed: 9726234 MGI: J:49410
Vidal-Puig A; Jimenez-Linan M; Lowell BB; Hamann A; Hu E; Spiegelman B; Flier JS; Moller DE. 1996. Regulation of PPAR gamma gene expression by nutrition and obesity in rodents. J Clin Invest 97(11):2553-61. PubMed: 8647948 MGI: J:33358
Vieira E; Marroqui L; Batista TM; Caballero-Garrido E; Carneiro EM; Boschero AC; Nadal A; Quesada I. 2012. The clock gene Rev-erbalpha regulates pancreatic beta-cell function: modulation by leptin and high-fat diet. Endocrinology 153(2):592-601. PubMed: 22166979 MGI: J:181732
Vienberg SG; Kleinridders A; Suzuki R; Kahn CR. 2015. Differential effects of angiopoietin-like 4 in brain and muscle on regulation of lipoprotein lipase activity. Mol Metab 4(2):144-50. PubMed: 25685701 MGI: J:220980
Villanueva CJ; Waki H; Godio C; Nielsen R; Chou WL; Vargas L; Wroblewski K; Schmedt C; Chao LC; Boyadjian R; Mandrup S; Hevener A; Saez E; Tontonoz P. 2011. TLE3 is a dual-function transcriptional coregulator of adipogenesis. Cell Metab 13(4):413-27. PubMed: 21459326 MGI: J:172245
Villasenor A; Wang ZV; Rivera LB; Ocal O; Asterholm IW; Scherer PE; Brekken RA; Cleaver O; Wilkie TM. 2010. Rgs16 and Rgs8 in embryonic endocrine pancreas and mouse models of diabetes. Dis Model Mech 3(9-10):567-80. PubMed: 20616094 MGI: J:163324
Voros G; Maquoi E; Demeulemeester D; Clerx N; Collen D; Lijnen HR. 2005. Modulation of angiogenesis during adipose tissue development in murine models of obesity. Endocrinology 146(10):4545-54. PubMed: 16020476 MGI: J:129817
Voros G; Sandy JD; Collen D; Lijnen HR. 2006. Expression of aggrecan(ases) during murine preadipocyte differentiation and adipose tissue development. Biochim Biophys Acta 1760(12):1837-44. PubMed: 17011710 MGI: J:117021
Wade JM; Juneja P; MacKay AW; Graham J; Havel PJ; Tecott LH; Goulding EH. 2008. Synergistic impairment of glucose homeostasis in ob/ob mice lacking functional serotonin 2C receptors. Endocrinology 149(3):955-61. PubMed: 18039786 MGI: J:135963
Wan M; Easton RM; Gleason CE; Monks BR; Ueki K; Kahn CR; Birnbaum MJ. 2012. Loss of Akt1 in mice increases energy expenditure and protects against diet-induced obesity. Mol Cell Biol 32(1):96-106. PubMed: 22037765 MGI: J:182721
Wang CY; X738b X798e X9685; Stapleton DS; Schueler KL; Rabaglia ME; Oler AT; Keller MP; Kendziorski CM; Broman KW; Yandell BS; Schadt EE; Attie AD. 2012. Tsc2, a positional candidate gene underlying a quantitative trait locus for hepatic steatosis. J Lipid Res 53(8):1493-1501. PubMed: 22628617 MGI: J:186560
Wang F; Tong Q. 2008. Transcription factor PU.1 is expressed in white adipose and inhibits adipocyte differentiation. Am J Physiol Cell Physiol 295(1):C213-20. PubMed: 18463231 MGI: J:138523
Wang J; Liu R; Wang F; Hong J; Li X; Chen M; Ke Y; Zhang X; Ma Q; Wang R; Shi J; Cui B; Gu W; Zhang Y; Zhang Z; Wang W; Xia X; Liu M; Ning G. 2013. Ablation of LGR4 promotes energy expenditure by driving white-to-brown fat switch. Nat Cell Biol 15(12):1455-63. PubMed: 24212090 MGI: J:208298
Wang QA; Tao C; Jiang L; Shao M; Ye R; Zhu Y; Gordillo R; Ali A; Lian Y; Holland WL; Gupta RK; Scherer PE. 2015. Distinct regulatory mechanisms governing embryonic versus adult adipocyte maturation. Nat Cell Biol 17(9):1099-111. PubMed: 26280538 MGI: J:227352
Wang X; Feng J; Yu C; Shen QW; Wang Y. 2015. Alterations in oral [1-(14)C] 18:1n-9 distribution in lean wild-type and genetically obese (ob/ob) mice. PLoS One 10(3):e0122028. PubMed: 25826747 MGI: J:229256
Wang X; Ota N; Manzanillo P; Kates L; Zavala-Solorio J; Eidenschenk C; Zhang J; Lesch J; Lee WP; Ross J; Diehl L; van Bruggen N; Kolumam G; Ouyang W. 2014. Interleukin-22 alleviates metabolic disorders and restores mucosal immunity in diabetes. Nature 514(7521):237-41. PubMed: 25119041 MGI: J:217078
Wang XQ; Lee S; Wilson H; Seeger M; Iordanov H; Gatla N; Whittington A; Bach D; Lu JY; Paller AS. 2014. Ganglioside GM3 Depletion Reverses Impaired Wound Healing in Diabetic Mice by Activating IGF-1 and Insulin Receptors. J Invest Dermatol 134(5):1446-55. PubMed: 24326453 MGI: J:208060
Wang Y; Botolin D; Xu J; Christian B; Mitchell E; Jayaprakasam B; Nair MG; Peters JM; Busik JV; Olson LK; Jump DB. 2006. Regulation of hepatic fatty acid elongase and desaturase expression in diabetes and obesity. J Lipid Res 47(9):2028-41. PubMed: 16790840 MGI: J:114583
Wang YC; Li Y; Wang XY; Zhang D; Zhang H; Wu Q; He YQ; Wang JY; Zhang L; Xia H; Yan J; Li X; Ying H. 2013. Circulating miR-130b mediates metabolic crosstalk between fat and muscle in overweight/obesity. Diabetologia 56(10):2275-85. PubMed: 23868745 MGI: J:203291
Warne JP; Varonin JM; Nielsen SS; Olofsson LE; Kaelin CB; Chua S Jr; Barsh GS; Koliwad SK; Xu AW. 2013. Coordinated regulation of hepatic energy stores by leptin and hypothalamic agouti-related protein. J Neurosci 33(29):11972-85. PubMed: 23864684 MGI: J:199803
Watanabe K; Watson E; Cremona ML; Millings EJ; Lefkowitch JH; Fischer SG; LeDuc CA; Leibel RL. 2013. ILDR2: an endoplasmic reticulum resident molecule mediating hepatic lipid homeostasis. PLoS One 8(6):e67234. PubMed: 23826244 MGI: J:204339
Watanabe M; Houten SM; Wang L; Moschetta A; Mangelsdorf DJ; Heyman RA; Moore DD; Auwerx J. 2004. Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c. J Clin Invest 113(10):1408-18. PubMed: 15146238 MGI: J:120199
Watanabe T; Kubota N; Ohsugi M; Kubota T; Takamoto I; Iwabu M; Awazawa M; Katsuyama H; Hasegawa C; Tokuyama K; Moroi M; Sugi K; Yamauchi T; Noda T; Nagai R; Terauchi Y; Tobe K; Ueki K; Kadowaki T. 2009. Rimonabant ameliorates insulin resistance via both adiponectin-dependent and adiponectin-independent pathways. J Biol Chem 284(3):1803-12. PubMed: 19008231 MGI: J:145886
Watson E; Hahm S; Mizuno TM; Windsor J; Montgomery C; Scherer PE; Mobbs CV; Salton SR. 2005. VGF ablation blocks the development of hyperinsulinemia and hyperglycemia in several mouse models of obesity. Endocrinology 146(12):5151-63. PubMed: 16141392 MGI: J:129798
Watson SL; Watson CJ; Baghdoyan HA; Lydic R. 2014. Adenosine A(1) receptors in mouse pontine reticular formation modulate nociception only in the presence of systemic leptin. Neuroscience 275:531-9. PubMed: 24976513 MGI: J:215652
Wei Z; Peterson JM; Lei X; Cebotaru L; Wolfgang MJ; Baldeviano GC; Wong GW. 2012. C1q/TNF-related protein-12 (CTRP12), a novel adipokine that improves insulin sensitivity and glycemic control in mouse models of obesity and diabetes. J Biol Chem 287(13):10301-15. PubMed: 22275362 MGI: J:183116
Weigle DS; Bukowski TR; Foster DC; Holderman S; Kramer JM; Lasser G; Lofton-Day CE; Prunkard DE; Raymond C; Kuijper JL. 1995. Recombinant ob protein reduces feeding and body weight in the ob/ob mouse. J Clin Invest 96(4):2065-70. PubMed: 7560100 MGI: J:29075
Weinstock PH; Levak-Frank S; Hudgins LC; Radner H; Friedman JM ; Zechner R ; Breslow JL. 1997. Lipoprotein lipase controls fatty acid entry into adipose tissue, but fat mass is preserved by endogenous synthesis in mice deficient in adipose tissue lipoprotein lipase. Proc Natl Acad Sci U S A 94(19):10261-6. PubMed: 9294198 MGI: J:42930
Wellen KE; Fucho R; Gregor MF; Furuhashi M; Morgan C; Lindstad T; Vaillancourt E; Gorgun CZ; Saatcioglu F; Hotamisligil GS. 2007. Coordinated regulation of nutrient and inflammatory responses by STAMP2 is essential for metabolic homeostasis. Cell 129(3):537-48. PubMed: 17482547 MGI: J:187736
Wendel AA; Li LO; Li Y; Cline GW; Shulman GI; Coleman RA. 2010. Glycerol-3-phosphate acyltransferase 1 deficiency in ob/ob mice diminishes hepatic steatosis but does not protect against insulin resistance or obesity. Diabetes 59(6):1321-9. PubMed: 20200319 MGI: J:169655
Wendel AA; Purushotham A; Liu LF; Belury MA. 2008. Conjugated linoleic acid fails to worsen insulin resistance but induces hepatic steatosis in the presence of leptin in ob/ob mice. J Lipid Res 49(1):98-106. PubMed: 17906221 MGI: J:130036
Westergren HU; Gronros J; Heinonen SE; Miliotis T; Jennbacken K; Sabirsh A; Ericsson A; Jonsson-Rylander AC; Svedlund S; Gan LM. 2015. Impaired Coronary and Renal Vascular Function in Spontaneously Type 2 Diabetic Leptin-Deficient Mice. PLoS One 10(6):e0130648. PubMed: 26098416 MGI: J:237893
Wieland CW; Florquin S; Chan ED; Leemans JC; Weijer S; Verbon A; Fantuzzi G; van der Poll T. 2005. Pulmonary Mycobacterium tuberculosis infection in leptin-deficient ob/ob mice. Int Immunol 17(11):1399-408. PubMed: 16141243 MGI: J:102314
Winer S; Chan Y; Paltser G; Truong D; Tsui H; Bahrami J; Dorfman R; Wang Y; Zielenski J; Mastronardi F; Maezawa Y; Drucker DJ; Engleman E; Winer D; Dosch HM. 2009. Normalization of obesity-associated insulin resistance through immunotherapy. Nat Med 15(8):921-9. PubMed: 19633657 MGI: J:152185
Wolfrum C; Asilmaz E; Luca E; Friedman JM; Stoffel M. 2004. Foxa2 regulates lipid metabolism and ketogenesis in the liver during fasting and in diabetes. Nature 432(7020):1027-32. PubMed: 15616563 MGI: J:95662
Wolfrum C; Howell JJ; Ndungo E; Stoffel M. 2008. Foxa2 activity increases plasma high density lipoprotein levels by regulating apolipoprotein M. J Biol Chem 283(24):16940-9. PubMed: 18381283 MGI: J:138581
Won EY; Yoon MK; Kim SW; Jung Y; Bae HW; Lee D; Park SG; Lee CH; Hwang GS; Chi SW. 2013. Gender-specific metabolomic profiling of obesity in leptin-deficient ob/ob mice by 1H NMR spectroscopy. PLoS One 8(10):e75998. PubMed: 24098417 MGI: J:209039
Won YS; Song JW; Lim JH; Lee MY; Moon OS; Kim HC; Son HY; Kwon HJ. 2016. Genetically obese (ob/ob) mice are resistant to the lethal effects of thioacetamide hepatotoxicity. Toxicol Appl Pharmacol 291:38-45. PubMed: 26701066 MGI: J:237648
Wong GW; Krawczyk SA; Kitidis-Mitrokostas C; Ge G; Spooner E; Hug C; Gimeno R; Lodish HF. 2009. Identification and characterization of CTRP9, a novel secreted glycoprotein, from adipose tissue that reduces serum glucose in mice and forms heterotrimers with adiponectin. FASEB J 23(1):241-58. PubMed: 18787108 MGI: J:146036
Wong IP; Nguyen AD; Khor EC; Enriquez RF; Eisman JA; Sainsbury A; Herzog H; Baldock PA. 2013. Neuropeptide Y is a critical modulator of leptin's regulation of cortical bone. J Bone Miner Res 28(4):886-98. PubMed: 23044938 MGI: J:233258
Wright WS; Longo KA; Dolinsky VW; Gerin I; Kang S; Bennett CN; Chiang SH; Prestwich TC; Gress C; Burant CF; Susulic VS; MacDougald OA. 2007. Wnt10b inhibits obesity in ob/ob and agouti mice. Diabetes 56(2):295-303. PubMed: 17259372 MGI: J:121960
Wu AL; Coulter S; Liddle C; Wong A; Eastham-Anderson J; French DM; Peterson AS; Sonoda J. 2011. FGF19 regulates cell proliferation, glucose and bile acid metabolism via FGFR4-dependent and independent pathways. PLoS One 6(3):e17868. PubMed: 21437243 MGI: J:171687
Wu D; Molofsky AB; Liang HE; Ricardo-Gonzalez RR; Jouihan HA; Bando JK; Chawla A; Locksley RM. 2011. Eosinophils sustain adipose alternatively activated macrophages associated with glucose homeostasis. Science 332(6026):243-7. PubMed: 21436399 MGI: J:170307
Wu Q; Whiddon BB; Palmiter RD. 2012. Ablation of neurons expressing agouti-related protein, but not melanin concentrating hormone, in leptin-deficient mice restores metabolic functions and fertility. Proc Natl Acad Sci U S A 109(8):3155-60. PubMed: 22232663 MGI: J:181947
Wu X; Ge H; Lemon B; Vonderfecht S; Baribault H; Weiszmann J; Gupte J; Gardner J; Lindberg R; Wang Z; Li Y. 2010. Separating mitogenic and metabolic activities of fibroblast growth factor 19 (FGF19). Proc Natl Acad Sci U S A 107(32):14158-63. PubMed: 20660733 MGI: J:163608
Wu X; Ge H; Lemon B; Weiszmann J; Gupte J; Hawkins N; Li X; Tang J; Lindberg R; Li Y. 2009. Selective activation of FGFR4 by an FGF19 variant does not improve glucose metabolism in ob/ob mice. Proc Natl Acad Sci U S A 106(34):14379-84. PubMed: 19706524 MGI: J:151994
Wu X; Weiszmann J; Ge H; Baribault H; Stevens J; Hawkins N; Vonderfecht S; Gardner J; Gupte J; Sheng J; Wang M; Li Y. 2012. A unique FGF23 with the ability to activate FGFR signaling through both alphaKlotho and betaKlotho. J Mol Biol 418(1-2):82-9. PubMed: 22370560 MGI: J:197702
Wu Y; Kim JY; Zhou S; Smas CM. 2008. Differential screening identifies transcripts with depot-dependent expression in white adipose tissues. BMC Genomics 9:397. PubMed: 18721461 MGI: J:141023
Wueest S; Rapold RA; Schumann DM; Rytka JM; Schildknecht A; Nov O; Chervonsky AV; Rudich A; Schoenle EJ; Donath MY; Konrad D. 2010. Deletion of Fas in adipocytes relieves adipose tissue inflammation and hepatic manifestations of obesity in mice. J Clin Invest 120(1):191-202. PubMed: 19955656 MGI: J:156776
Xia Z; Sniderman AD; Cianflone K. 2002. Acylation-stimulating Protein (ASP) Deficiency Induces Obesity Resistance and Increased Energy Expenditure in ob/ob Mice. J Biol Chem 277(48):45874-9. PubMed: 12244109 MGI: J:80546
Xiang L; Hester RL. 2009. Adipocyte-derived factor reduces vasodilatory capability in ob-/ob- mice. Am J Physiol Heart Circ Physiol 297(2):H689-95. PubMed: 19502550 MGI: J:151096
Xie H; Lim B; Lodish HF. 2009. MicroRNAs induced during adipogenesis that accelerate fat cell development are downregulated in obesity. Diabetes 58(5):1050-7. PubMed: 19188425 MGI: J:151131
Xin XG; Huang XF. 1998. Down-regulated NPY receptor subtype-5 mRNA expression in genetically obese mouse brain. Neuroreport 9(4):737-41. PubMed: 9559948 MGI: J:46895
Xu A; Liu J; Liu P; Jia M; Wang H; Tao L. 2014. Mitochondrial translocation of Nur77 induced by ROS contributed to cardiomyocyte apoptosis in metabolic syndrome. Biochem Biophys Res Commun 446(4):1184-9. PubMed: 24680679 MGI: J:219470
Xu H; Barnes GT; Yang Q; Tan G; Yang D; Chou CJ; Sole J; Nichols A; Ross JS; Tartaglia LA; Chen H. 2003. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112(12):1821-30. PubMed: 14679177 MGI: J:86952
Xu J; Stanislaus S; Chinookoswong N; Lau YY; Hager T; Patel J; Ge H; Weiszmann J; Lu SC; Graham M; Busby J; Hecht R; Li YS; Li Y; Lindberg RA; Veniant MM. 2009. Acute glucose-lowering and insulin-sensitizing action of FGF21 in insulin resistant mouse models----Association with liver and adipose tissue effects. Am J Physiol Endocrinol Metab :. PubMed: 19706786 MGI: J:159573
Xu J; Wang P; Li Y; Li G; Kaczmarek LK; Wu Y; Koni PA; Flavell RA; Desir GV. 2004. The voltage-gated potassium channel Kv1.3 regulates peripheral insulin sensitivity. Proc Natl Acad Sci U S A 101(9):3112-7. PubMed: 14981264 MGI: J:88651
Xu J; Yin L; Xu Y; Li Y; Zalzala M; Cheng G; Zhang Y. 2014. Hepatic carboxylesterase 1 is induced by glucose and regulates postprandial glucose levels. PLoS One 9(10):e109663. PubMed: 25285996 MGI: J:223470
Xu N; Nilsson-Ehle P; Hurtig M; Ahren B. 2004. Both leptin and leptin-receptor are essential for apolipoprotein M expression in vivo. Biochem Biophys Res Commun 321(4):916-21. PubMed: 15358114 MGI: J:91738
Xu X; Grijalva A; Skowronski A; van Eijk M; Serlie MJ; Ferrante AW Jr. 2013. Obesity activates a program of lysosomal-dependent lipid metabolism in adipose tissue macrophages independently of classic activation. Cell Metab 18(6):816-30. PubMed: 24315368 MGI: J:206140
Xue P; Hou Y; Chen Y; Yang B; Fu J; Zheng H; Yarborough K; Woods CG; Liu D; Yamamoto M; Zhang Q; Andersen ME; Pi J. 2013. Adipose deficiency of Nrf2 in ob/ob mice results in severe metabolic syndrome. Diabetes 62(3):845-54. PubMed: 23238296 MGI: J:208590
Xue Y; Shen L; Cui Y; Zhang H; Chen Q; Cui A; Fang F; Chang Y. 2013. Tff3, as a novel peptide, regulates hepatic glucose metabolism. PLoS One 8(9):e75240. PubMed: 24086476 MGI: J:207742
Yadav VK; Oury F; Tanaka KF; Thomas T; Wang Y; Cremers S; Hen R; Krust A; Chambon P; Karsenty G. 2011. Leptin-dependent serotonin control of appetite: temporal specificity, transcriptional regulation, and therapeutic implications. J Exp Med 208(1):41-52. PubMed: 21187319 MGI: J:176858
Yahagi N; Shimano H; Hasty AH; Matsuzaka T; Ide T; Yoshikawa T; Amemiya-Kudo M; Tomita S; Okazaki H; Tamura Y; Iizuka Y; Ohashi K; Osuga J; Harada K; Gotoda T; Nagai R; Ishibashi S; Yamada N. 2002. Absence of sterol regulatory element-binding protein-1 (SREBP-1) ameliorates fatty livers but not obesity or insulin resistance in Lep(ob)/Lep(ob) mice. J Biol Chem 277(22):19353-7. PubMed: 11923308 MGI: J:76758
Yahagi N; Shimano H; Matsuzaka T; Najima Y; Sekiya M; Nakagawa Y; Ide T; Tomita S; Okazaki H; Tamura Y; Iizuka Y; Ohashi K; Gotoda T; Nagai R; Kimura S; Ishibashi S; Osuga J; Yamada N. 2003. p53 Activation in adipocytes of obese mice. J Biol Chem 278(28):25395-400. PubMed: 12734185 MGI: J:120652
Yahagi N; Shimano H; Matsuzaka T; Sekiya M; Najima Y; Okazaki S; Okazaki H; Tamura Y; Iizuka Y; Inoue N; Nakagawa Y; Takeuchi Y; Ohashi K; Harada K; Gotoda T; Nagai R; Kadowaki T; Ishibashi S; Osuga J; Yamada N. 2004. p53 involvement in the pathogenesis of fatty liver disease. J Biol Chem 279(20):20571-5. PubMed: 14985341 MGI: J:124263
Yalcin EB; Kulkarni SR; Slitt AL; King R. 2016. Bisphenol A sulfonation is impaired in metabolic and liver disease. Toxicol Appl Pharmacol 292:75-84. PubMed: 26712468 MGI: J:230578
Yamada N; Katsuura G; Ochi Y; Ebihara K; Kusakabe T; Hosoda K; Nakao K. 2011. Impaired CNS leptin action is implicated in depression associated with obesity. Endocrinology 152(7):2634-43. PubMed: 21521746 MGI: J:174906
Yamaoka M; Maeda N; Takayama Y; Sekimoto R; Tsushima Y; Matsuda K; Mori T; Inoue K; Nishizawa H; Tominaga M; Funahashi T; Shimomura I. 2014. Adipose hypothermia in obesity and its association with period homolog 1, insulin sensitivity, and inflammation in fat. PLoS One 9(11):e112813. PubMed: 25397888 MGI: J:225142
Yamauchi T; Kamon J; Waki H; Imai Y; Shimozawa N; Hioki K; Uchida S; Ito Y; Takakuwa K; Matsui J; Takata M; Eto K; Terauchi Y; Komeda K; Tsunoda M; Murakami K; Ohnishi Y; Naitoh T; Yamamura K; Ueyama Y; Froguel P; Kimura S; Nagai R; Kadowaki T. 2003. Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis. J Biol Chem 278(4):2461-8. PubMed: 12431986 MGI: J:81727
Yan C; Chen J; Li M; Xuan W; Su D; You H; Huang Y; Chen N; Liang X. 2016. A decrease in hepatic microRNA-9 expression impairs gluconeogenesis by targeting FOXO1 in obese mice. Diabetologia 59(7):1524-32. PubMed: 27003684 MGI: J:235874
Yan S; Zhang Q; Zhong X; Tang J; Wang Y; Yu J; Zhou Y; Zhang J; Guo F; Liu Y; FitzGerald GA; Yu Y. 2014. I prostanoid receptor-mediated inflammatory pathway promotes hepatic gluconeogenesis through activation of PKA and inhibition of AKT. Diabetes 63(9):2911-23. PubMed: 24722246 MGI: J:229876
Yang G; Badeanlou L; Bielawski J; Roberts AJ; Hannun YA; Samad F. 2009. Central role of ceramide biosynthesis in body weight regulation, energy metabolism, and the metabolic syndrome. Am J Physiol Endocrinol Metab 297(1):E211-24. PubMed: 19435851 MGI: J:151166
Yang M; Sun J; Zhang T; Liu J; Zhang J; Shi MA; Darakhshan F; Guerre-Millo M; Clement K; Gelb BD; Dolgnov G; Shi GP. 2008. Deficiency and inhibition of cathepsin K reduce body weight gain and increase glucose metabolism in mice. Arterioscler Thromb Vasc Biol 28(12):2202-8. PubMed: 18818416 MGI: J:159791
Yang M; Zhang Y; Pan J; Sun J; Liu J; Libby P; Sukhova GK; Doria A; Katunuma N; Peroni OD; Guerre-Millo M; Kahn BB; Clement K; Shi GP. 2007. Cathepsin L activity controls adipogenesis and glucose tolerance. Nat Cell Biol 9(8):970-7. PubMed: 17643114 MGI: J:129484
Yang R; Sikka G; Larson J; Watts VL; Niu X; Ellis C; Miller K; Camara A; Reinke C; Savransky V; Polotsky VY; O'Donnell CP; Berkowitz DE; Barouch LA. 2011. Restoring Leptin Signaling Reduces Hyperlipidemia and Improves Vascular Stiffness Induced by Chronic Intermittent Hypoxia. Am J Physiol Heart Circ Physiol :. PubMed: 21278136 MGI: J:168540
Yang RY; Yu L; Graham JL; Hsu DK; Lloyd KC; Havel PJ; Liu FT. 2011. Ablation of a galectin preferentially expressed in adipocytes increases lipolysis, reduces adiposity, and improves insulin sensitivity in mice. Proc Natl Acad Sci U S A 108(46):18696-701. PubMed: 21969596 MGI: J:180097
Yang S; Lin HZ; Hwang J; Chacko VP; Diehl AM. 2001. Hepatic hyperplasia in noncirrhotic fatty livers: is obesity-related hepatic steatosis a premalignant condition? Cancer Res 61(13):5016-23. PubMed: 11431335 MGI: J:70169
Yang SQ; Lin HZ; Mandal AK; Huang J; Diehl AM. 2001. Disrupted signaling and inhibited regeneration in obese mice with fatty livers: implications for nonalcoholic fatty liver disease pathophysiology. Hepatology 34(4 Pt 1):694-706. PubMed: 11584365 MGI: J:106504
Yang X; Wang X; Liu D; Yu L; Xue B; Shi H. 2014. Epigenetic regulation of macrophage polarization by DNA methyltransferase 3b. Mol Endocrinol 28(4):565-74. PubMed: 24597547 MGI: J:213063
Ye H; Charpin-El Hamri G; Zwicky K; Christen M; Folcher M; Fussenegger M. 2013. Pharmaceutically controlled designer circuit for the treatment of the metabolic syndrome. Proc Natl Acad Sci U S A 110(1):141-6. PubMed: 23248313 MGI: J:192622
Ye J; Gao Z; Yin J; He Q. 2007. Hypoxia is a potential risk factor for chronic inflammation and adiponectin reduction in adipose tissue of ob/ob and dietary obese mice. Am J Physiol Endocrinol Metab 293(4):E1118-28. PubMed: 17666485 MGI: J:125547
Yeh JK; Evans JF; Niu QT; Aloia JF. 2006. A possible role for melanocortin peptides in longitudinal growth. J Endocrinol 191(3):677-86. PubMed: 17170224 MGI: J:116680
Yeh YS; Goto T; Takahashi N; Egawa K; Takahashi H; Jheng HF; Kim YI; Kawada T. 2016. Geranylgeranyl pyrophosphate performs as an endogenous regulator of adipocyte function via suppressing the LXR pathway. Biochem Biophys Res Commun 478(3):1317-22. PubMed: 27569282 MGI: J:239014
Yekollu SK; Thomas R; O'Sullivan B. 2011. Targeting curcusomes to inflammatory dendritic cells inhibits NF-kappaB and improves insulin resistance in obese mice. Diabetes 60(11):2928-38. PubMed: 21885868 MGI: J:189374
Yi CX; Tschop MH; Woods SC; Hofmann SM. 2012. High-fat-diet exposure induces IgG accumulation in hypothalamic microglia. Dis Model Mech 5(5):686-90. PubMed: 22381575 MGI: J:187483
Yi P; Park JS; Melton DA. 2013. Betatrophin: a hormone that controls pancreatic beta cell proliferation. Cell 153(4):747-58. PubMed: 23623304 MGI: J:197679
Yin J; Gao Z; He Q; Zhou D; Guo Z; Ye J. 2009. Role of hypoxia in obesity-induced disorders of glucose and lipid metabolism in adipose tissue. Am J Physiol Endocrinol Metab 296(2):E333-42. PubMed: 19066318 MGI: J:146063
Yin J; Lee JH; Zhang J; Gao Z; Polotsky VY; Ye J. 2014. Regulation of hepatocyte growth factor expression by NF-kappaB and PPARgamma in adipose tissue. Am J Physiol Endocrinol Metab 306(8):E929-36. PubMed: 24569592 MGI: J:212286
Yoon JC; Puigserver P; Chen G; Donovan J; Wu Z; Rhee J; Adelmant G; Stafford J; Kahn CR; Granner DK; Newgard CB; Spiegelman BM. 2001. Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1. Nature 413(6852):131-8. PubMed: 11557972 MGI: J:120036
Yoon JW; Leiter EH; Coleman DL; Kim MK; Pak CY; McArthur RG; Roncari DA. 1988. Genetic control of organ-reactive autoantibody production in mice by obesity (ob) diabetes (db) genes. Diabetes 37(9):1287-93. PubMed: 3044893 MGI: J:109940
Yoshihara E; Fujimoto S; Inagaki N; Okawa K; Masaki S; Yodoi J; Masutani H. 2010. Disruption of TBP-2 ameliorates insulin sensitivity and secretion without affecting obesity. Nat Commun 1:127. PubMed: 21119640 MGI: J:220940
Yoshimoto S; Loo TM; Atarashi K; Kanda H; Sato S; Oyadomari S; Iwakura Y; Oshima K; Morita H; Hattori M; Honda K; Ishikawa Y; Hara E; Ohtani N. 2013. Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome. Nature 499(7456):97-101. PubMed: 23803760 MGI: J:204711
Yu Y; Liu Y; Shi FD; Zou H; Matarese G; La Cava A. 2013. Cutting Edge: Leptin-Induced RORgammat Expression in CD4+ T Cells Promotes Th17 Responses in Systemic Lupus Erythematosus. J Immunol 190(7):3054-8. PubMed: 23447682 MGI: J:194839
Yuan M; Konstantopoulos N; Lee J; Hansen L; Li ZW; Karin M; Shoelson SE. 2001. Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta. Science 293(5535):1673-7. PubMed: 11533494 MGI: J:94827
Zachariah Tom R; Garcia-Roves PM; Sjogren RJ; Jiang LQ; Holmstrom MH; Deshmukh AS; Vieira E; Chibalin AV; Bjornholm M; Zierath JR. 2014. Effects of AMPK activation on insulin sensitivity and metabolism in leptin-deficient ob/ob mice. Diabetes 63(5):1560-71. PubMed: 24487023 MGI: J:229353
Zhang CY; Baffy G; Perret P; Krauss S; Peroni O; Grujic D; Hagen T; Vidal-Puig AJ; Boss O; Kim YB; Zheng XX; Wheeler MB; Shulman GI; Chan CB; Lowell BB. 2001. Uncoupling protein-2 negatively regulates insulin secretion and is a major link between obesity, beta cell dysfunction, and type 2 diabetes. Cell 105(6):745-55. PubMed: 11440717 MGI: J:75196
Zhang D; Li Y; Yao X; Wang H; Zhao L; Jiang H; Yao X; Zhang S; Ye C; Liu W; Cao H; Yu S; Wang YC; Li Q; Jiang J; Liu Y; Zhang L; Liu Y; Iwai N; Wang H; Li J; Li J; Li X; Jin ZB; Ying H. 2016. miR-182 Regulates Metabolic Homeostasis by Modulating Glucose Utilization in Muscle. Cell Rep 16(3):757-68. PubMed: 27396327 MGI: J:238680
Zhang F; Dey D; Branstrom R; Forsberg L; Lu M; Zhang Q; Sjoholm A. 2009. BLX-1002, a novel thiazolidinedione with no PPAR affinity, stimulates AMP-activated protein kinase activity, raises cytosolic Ca2+, and enhances glucose-stimulated insulin secretion in a PI3K-dependent manner. Am J Physiol Cell Physiol 296(2):C346-54. PubMed: 19052259 MGI: J:146323
Zhang H; Shen WJ; Cortez Y; Kraemer FB; Azhar S. 2013. Nordihydroguaiaretic acid improves metabolic dysregulation and aberrant hepatic lipid metabolism in mice by both PPARalpha-dependent and -independent pathways. Am J Physiol Gastrointest Liver Physiol 304(1):G72-86. PubMed: 23104557 MGI: J:194703
Zhang J; Li L; Li J; Liu Y; Zhang CY; Zhang Y; Zen K. 2015. Protein tyrosine phosphatase 1B impairs diabetic wound healing through vascular endothelial growth factor receptor 2 dephosphorylation. Arterioscler Thromb Vasc Biol 35(1):163-74. PubMed: 25395617 MGI: J:236588
Zhang J; Nakatsu Y; Shinjo T; Guo Y; Sakoda H; Yamamotoya T; Otani Y; Okubo H; Kushiyama A; Fujishiro M; Fukushima T; Tsuchiya Y; Kamata H; Iwashita M; Nishimura F; Katagiri H; Takahashi S; Kurihara H; Uchida T; Asano T. 2013. Par14 protein associates with insulin receptor substrate 1 (IRS-1), thereby enhancing insulin-induced IRS-1 phosphorylation and metabolic actions. J Biol Chem 288(28):20692-701. PubMed: 23720771 MGI: J:201792
Zhang L; Song NN; Chen JY; Huang Y; Li H; Ding YQ. 2012. Satb2 is required for dendritic arborization and soma spacing in mouse cerebral cortex. Cereb Cortex 22(7):1510-9. PubMed: 21885532 MGI: J:198550
Zhang LL; Yan Liu D; Ma LQ; Luo ZD; Cao TB; Zhong J; Yan ZC; Wang LJ; Zhao ZG; Zhu SJ; Schrader M; Thilo F; Zhu ZM; Tepel M. 2007. Activation of transient receptor potential vanilloid type-1 channel prevents adipogenesis and obesity. Circ Res 100(7):1063-70. PubMed: 17347480 MGI: J:133914
Zhang P; O'Loughlin L; Brindley DN; Reue K. 2008. Regulation of lipin-1 gene expression by glucocorticoids during adipogenesis. J Lipid Res 49(7):1519-28. PubMed: 18362392 MGI: J:138464
Zhang W; Lilja L; Mandic SA; Gromada J; Smidt K; Janson J; Takai Y; Bark C; Berggren PO; Meister B. 2006. Tomosyn is expressed in beta-cells and negatively regulates insulin exocytosis. Diabetes 55(3):574-81. PubMed: 16505218 MGI: J:106861
Zhang W; Wang P; Chen S; Zhang Z; Liang T; Liu C. 2016. Rhythmic expression of miR-27b-3p targets the clock gene Bmal1 at the posttranscriptional level in the mouse liver. FASEB J 30(6):2151-60. PubMed: 26919869 MGI: J:239355
Zhang X; Zhang G; Zhang H; Karin M; Bai H; Cai D. 2008. Hypothalamic IKKbeta/NF-kappaB and ER stress link overnutrition to energy imbalance and obesity. Cell 135(1):61-73. PubMed: 18854155 MGI: J:149873
Zhang Y; Gan Z; Huang P; Zhou L; Mao T; Shao M; Jiang X; Chen Y; Ying H; Cao M; Li J; Li J; Zhang WJ; Yang L; Liu Y. 2012. A role for protein inhibitor of activated STAT1 (PIAS1) in lipogenic regulation through SUMOylation-independent suppression of liver X receptors. J Biol Chem 287(45):37973-85. PubMed: 22969086 MGI: J:192963
Zhang Y; Proenca R; Maffei M; Barone M; Leopold L; Friedman JM. 1994. Positional cloning of the mouse obese gene and its human homologue [published erratum appears in Nature 1995 Mar 30;374(6521):479] [see comments] Nature 372(6505):425-32. PubMed: 7984236 MGI: J:20512
Zhang Z; Turer E; Li X; Zhan X; Choi M; Tang M; Press A; Smith SR; Divoux A; Moresco EM; Beutler B. 2016. Insulin resistance and diabetes caused by genetic or diet-induced KBTBD2 deficiency in mice. Proc Natl Acad Sci U S A 113(42):E6418-E6426. PubMed: 27708159 MGI: J:236520
Zhi Z; Chao JR; Wietecha T; Hudkins KL; Alpers CE; Wang RK. 2014. Noninvasive imaging of retinal morphology and microvasculature in obese mice using optical coherence tomography and optical microangiography. Invest Ophthalmol Vis Sci 55(2):1024-30. PubMed: 24458155 MGI: J:229286
Zhou L; Park SY; Xu L; Xia X; Ye J; Su L; Jeong KH; Hur JH; Oh H; Tamori Y; Zingaretti CM; Cinti S; Argente J; Yu M; Wu L; Ju S; Guan F; Yang H; Choi CS; Savage DB; Li P. 2015. Insulin resistance and white adipose tissue inflammation are uncoupled in energetically challenged Fsp27-deficient mice. Nat Commun 6:5949. PubMed: 25565658 MGI: J:219747
Zhou X; Benson KF; Ashar HR; Chada K. 1995. Mutation responsible for the mouse pygmy phenotype in the developmentally regulated factor HMGI-C [see comments] Nature 376(6543):771-4. PubMed: 7651535 MGI: J:28571
Zhu X; Chung S; Bi X; Chuang CC; Brown AL; Liu M; Seo J; Cuffe H; Gebre AK; Boudyguina E; Parks JS. 2013. Myeloid cell-specific ABCA1 deletion does not worsen insulin resistance in HF diet-induced or genetically obese mouse models. J Lipid Res 54(10):2708-17. PubMed: 23894207 MGI: J:202623
Ziouzenkova O; Orasanu G; Sharlach M; Akiyama TE; Berger JP; Viereck J; Hamilton JA; Tang G; Dolnikowski GG; Vogel S; Duester G; Plutzky J. 2007. Retinaldehyde represses adipogenesis and diet-induced obesity. Nat Med 13(6):695-702. PubMed: 17529981 MGI: J:121870
Zyromski NJ; Mathur A; Pitt HA; Lu D; Gripe JT; Walker JJ; Yancey K; Wade TE; Swartz-Basile DA. 2008. A murine model of obesity implicates the adipokine milieu in the pathogenesis of severe acute pancreatitis. Am J Physiol Gastrointest Liver Physiol 295(3):G552-8. PubMed: 18583460 MGI: J:141913
van der Meulen T; Donaldson CJ; Caceres E; Hunter AE; Cowing-Zitron C; Pound LD; Adams MW; Zembrzycki A; Grove KL; Huising MO. 2015. Urocortin3 mediates somatostatin-dependent negative feedback control of insulin secretion. Nat Med 21(7):769-76. PubMed: 26076035 MGI: J:224754
van der Velde M; van der Eerden BC; Sun Y; Almering JM; van der Lely AJ; Delhanty PJ; Smith RG; van Leeuwen JP. 2012. An age-dependent interaction with leptin unmasks ghrelin's bone-protective effects. Endocrinology 153(8):3593-602. PubMed: 22700774 MGI: J:189083
von Meyenn F; Porstmann T; Gasser E; Selevsek N; Schmidt A; Aebersold R; Stoffel M. 2013. Glucagon-induced acetylation of Foxa2 regulates hepatic lipid metabolism. Cell Metab 17(3):436-47. PubMed: 23416070 MGI: J:198161

Genetic overview

Research Applications

Base Price

Detailed Description

Control Suggestions

Additional Information

Selected References

Lepob

Allele Symbol: Lepob

Disease Terms

Research Areas By Genotype

This mouse can be used to support research in many areas including:

Genotype: Lepob related

Mammalian Phenotype Terms by Genotype

Genotype: Lepob/LepobBKS.Cg-Lepob/J

mortality/aging

growth/size/body region phenotype

homeostasis/metabolism phenotype

endocrine/exocrine gland phenotype

renal/urinary system phenotype

Genotype: Lepob/Lep+involves: C57BL/6J

skeleton phenotype

Genotype: Lepob/Lep+involves: 129X1/SvJ * C57BL/6

liver/biliary system phenotype

Genotype: Lepob/LepobB6.Cg-Lepob/J

growth/size/body region phenotype

renal/urinary system phenotype

immune system phenotype

neoplasm

hematopoietic system phenotype

nervous system phenotype

liver/biliary system phenotype

integument phenotype

skeleton phenotype

homeostasis/metabolism phenotype

cardiovascular system phenotype

muscle phenotype

adipose tissue phenotype

behavior/neurological phenotype

reproductive system phenotype

respiratory system phenotype

endocrine/exocrine gland phenotype

Genotype: Lepob/LepobB6.Cg-Lepob/JRj

cellular phenotype

liver/biliary system phenotype

Genotype: Lepob/LepobB6.Cg-Lepob/OlaHsd

digestive/alimentary phenotype

immune system phenotype

liver/biliary system phenotype

Genotype: Lepob/Lepobinvolves: 129/Sv * C57BL/6

homeostasis/metabolism phenotype

endocrine/exocrine gland phenotype

behavior/neurological phenotype

growth/size/body region phenotype

adipose tissue phenotype

liver/biliary system phenotype

Genotype: Lepob/LepobBTBR.Cg-Lepob/WiscJ

cardiovascular system phenotype

growth/size/body region phenotype

homeostasis/metabolism phenotype

renal/urinary system phenotype

endocrine/exocrine gland phenotype

Genotype: Lepob/Lepobinvolves: STOCK Mlphln a Tgfawa1 Cdh23v Ednrbs

growth/size/body region phenotype

cardiovascular system phenotype

immune system phenotype

limbs/digits/tail phenotype

embryo phenotype

hematopoietic system phenotype

liver/biliary system phenotype

behavior/neurological phenotype

homeostasis/metabolism phenotype

endocrine/exocrine gland phenotype

adipose tissue phenotype

skeleton phenotype

reproductive system phenotype

nervous system phenotype

Genotype: Lepob/Lepobinvolves: 129X1/SvJ * C57BL/6

growth/size/body region phenotype

integument phenotype

Lep^ob

Allele Symbol: Lep^ob

Genotype: Lep^ob related

Genotype: Lep^ob/Lep^ob
BKS.Cg-Lep^ob/J

Genotype: Lep^ob/Lep⁺
involves: C57BL/6J

Genotype: Lep^ob/Lep⁺
involves: 129X1/SvJ * C57BL/6

Genotype: Lep^ob/Lep^ob
B6.Cg-Lep^ob/J

Genotype: Lep^ob/Lep^ob
B6.Cg-Lep^ob/JRj

Genotype: Lep^ob/Lep^ob
B6.Cg-Lep^ob/OlaHsd

Genotype: Lep^ob/Lep^ob
involves: 129/Sv * C57BL/6

Genotype: Lep^ob/Lep^ob
BTBR.Cg-Lep^ob/WiscJ

Genotype: Lep^ob/Lep^ob
involves: STOCK Mlph^ln a Tgfa^wa1 Cdh23^v Ednrb^s

Genotype: Lep^ob/Lep^ob
involves: 129X1/SvJ * C57BL/6

Genotype: Lep^ob/Lep^ob
involves: BTBR * C57BL/6 * V stock

Genotype: Lep^ob/Lep^ob
involves: C57BL/6J

Genotype: Lep^ob/Lep^ob
BTBR.Cg-Lep^ob

Genotype: Lep^ob/Lep^ob
FVB.Cg-Lep^ob/Chua

Genotype: Lep^ob/Lep^ob
involves: C57BL/6

Genotype: Lep^ob/Lep^ob
B6.Cg-Lep^ob/JBomTac

Genotype: Lep^ob/Lep^ob
D2.Cg-Lep^ob/Chua

Additional - Lep^ob related